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Abstract 
The overall objectives of the current dissertation were to 1) establish the neural 
coding principles employed by the sympathetic nervous system (SNS) in response to acute 
physiological stress; and 2) to determine the various mechanisms of control underlying these 
sympathetic neural recruitment strategies. This research tested the working hypothesis that 
efferent post-ganglionic muscle sympathetic nerve activity exhibits neural coding patterns 
reflecting increased firing of lower-threshold axons, recruitment of latent sub-populations of 
higher-threshold axons, as well as malleable synaptic delays, and further, that these strategies 
are governed by factors such as reflex-specificity, stress severity, perception of effort or 
stress, age, and cardiovascular disease. Specifically, we utilized a novel signal processing 
approach to study sympathetic action potential discharge patterning during periods of acute 
reflex-mediated sympathoexcitation. Overall, these studies support the working hypothesis 
and confirm that neural coding principles operate within the SNS. Specifically, in response to 
acute homeostatic perturbation, the SNS has options to increase the firing rate of already-
active, lower-threshold axons, recruit sub-populations of previously silent (i.e., not present at 
baseline), larger-sized and faster conducting sympathetic axons, as well as modify acutely 
synaptic delays. Study 1 demonstrated that the ability to recruit latent neural sub-populations 
represents a fixed, reflex-independent recruitment strategy, as this pattern was observed 
during chemoreflex- and baroreflex-mediated sympathoexcitation. In turn, this option 
appears reserved for severe stress scenarios. Furthermore, study 2 suggests that central, 
perceptual features may play a specific role in modifying the synaptic delay aspect of efferent 
discharge timing, whereas peripheral-reflex mechanisms mediate the recruitment of latent 
axons. Study 3 demonstrates that, while the ability to acutely modify synaptic delays appears 
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preserved, the ability to increase firing frequency of already-active axons, and importantly, 
the capacity of the SNS to recruit latent sub-populations of higher-threshold axons are 
reduced with healthy aging and perhaps lost altogether with cardiovascular disease. Finally, 
study 4 suggests that the lack of ventilation itself, rather than the ever-increasing chemical 
drive, mediates the robust sympathetic neural recruitment observed during apnea. In 
conclusion, the series of studies contained herein confirm the presence of neural coding 
patterns in human efferent post-ganglionic sympathetic nerve activity. 
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Chapter 1  
1 Introduction 
1.1 Overview 
The foundation of ‘integrative physiology’ as we know it today may well be 
rooted in the seminal workings of Claude Bernard (1813-1878), a French physiologist 
who noted, “…all of the vital mechanisms, however varied they may be, have always 
one goal, to maintain the uniformity of the conditions of life in the internal environment 
[milieu intérieur]…the constancy of the internal environment is the condition for free 
and independent life…” (Bernard, 1974). In this sense, the concept of ‘homeostasis’, a 
fundamental principle of physiology, was born, the term being devised sometime later 
by Walter B. Cannon (1871-1945), an American physiologist (Cannon, 1929). 
Homeostasis, therefore, represents the tendency of an organism to regulate its internal 
stability, owing largely to a coordinated system of feedback controls, so as to stabilize 
its health and functioning in the face of external challenge. As such, the concept of 
‘homeostasis’ has become somewhat synonymous with the domain of ‘physiology’. In 
this regard, a full understanding of, and appreciation for, the integrative regulation and 
functioning (i.e., physiology) of the human body, requires that integrative physiologists 
break down the individual phenomena, or ‘parts’, that together constitute the existence 
of living beings.  
 Certainly, the autonomic nervous system (ANS), and especially, its sympathetic 
division, is of fundamental importance in both the short- and long-term regulation and 
maintenance of the cardiovascular system in humans. Indeed, the bidirectional 
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relationship that exists between autonomic dysregulation and numerous cardiovascular 
disease-related pathologies represents perhaps the best evidence for the fundamental 
role played by the ANS in maintaining cardiovascular homeostasis (Esler, 2010; 
Malpas, 2010). For example, sympathetic nervous system (SNS) dysregulation 
represents a hallmark of, among others, essential hypertension (Grassi et al. 2010; 
Parati & Esler, 2012), coronary artery disease (CAD) (Graham et al. 2002; Graham et 
al. 2004), heart failure (Floras, 2009; Triposkiadis et al. 2009), obstructive sleep apnea 
(Somers et al. 1995; Narkiewicz & Somers, 2003), and even, increasing age (Seals & 
Esler, 2000). Therefore, as mentioned above, a thorough understanding of the 
pathophysiology of these (or any) disease and/or aging process requires the careful 
study of the individual ‘parts’ that together comprise the dysfunctional system. But 
first, one must understand the ‘normal’ processes in health.  
 The SNS represents a major medium through which homeostatic adjustments to 
stress are achieved, occurring mostly as a result of its vasoconstrictor actions, and thus, 
control of blood pressure and distribution of blood flow (Shoemaker et al. 2016). This 
process has been largely referred to as sympathetic neural control of the circulation. In 
brief, sympathetic neural control involves central integration of sensory afferent and 
cortical/subcortical signals within the brainstem autonomic nuclei and spinal cord 
(Barman & Gebber, 2000), synapses at peripheral sympathetic ganglia (Jänig & 
McLachlan, 1992), efferent post-ganglionic nerve activity, neurotransmitter release, and 
ultimately, the end-organ effect (Shoemaker et al. 2016). As such, each of these 
individual junctures, or ‘parts’, offer unique sites of control in which sympathetic 
outflow can be coded and modified in response to homeostatic challenge. The focus of 
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the series of studies in this dissertation is on the patterns of sympathetic neural coding 
and the recruitment strategies used by the efferent SNS to increase sympathetic drive in 
the face of physiological stress. 
 Indeed, patterns of neural coding form the basis of all stimulus-response 
processes requiring exchange and processing of neural information. Specifically, these 
can include variations in the frequency or rate of neuron firing (i.e., rate coding), 
recruitment of additional, higher-threshold neurons (i.e., population coding), as well as 
variations in the timing of activity amongst neurons (i.e., temporal coding). To date, 
limited access to direct neural recordings in humans, as well as technological 
limitations, have precluded a definitive understanding of the neural coding principles 
used by the ANS, as opposed to more well-known and defined patterns in other 
peripheral organ systems. For example, rate- and population coding patterns exist in the 
somatic nervous system during the generation of ever-increasing muscular contraction 
force (i.e., Henneman’s size principle) (Henneman et al. 1965). However, whether the 
SNS operates in a similar manner remains largely unknown.  
 With the introduction of the microneurographic technique (Hagbarth & Vallbo, 
1968; Vallbo et al. 2004), direct neural recordings from the populations of post-
ganglionic sympathetic axons innervating the skeletal muscle vasculature (i.e., muscle 
sympathetic nerve activity; MSNA) are possible in humans. Indeed, this tool has proven 
instrumental in understanding sympathetic neural control of the circulation in both 
health and disease (Wallin & Charkoudian, 2007; Charkoudian & Rabbitts, 2009; 
Shoemaker et al. 2016; Joyner et al. 2015). Traditionally, due to an inherently noisy 
signal, analysis of this multi-fibre MSNA signal has been largely constrained to the 
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integrated neurogram that exposes the timing and location of sympathetic ‘bursts’ that, 
in turn, reflect periods of efferent action potential (AP) synchronization (i.e., 
sympathetic APs firing more or less at the same time) (Delius et al. 1972). Nonetheless, 
inferences regarding central neural recruitment strategies have been drawn from the 
integrated MSNA neurogram. That is, early observations that larger integrated 
sympathetic bursts expressed shorter reflex latencies (i.e., faster neural conduction 
rates) led Wallin et al. (1994) to hypothesize that potential may exist for malleable 
synaptic delays and/or the ability to recruit sub-populations of neurons with varying 
recruitment thresholds and conduction velocities. Indeed, the strength of any given 
burst reflects both the number (Ninomiya et al. 1993) and size (Salmanpour et al. 
2011a) of axons recruited within that burst. Therefore, variations in the strength (i.e., 
size) of sympathetic bursts represent the discharge patterns used by the SNS to elevate 
efferent neural drive. In this regard, these axonal recruitment patterns ultimately 
represent the strategies used by the central nervous system (CNS) to fine-tune efferent 
sympathetic nerve activity and control the cardiovascular system, and, by extension, 
maintain homeostasis.  
 With the use of these features, the concept of neural coding in the SNS was 
advanced by Macefield et al. (1994) with the introduction of single-axon sympathetic 
recordings. These data indicated that, when active, a given axon will fire generally once 
per integrated sympathetic burst at rest (Macefield et al. 1994; Macefield & Wallin, 
1999), but perhaps more (i.e., two to three times) during periods of acute (Macefield & 
Wallin, 1999; Elam & Macefield, 2001; Murai et al. 2006) or chronic (Elam et al. 2002; 
Ashley et al. 2010) sympathoexcitation. However, information regarding the 
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populations of axons available for recruitment, and therefore, the neural recruitment 
strategies available to the SNS to alter efferent outflow, cannot be extracted from 
single-unit recordings, but instead require a multi-unit approach.  
Recently, technological advancements have been made that allow for the 
extraction, quantification, and morphological classification of the populations of 
sympathetic APs comprising each integrated MSNA burst (Salmanpour et al. 2010). 
With the use of this approach, Steinback et al. (2010b) reported increased firing rates of 
axons already-active at baseline, as well as recruitment of previously silent (i.e., not 
active at baseline) sub-populations of larger-sized, faster conducting sympathetic axons 
during voluntary apnea-induced sympathoexcitation. In contrast, recruitment of latent 
neural sub-populations was not observed during baroreceptor unloading induced via 
−60 mmHg lower body negative pressure (LBNP) (Salmanpour et al. 2011a). In this 
scenario, increases in sympathetic outflow were achieved through increased firing rate 
of axons already-active at baseline. The reasons for the observed difference in 
recruitment patterns between studies are unknown, but could involve varying thresholds 
for recruitment of these latent axons (i.e., stress severity), interindividual variability, 
and/or reflex-specific neural recruitment strategies. Therefore, additional data are 
needed, in the same individuals, on the reflex-specific neural recruitment strategies 
available to the SNS to alter efferent post-ganglionic outflow in response to physiologic 
stress. This background formed the rationale for Study 1 of this dissertation. Briefly, 
sympathetic neural recruitment strategies were studied during both chemoreflex- (i.e., 
as inferred from voluntary apnea) and baroreflex- (i.e., −80 mmHg LBNP) mediated 
sympathoexcitation in the same individuals.  
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Furthermore, in preliminary studies, Salmanpour et al. (2011b) demonstrated an 
acute downward shift in the AP cluster size-latency relationship during reflex-mediated 
stress. That is, all APs at baseline displayed shorter reflex latency during a subsequent 
Valsalva maneuver, providing evidence perhaps for the possibility of acute synaptic 
delay modifications somewhere within the reflex pathway, as previously hypothesized 
(Wallin et al. 1994). However, in addition to reflex-specific recruitment strategies, a 
persistent question remains, particularly with the apnea data (Steinback et al. 2010b; 
Breskovic et al. 2011), as to whether or not these neural coding patterns are influenced 
by a central (i.e., perception of effort or stress) phenomena, or by the reflex stress itself 
(i.e., a peripheral-reflex mechanism). Specifically, voluntary apnea and the Valsalva 
maneuver, as opposed to lower body suction, exhibit a certain level of volitional stress 
that is likely related to perception of effort or stress and/or individual tolerance for the 
maneuver. As such, the exact central versus peripheral elements of these sympathetic 
neural coding principles requires investigation. This background formed the rationale 
for Study 2 of this dissertation, in which sympathetic neural recruitment patterns were 
investigated during fatiguing static handgrip (SHG) exercise and a subsequent period of 
post-exercise circulatory occlusion (PECO). Specifically, this model (i.e., exercise 
pressor reflex) was used as the physiologic response to fatiguing exercise (and PECO) 
represents a unique scenario in which the central and peripheral features of the reflex 
can be studied separately as they occur over time.  
Furthermore, the majority of studies to date have investigated young, healthy 
populations, and therefore, the malleability of these recruitment strategies with 
increasing age and cardiovascular disease remains unknown. As such, this formed the 
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rationale for Study 3 of this dissertation. Briefly, CAD patients completed maximal 
voluntary apneas, which served as a stimulus for sympathoexcitation, and neural 
recruitment patterns were compared to that of young healthy and older healthy 
individuals to account for the concurrent effect of age.  
Finally, while voluntary apnea appears to provide the most powerful stimulus 
for sympathetic axonal recruitment (Steinback et al. 2010b), the exact mechanisms 
mediating this robust sympathetic response are uncertain and appear diverse. 
Specifically, the roles played by ventilation (or the lack thereof in the case of apnea) 
versus the chemoreflex activation itself in eliciting the recruitment response are 
unknown. This formed the rationale for Study 4 of this dissertation, in which 
sympathetic neural discharge patterns were studied during prolonged voluntary apnea 
(i.e., absence of ventilation) and during asphyxic rebreathing (i.e., presence of 
ventilation) in trained breath-hold divers. In this sense, we studied the dissociated 
influences of chemoreceptor stimuli (i.e., hypoxia and hypercapnia) and ventilation on 
sympathetic AP recruitment patterns during varying levels of high chemoreflex stress. 
As such, the overall objectives of the research contained herein are to 1) 
Establish the neural coding principles employed by the SNS in response to acute 
physiological (i.e., homeostatic) stress; and 2) To determine the various mechanisms of 
control underlying these sympathetic neural recruitment strategies. The working 
hypothesis to be tested is that efferent post-ganglionic MSNA exhibits neural coding 
patterns reflecting increased firing rates of lower-threshold axons, latent sub-
populations of higher-threshold axons, as well as malleable synaptic delays and/or 
central processing times, and further, that these are modified by factors such as reflex-
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specificity, stress severity, perception of effort or stress, age, and cardiovascular 
disease.  
Study 1. Sympathetic neural recruitment strategies: responses to severe 
chemoreflex and baroreflex stress 
Objective: To test the hypothesis that neural coding strategies exist within the SNS 
and to determine reflex-specific neural recruitment strategies during severe 
chemoreflex- and baroreflex-mediated stress. 
Study 2. Central vs. peripheral determinants of sympathetic neural recruitment: 
insights from static handgrip exercise and postexercise circulatory occlusion 
Objective: To investigate the varying roles played by central versus peripheral 
elements in the control of sympathetic neural recruitment during acute physiological 
stress. 
Study 3. Effects of aging and coronary artery disease on sympathetic neural 
recruitment strategies during end-inspiratory and end-expiratory apnea 
Objective: To test the hypothesis that cardiovascular disease impairs sympathetic 
neural recruitment. 
Study 4. Ventilation inhibits sympathetic action potential recruitment even during 
severe chemoreflex stress 
Objective: To determine the influence of ventilation on sympathetic neural 
recruitment during varying levels of high chemoreflex stress. 
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1.2 Autonomic Nervous System 
The ANS represents a highly complex, multi-faceted neural network that, in an 
involuntary manner (i.e., without conscious control), maintains and controls most 
visceral organs within the body’s internal environment. In this sense, the ANS 
coordinates numerous bodily functions and is critical to the maintenance of physiologic 
homeostasis, and by extension, many life-sustaining outcomes. Of great importance, 
and a focus of this dissertation, is the ANS control of the cardiovascular system, 
occurring largely through the reflexive regulation of blood pressure and distribution of 
blood flow (Shoemaker et al. 2016). In this sense, these variables are tonically, and 
reflexively, regulated to ensure adequate perfusion and delivery of oxygen throughout 
the body in an attempt to meet the metabolic demands of all organs and tissues. 
Specifically, the ANS is comprised of two main branches; that is, the parasympathetic 
nervous system (PNS) and the SNS. The PNS and SNS function antagonistically, 
synergistically, and/or independently to regulate cardiovascular function, among other 
effector systems, both at rest and in the face of physiological perturbation. Importantly, 
dysregulation of the ANS represents the basis for, or a consequence of, many chronic 
cardiovascular disease-related pathologies (Somers et al. 1995; Narkiewicz & Somers, 
2003; Floras, 2009; Esler, 2010; Grassi et al. 2010; Malpas, 2010; Parati & Esler, 
2012), highlighting its fundamental role in homeostatic cardiovascular control. Thus, an 
appreciation for, and thorough understanding of, the intricate nature of autonomic 
neural control in both health and disease represents a critical endeavor in the 
understanding of ‘normal’ homeostatic mechanisms, as well as the pathophysiological 
basis of many chronic disease states. 
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1.2.1 Parasympathetic Nervous System 
The PNS involves a two-neuron efferent system with pre-ganglionic neurons 
situated in the CNS and post-ganglionic neurons located at peripheral ganglia (Shields, 
1993). The PNS consists of long, myelinated or unmyelinated pre-ganglionic fibres that 
synapse onto unmyelinated post-ganglionic fibres near or within the target organ 
(Wehrwein et al. 2016). In general, cell bodies of PNS pre-ganglionic fibres originate 
within regions of the brainstem, as well as in the sacral spinal cord (Wehrwein et al. 
2016). Within these regions, the oculomotor (CN III), facial (CN VII), 
glossopharyngeal (CN IX), and vagus (CN X) nerves form the pre-ganglionic 
parasympathetic nerves which, in turn, synapse with post-ganglionic neurons through 
the binding of acetylcholine (ACh) onto nicotinic cholinergic receptors (Shields, 1993; 
Wehrwein et al. 2016). With respect to cardiac function, PNS control is mediated via 
the vagus nerve through the binding of ACh onto muscarinic receptors located within 
the heart (Brodde & Michel, 1999). Although several subtypes of muscarinic receptors 
have been identified (Brodde & Michel, 1999), the predominant receptor found in the 
human heart is the M2 receptor subtype (Peralta et al. 1987; Hulme et al. 1990). In 
brief, activation of M2 receptors via ACh binding, coupling to an inhibitory G-protein, 
leads to inhibition of adenylate cyclase activity, which subsequently inhibits 
intracellular cyclic adenosine monophosphate (cAMP), resulting in decreased 
intracellular calcium (Ca2+) levels. Furthermore, binding of ACh to M2 receptors causes 
increased outward, hyperpolarizing potassium (K+) currents, which decreases sinoatrial 
node firing rate and slows conduction within the atrioventricular node. Therefore, the 
net result of vagal (i.e., PNS) stimulation of the heart is reduced cardiac contractility 
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and conduction velocity, and importantly, decreased heart rate. While the importance of 
parasympathetic neural control of the circulation cannot be understated, its effects are 
limited to the heart, and therefore, cardiac function, whereas the SNS innervates the 
heart, blood vessels, and other visceral organs to provide widespread control of cardiac 
and vascular function. In this sense, the SNS exerts considerable control over 
cardiovascular homeostasis. Thus, neuro-circulatory control in the context of the SNS, 
and more specifically, sympathetic neural control of the vasculature, represents the 
focus of this dissertation.  
1.2.2 Sympathetic Nervous System 
Similar to the PNS, the peripheral elements of the SNS also operate via a two-
neuron efferent system to effectively modulate homeostatic cardiovascular control; that 
is, short, myelinated pre-ganglionic neurons originating in the CNS synapse with post-
ganglionic neurons located at peripheral ganglia, whose long, unmyelinated axons 
travel to visceral targets within the periphery to exert appropriate end-organ responses 
(Shields, 1993; Wehrwein et al. 2016). Specifically, the cell bodies of SNS pre-
ganglionic neurons lie in the intermediolateral (IML) cell column within the first 
thoracic to the first two lumbar regions of the spinal cord (i.e., T1-L2) (Shields, 1993). 
Here, the SNS pre-ganglionic fibres exit via the ventral root to form the white rami, 
where they synapse with post-ganglionic neurons within prevertebral ganglia and/or 
paravertebral ganglia located at the sympathetic chains (Wehrwein et al. 2016). At 
these peripheral ganglia, pre-ganglionic neurons release ACh, which binds to nicotinic 
cholinergic receptors located on post-ganglionic neuron cell-bodies which, in turn, 
stimulates an AP in the post-ganglionic neuron. The AP descends along the axon until it 
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reaches the distal end of the neuron. Sympathetic post-ganglionic axons that innervate 
cardiovascular tissue (i.e., cardiac and vascular smooth muscle) branch extensively, 
coming into close contact with several regional effector cells. Here, sympathetic post-
ganglionic fibres become beaded with enlargements known as varicosities, in which 
they release their neurotransmitters from. Specifically, once the AP arrives at the 
varicosity, the ensuing depolarization initiates the opening of voltage-gated Ca2+ 
channels, resulting in an influx of Ca2+ and the exocytosis of synaptic vesicles 
containing neurotransmitters. Sympathetic post-ganglionic neurons release several 
neurotransmitters, including norepinephrine (NE), neuropeptide Y (NPY), and 
adenosine triphosphate (ATP) (Burnstock, 1990; Lundberg et al. 1990) that, in turn, 
stimulate receptors located on the effector organs and tissues, as described below. 
Additionally, sympathetic pre-ganglionic fibres can also travel to the medullary portion 
of the adrenal gland, where they release ACh onto nicotinic cholinergic receptors 
located on chromaffin cells. In this scenario, the adrenal medulla releases NE and 
epinephrine, in an approximate 1:4 ratio (Jänig, 2008), into the circulation, where they 
can bind to receptors located on effector targets.  
Of importance to neuro-cardiovascular control are receptors located at the heart, 
and perhaps more importantly, on smooth muscle cells of the vasculature within 
skeletal muscle and other visceral organs. Briefly, at the heart, NE and epinephrine bind 
to β1- and β2-adrenergic receptors, which, through a stimulatory G-protein, activates 
adenylate cyclase, thereby catalyzing the conversion of ATP to cAMP. This causes 
increases in cAMP-dependent protein-kinase A activity, thus activating L-type Ca2+ 
channels. The net result is increased intracellular Ca2+ levels, and thus, increased heart 
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rate and cardiac contractility. Within blood vessels, neurally released NE and 
epinephrine bind to α1-adrenergic receptors which, through a Gq-protein, stimulates 
phospholipase C, leading to the formation of inositol triphosphate and diacylglycerol, 
and, in turn, increased intracellular Ca2+ and protein kinase C activation, respectively. 
The rise in Ca2+ activates calmodulin-dependent myosin light chain kinase to increase 
myosin ATPase activity, causing myosin and actin binding, and therefore, vascular 
smooth muscle contraction. Therefore, the net result is overall vasoconstriction. 
Similarly, activation of α2-adrenergic receptors via NE binding is coupled to an 
inhibitory G-protein which inhibits adenylate cyclase and decreases cAMP levels. 
Briefly, this causes less myosin light chain kinase inhibition and greater intracellular 
Ca2+ levels. Again, the net result is vasoconstriction. In addition to NE, as mentioned 
above, vascular sympathetic nerves also co-release NPY and ATP (Burnstock, 1990; 
Lundberg et al. 1990). Both neurotransmitters can cause net vasoconstriction through 
the activation of NPY Y1 receptors, via NPY, and purinergic P2X1 receptors, via ATP, 
which act to increase intracellular Ca2+ levels, and therefore, vascular smooth muscle 
contraction. The release of these co-transmitters and the subsequent contribution to the 
functional sympathetic vasoconstrictor response may ultimately depend on the 
patterning and rate of sympathetic discharge that, in turn, likely exerts important 
influences on end-organ homeostatic stress responses (Huidobro-Toro & Donoso, 
2004). In this sense, technological advancements allowing for direct recordings of 
sympathetic post-ganglionic vasoconstrictor discharge (i.e., microneurography; 
described in detail later) has initiated an exciting era of research with respect to 
sympathetic neurovascular control. 
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1.3 Sympathetic Neural Control of the Circulation 
Overall, the concept of sympathetic neurovascular control represents a highly 
integrative and multi-faceted process of regulation that involves central integration of 
sensory signals within the brainstem and spinal cord (Barman & Gebber, 2000), 
synapses at peripheral ganglia (Jänig & McLachlan, 1992), recruitable efferent post-
ganglionic sympathetic nerve traffic, neurotransmitter release, and finally, the end-
organ response (Shoemaker et al. 2016). Ultimately, each of these elements offer 
unique and complex levels of regulation, that combined, represent a key mechanism of 
control over cardiovascular homeostasis. Therefore, to fully appreciate the complexity 
and integrative nature of sympathetic neuro-circulatory control in health, and perhaps 
more importantly, in disease, a thorough and systematic understanding of each 
individual element of control, or ‘part’, is critical. In line with this, recruitment patterns 
in efferent sympathetic nerve activity form the scope of this dissertation. For detailed 
information on other regulatory segments within the sympathetic neural control 
complex, such as the central and ganglionic features (McAllen & Malpas, 1997; Jänig 
& Häbler, 2003; McLachlan, 2003), or the efferent nerve activity–vascular contraction 
integration (Shoemaker et al. 2016), the reader is referred to existing comprehensive 
reviews. Nonetheless, the concept of sympathetic neurovascular control has been well-
studied in three fundamental reflexes; that is, the baroreflex, chemoreflex, and exercise 
pressor reflex. These efforts are described briefly in the sections below. 
1.3.1 Baroreflex 
The arterial baroreflex provides short-term regulation of arterial blood pressure 
around a set-point (determined by the state of the individual), via a negative feedback 
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control system that responds to beat-to-beat changes in blood pressure by reflexively 
altering ANS (i.e., PNS and SNS) activity. The arterial baroreflex consists of 
baroreceptors located in the carotid sinus, at the bifurcation of the internal and external 
carotid artery, as well as the aortic arch (Dampney, 1994). The carotid and aortic 
baroreceptors are composed of mechanosensitive afferent neurons located within the 
medial-adventitial wall of the vessel that respond to stretch or distortion of the arterial 
wall due to changes in blood pressure, or more specifically, transmural pressure 
(Dampney, 1994). Afferent baroreceptor discharge is relayed from the carotid sinus (via 
the glossopharyngeal nerve) and the aortic arch (via the vagus nerve) to the nucleus 
tractus solitarius (NTS) in the medulla oblongata region of the brainstem (Dampney, 
1994; Aicher et al. 2000). Here, NTS neurons project to and excite (via the release of 
glutamate) the caudal ventrolateral medulla (CVLM). CVLM neurons are interneurons 
in the baroreflex pathway and project to the rostral ventrolateral medulla (RVLM), and 
through the release of ɣ-aminobutyric-acid (GABA), inhibit the RVLM. The RVLM 
represents the primary regulator of the SNS, sending excitatory messages to 
sympathetic pre-ganglionic neurons located in the IML of the spinal cord, as mentioned 
above. As such, when baroreceptors are activated (i.e., by increased blood pressure), the 
NTS activates the CVLM, thus inhibiting the RVLM, which, in turn, inhibits 
sympathetic nerve activity to decrease blood pressure (i.e., vasodilation) back to its set-
point. In this scenario, PNS activity is simultaneously increased to cause reductions in 
heart rate and cardiac contractility. On the other hand, when blood pressure levels 
decrease, less afferent baroreceptor discharge causes less excitation of the NTS, less 
activation of the CVLM, and therefore, disinhibition (i.e., activation) of the RVLM. 
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This, in turn, causes increases in efferent sympathetic nerve activity to the periphery, 
and therefore, vasoconstriction (i.e., to increase blood pressure). 
 Orthostatic (i.e., postural) stress represents a common method of studying 
baroreflex-mediated neuro-circulatory control due to reductions in venous return, 
cardiac output, and thus, blood pressure. This results in baroreceptor ‘unloading’, 
reductions in afferent discharge to central sympathetic sites, and therefore, as described 
above, increases in sympathetic nerve activity and peripheral vascular resistance to 
maintain arterial blood pressure (Sundlöf & Wallin, 1978a; Victor & Leimbach, 1987). 
In a laboratory setting, orthostatic stress is often simulated using LBNP, although other 
methods are often utilized. In brief, during LBNP, participants lie supine with their 
lower body sealed within a chamber at the level of the iliac crest. Next, negative suction 
is created, such that blood is shunted away from the thoracic cavity and into the 
capacitance vessels of the lower body, thereby unloading the baroreceptors. Indeed, 
LBNP elicits robust and graded (i.e., with severity) increases in efferent sympathetic 
nerve outflow, vasoconstriction, and, by extension, total vascular resistance (Rea & 
Wallin, 1989; Taylor et al. 1992; Ryan et al. 2011). Furthermore, the patterning of 
sympathetic discharge may differ with LBNP stress severity, such that both rate and 
strength of firing increase at lower levels of suction (i.e., up to approximately −30 
mmHg), whereas, at higher levels of LBNP, the strength of sympathetic discharge 
appears emphasized (Ichinose et al. 2004; Ichinose et al. 2006).  
1.3.2 Chemoreflex 
The chemoreflex represents a highly complex and coordinated homeostatic 
response to systemic hypoxia and/or hypercapnia that ultimately serves to regulate 
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cardiorespiratory function to maintain and defend perfusion to the body’s critical organs 
and tissues. Briefly, the chemoreflex includes peripheral chemoreceptors, located 
primarily in the carotid bodies, but also, the aortic bodies, as well as the central 
chemoreceptors, located within the brainstem. In general, peripheral chemoreceptors 
respond primarily to hypoxia, but also to hypercapnia/H+ concentration (Marshall, 
1994), while central chemoreceptors respond to increased brain interstitial 
hypercapnia/H+ concentration (Nattie & Li, 2012). The net result of peripheral and/or 
central chemoreceptor activation is reflex-induced increases in respiration, as well as 
autonomic circulatory arousal. Indeed, the homeostatic response to chemoreflex 
activation involves large increases in post-ganglionic sympathetic nerve activity (Saito 
et al. 1988; Morgan et al. 1995; Leuenberger et al. 2005), mediated through an 
excitatory NTS to RVLM to IML neural reflex arc (Koshiya et al. 1993), to influence 
systemic vascular resistance and distribution of blood flow, and ultimately, maintain 
brain perfusion.   
 Importantly, when the effects of hypoxia and hypercapnia are combined, such as 
occurs during asphyxic rebreathing or breathing a hypoxic-hypercapnic gas mixture, a 
synergistic effect occurs, such that the sympathoexcitatory response is potentiated 
(Somers et al. 1989a; Jouett et al. 2015). Furthermore, voluntary apnea (i.e., absence of 
active ventilation) appears to elicit an even more robust sympathetic response (Somers 
et al. 1989b; Steinback et al. 2010a), reflecting increases in both frequency and strength 
of sympathetic discharge. 
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1.3.3 Exercise Pressor Reflex 
The exercise pressor reflex is of fundamental importance in mediating the 
necessary neural cardiovascular adjustments to fatiguing exercise, which include 
increases in blood pressure and elevated sympathetic drive. In brief, mechanically- and 
metabolically-sensitive sensory afferent fibres within active skeletal muscle provide 
feedback to cardiovascular control centers within the brain stem in response to 
mechanical and chemical stimuli, respectively (Alam & Smirk, 1937; McCloskey & 
Mitchell, 1972; Kaufman et al. 1983; Mitchell et al. 1983). Specifically, muscle 
mechanoreflex sensory afferents are comprised of Type III sensory neurons and 
respond primarily to mechanical stretch and deformation induced by muscular 
contraction (Mitchell et al. 1983). On the other hand, muscle metaboreflex sensory 
afferents are comprised of Type IV sensory neurons and are stimulated via the build-up 
of metabolites (i.e., chemical stimuli) produced by the working skeletal muscle 
(Mitchell et al. 1983). However, this organization is not absolute, as some Type III 
fibres respond to metabolic stimuli, whereas some Type IV fibres respond the 
mechanical stimuli. Nonetheless, the exercise pressor reflex elicits large increases in 
sympathetic nerve activity (Mark et al. 1985; Seals et al. 1988; Victor et al. 1988; 
Wallin et al. 1989; Shoemaker et al. 2007), albeit after a delay (Mark et al. 1985), the 
timing of which depends on exercise intensity (Hashimoto et al. 1998). Furthermore, 
sympathetic outflow remains elevated during PECO, which serves to trap exercise-
induced metabolites within the previously-active skeletal muscle (thereby, isolating the 
metaboreflex) (Alam & Smirk, 1937), suggesting a dominant role for the muscle 
metaboreflex in eliciting the robust sympathetic response. 
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1.4 Muscle Sympathetic Nerve Activity 
In the late 1960s (Hagbarth & Vallbo, 1968), the study of sympathetic neuro-
circulatory control was greatly advanced in humans with the development of the 
microneurographic technique by Hagbarth and Vallbo in Uppsala, Sweden (Vallbo et 
al. 2004). Specifically, microneurography allows for direct real-time recordings from 
the populations of post-ganglionic sympathetic axons innervating the skeletal muscle 
vasculature (i.e., MSNA) in human peripheral nerves. The recordings are referred to as 
“multi-unit” in that several axons are recorded from simultaneously. Sympathetic 
outflow directed to skeletal muscle, as opposed to skin (Hagbarth et al. 1972), is related 
to blood pressure and accurately reflects both age-related and pathological states 
(Sundlöf & Wallin, 1978b; Wallin & Charkoudian, 2007); thus, MSNA represents the 
neural signal of interest in this dissertation. Advantages of the microneurographic 
technique versus other measures of sympathetic nerve activity (i.e., plasma 
catecholamine levels, NE spillover, etc.) include its direct and continuous nature and its 
excellent temporal resolution. Disadvantages include the technical demands of the skill 
and its pseudo-invasive nature (thereby, limiting its practicality), its focus on one 
regional vascular bed, as well as uncertainty over how best, and how accurately, to 
interpret and analyze the recorded signal (White et al. 2015; Joyner, 2016). In general, 
however, levels of MSNA reflect levels of sympathetic outflow to the heart and other 
visceral beds (Wallin et al. 1992; Wallin et al. 1996; Lambert et al. 1997; Grassi & 
Esler, 1999), reinforcing the relevance of this important neural signal. Indeed, over the 
past 50 years or so, microneurography has proven an invaluable research tool in the 
study of sympathetic neurovascular control at rest, and in response to physiological 
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stress, in both health and disease (Wallin & Charkoudian, 2007; Charkoudian & 
Rabbitts, 2009; Shoemaker et al. 2016; Joyner et al. 2015). 
 In theory, any accessible peripheral nerve can be used for microneurographic 
recordings; however, the most widely used is likely the peroneal nerve at or just 
proximal to the fibular head, as it is readily accessible and close to the skin, relatively 
large, and fairly easy to stabilize (i.e., the lower limb) for long durations of time (White 
et al. 2015). Certainly, the peroneal nerve, along with other human mixed nerves, 
contains unmyelinated efferent sympathetic axons (i.e., C-fibers), albeit in a mix of 
other sensory and motor fibres. Though limited data exist in humans on the anatomical 
arrangement and distribution of these sympathetic fibres within peripheral nerves, 
Tompkins et al. (2013) demonstrated, using immunohistochemical techniques, that 
sympathetic fibres were dispersed throughout approximately 25 to 38 fascicles within 
the human peroneal nerve. Throughout these fascicles, sympathetic fibres existed either 
individually or in bundled groups of approximately two- to 44 axons, although the 
distribution favoured smaller bundles (i.e., median value of five axons/bundle). Finally, 
the axons also displayed variations in size, with diameters ranging from approximately 
0.5 to 2 µm. Therefore, within the human peroneal nerve, post-ganglionic sympathetic 
fibres exist in bundles of axons that vary both in number and size.  
As such, microneurography involves the manual manipulation and positioning 
of a recording electrode into an active bundle of efferent sympathetic axons within the 
peroneal nerve. Specifically, the technique entails the use of two electrodes. First, a 
‘reference’ electrode is positioned subcutaneously approximately 1-3 cm from the 
recording site. Next, a tungsten ‘recording’ electrode (35 mm long, 200 µm in diameter, 
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and tapered to a 1-5 µm uninsulated tip) is inserted percutaneously into the nerve and is 
manually, and carefully, manipulated until an adequate MSNA recording site is located. 
This is confirmed by the presence of a characteristic pulse-synchronous burst pattern, 
absence of skin paresthesia, and a signal that increases in response to voluntary apnea, 
but not during arousal to loud noise (Delius et al. 1972). The recorded raw neural signal 
is first preamplified with a gain of 1000 (using preamplifier and isolation amplifier; 
gain of 100 and 10, respectively) and further amplified with a gain of 75 (using a 
variable gain amplifier; gain of 0.1-99). The neural activity is then band-pass filtered 
(bandwidth of 700-2000 Hz) before being rectified and integrated (using a leaky 
integrator; 0.1 s time constant) to obtain a mean voltage neurogram. These steps 
ultimately reduce background noise to expose both the timing and location of 
sympathetic ‘bursts’ that, in turn, reflect periods of efferent AP synchronization (Delius 
et al. 1972). In this sense, variations in the size and number of APs within and between 
sympathetic bursts is lost in the integration process. Nonetheless, MSNA is 
characterized by spontaneously, and irregularly, occurring bursts of pulse-synchronous 
impulses (i.e., APs) that are separated by periods of neural silence (Hagbarth & Vallbo, 
1968). These integrated sympathetic bursts are entrained to the cardiac cycle via a 
baroreflex mechanism, in that they are initiated during diastole and turned off during 
systole (Sundlöf & Wallin, 1978b). Indeed, Fagius et al. (1985) demonstrated that 
baroreceptor deafferentation via temporary bilateral block of the vagus and 
glossopharyngeal nerves led to marked increases in muscle sympathetic outflow and a 
loss of MSNA cardiac rhythmicity. Confirmation that these recorded bursts indeed 
represent efferent post-ganglionic sympathetic outflow is evidenced by their conduction 
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velocities (~1 m/s) (Hagbarth & Vallbo, 1968; Fagius & Wallin, 1980), as well as their 
complete abolishment following ganglionic blockade (Delius et al. 1972).  
Sympathetic bursts are identified from the integrated MSNA neurogram if: 1) 
they exhibit pulse-synchrony; 2) they have a signal-to-noise ratio of at least 2:1 with 
respect to the previous period of neural silence between bursts; 3) they present with 
characteristic rising and falling slopes; and 4) APs are visible in the corresponding raw 
and filtered neurograms. The level of integrated sympathetic nerve activity is most 
commonly quantified using burst frequency and/or burst incidence. Burst frequency 
gives an indication of overall firing frequency and is expressed as the number of bursts 
per minute, whereas burst incidence involves the ‘normalization’ of burst frequency to 
heart rate, and therefore, is expressed as the number of bursts per 100 heartbeats. 
Furthermore, the level of total integrated activity (i.e., total MSNA) is often calculated 
as the product of burst frequency and burst amplitude (or area), although interpretation 
of the latter amplitude component is more complicated, as described below. Therefore, 
integrated burst frequency represents the most-widely reported MSNA index in the 
literature due to its relative ease of calculation and interpretation, and because it is 
highly reproducible over time (Sundlöf & Wallin, 1977; Kimmerly et al. 2004). In 
contrast, burst size demonstrates less test-retest reproducibility, presumably due to the 
fact that absolute burst size voltages are influenced by proximity of the recording 
electrode tip in relation to the active group of axons, a factor that is likely to differ 
between individuals and between recording sites. In this sense, interindividual 
comparisons of absolute burst amplitude are limited, and therefore, normalization 
procedures are often utilized. A commonly used approach is to normalize all bursts 
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within the recording period to the largest burst at baseline (or throughout the recording), 
which is assigned a value of 100 arbitrary units, although other methods are often 
employed (White et al. 2015). Another approach, developed by Sverrisdóttir and 
colleagues (Sverrisdóttir et al. 1998; Sverrisdóttir et al. 2000), involves the 
normalization of burst amplitude as above, followed by the creation of a relative burst 
amplitude distribution spectra or plot that describes the relative proportion of ‘small’ 
versus ‘large’ bursts within the integrated neurogram. Importantly, this method has 
demonstrated to be a more sensitive and specific indicator of altered MSNA 
(Sverrisdóttir et al. 1998), is reproducible (Kimmerly et al. 2004), and furthermore, has 
shown to independently discriminate clinical conditions (i.e., heart failure) with 
elevated, but similar, burst frequency (Sverrisdóttir et al. 2000). Therefore, burst 
amplitude offers unique insight into sympathetic neural control of the circulation above 
and beyond that of burst frequency or burst incidence. In this sense, burst size 
represents an important independent variable of interest, as outlined below. 
 Certainly, it has been hypothesized for some time that burst size is regulated in a 
differential manner as compared to burst frequency, thereby representing its own level 
of control (Malpas, 1995; Kienbaum et al. 2001). Highlighting this point, several 
studies have observed alterations in burst amplitude, without accompanying changes in 
burst frequency, in response to both baroreflex- (DiBona et al. 1997; Kimmerly & 
Shoemaker, 2003) and chemoreflex- (Malpas & Ninomiya, 1992; Malpas et al. 1996) 
induced stress. As such, changes in burst frequency alone may not adequately represent 
reflex-mediated sympathetic vasomotor control. Furthermore, changes in burst 
amplitude, reflecting altered AP discharge patterns, may be independently relevant for 
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neurovascular control (Malpas, 1998). Indeed, Fairfax et al. (2013) demonstrated that 
burst size alone, independent of burst pattern or frequency (i.e., single versus multiple 
bursts), influences directly the magnitude of decrease in leg vascular conductance (i.e., 
vasoconstriction). The importance of the burst amplitude index likely lies in the fact 
that the size of each integrated burst represents the true neural content of that burst; that 
is, burst size is reflective of both the number (Ninomiya et al. 1993; Salmanpour et al. 
2011a) and size (Salmanpour et al. 2011a) of axons recruited within that burst. 
Therefore, the content and variability of APs within and between integrated bursts 
reflect the recruitment patterns and strategies used by the CNS to fine-tune sympathetic 
outflow, and ultimately, control systemic vascular resistance and blood pressure at rest 
and in the face of physiological challenge. While the efforts outlined above for 
normalizing burst amplitude have proven somewhat fruitful (Kimmerly & Shoemaker, 
2003), considerable information is lost within the integrated neural signal. Specifically, 
the integration process eliminates all AP information (i.e., number and morphology), 
precluding the study of sympathetic neural discharge patterning. As such, investigation 
into the neural coding patterns utilized by the SNS has been limited over the years due 
to technical limitations in extracting AP information from raw MSNA recordings due to 
high levels of background noise.  
Nonetheless, early hypotheses regarding central recruitment strategies have been 
inferred from the integrated MSNA neurogram. For instance, Wallin et al. (1994) 
observed an inverse relationship between integrated burst amplitude and baroreflex 
latency; that is, larger sympathetic bursts expressed shorter reflex latencies. Baroreflex 
latency, as determined from the time-delay between the peak of the integrated burst and 
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the preceding R-wave related to that burst (Fagius & Wallin, 1980), has been found to 
be approximately 1.2 to 1.5 seconds in human peroneal nerve recordings (Fagius & 
Wallin, 1980). In turn, this reflex latency reflects the sum of time of all conduction 
components, including baroreceptor sensory afferent processing, central integration, 
spinal conduction time, and pre- and post-ganglionic efferent nerve segments. In this 
sense, the finding that larger sympathetic bursts expressed shorter conduction latencies 
was hypothesized to be due to either malleability of synaptic delays between the brain 
stem and peripheral nerve (i.e., ‘shortcuts’ in the neural pathway), and/or the presence 
of sub-populations of sympathetic fibres with varying conduction velocities and 
thresholds for recruitment (Wallin et al. 1994).  
The question of neural coding in human efferent sympathetic nerve activity was 
advanced by Macefield et al. (1994) with the introduction of single sympathetic fibre 
recordings. The single-unit approach uses the same methodology as outlined above for 
multi-unit recordings; however, the electrode has a much higher impedance and thus 
limits the overall area from which the neural signal is recorded. Data from this work 
indicates that, in general, when active at rest, a given axon will fire approximately once 
per sympathetic burst (Macefield et al. 1994; Macefield & Wallin, 1999), but perhaps 
more in certain pathological states (Elam et al. 2003; Lambert et al. 2008). Indeed, a 
shift towards greater likelihood of multiple firing of individual axons per burst has been 
demonstrated in hypertension (Lambert et al. 2007), obstructive sleep apnea syndrome 
(Elam et al. 2002), and chronic obstructive pulmonary disease (Ashley et al. 2010), but 
not in congestive heart failure (Macefield et al. 1999). Furthermore, multiple within-
burst firing has been observed during acute states of autonomic arousal, such as the 
26 
 
Valsalva maneuver (Murai et al. 2006), voluntary apnea (Macefield & Wallin, 1999), 
and following cardiac dysrhythmia (Elam & Macefield, 2001). Therefore, these data 
indicate that increased firing probability, and also, an increase in the within-burst firing 
of single axons, represent mechanisms by which sympathetic drive is elevated during 
physiological stress. However, given that only approximately 40% of bursts during 
apnea were associated with multiple spikes, Macefield and colleagues hypothesized that 
recruitment of additional neurons (along with increased firing probability) may be the 
primary mechanism by which sympathetic activation is achieved (Macefield & Wallin, 
1999). However, recruitment of new axons cannot be determined from single-fibre 
recordings. As such, information regarding the several recruitment strategies available 
to the SNS to alter efferent outflow in response to homeostatic challenge cannot be 
extracted using single-unit analyses, but instead, require a multi-unit analysis approach.   
Indeed, patterns of neural coding represent a fundamental feature of all neural 
exchange and processing. These patterns, among others, can include variations in the 
frequency, or rate, of individual spike firing (i.e., rate coding), varying thresholds for 
recruitment of additional neurons (i.e., population coding), and also, variations in the 
timing of neuronal activity (i.e., temporal coding). These coding patterns exist in the 
control of many bodily systems. For example, the recruitment strategies used by the 
skeletal motor system to respond to ever-increasing muscular contraction force follow 
Henneman’s size principle, whereby smaller motor units are recruited first, followed by 
recruitment of larger, faster conducting motor units as load intensity and force 
production increase (Henneman et al. 1965). Furthermore, once active, these units 
increase their firing rate (Westgaard & De Luca, 2001). Therefore, neural coding 
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patterns exist in the control of muscular activation. Whether these principles operate in 
the SNS, which regulates numerous homeostatic outcomes, is less clear in humans due 
to limited access to direct neural recordings, and furthermore, limitations in extracting 
multi-unit AP activity from the sympathetic neurogram.  
More recently, the investigation of neural coding in efferent sympathetic nerve 
activity has been furthered by technological advancements enabling the extraction and 
morphological classification of multi-unit APs from raw MSNA recordings 
(Salmanpour et al. 2010). One such method, developed by Salmanpour et al. (2010), 
and used in many subsequent experiments (Steinback et al. 2010b; Breskovic et al. 
2011; Salmanpour et al. 2011a,b; Maslov et al. 2012; Salmanpour & Shoemaker, 2012; 
Maslov et al. 2014a,b), uses wavelet-base methodology to detect and extract 
sympathetic APs from the noisy raw MSNA signal, thereby enabling the study of multi-
unit post-ganglionic neural discharge (Figure 1.1).  
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Figure 1.1: Schematic representation of action potential (AP) detection and 
classification.  
MSNA, muscle sympathetic nerve activity. Reproduced with permission from the 
American Physiological Society: “Badrov MB, Usselman CW & Shoemaker JK (2015). 
Sympathetic neural recruitment strategies: responses to severe chemoreflex and 
baroreflex stress. Am J Physiol Regul Integr Physiol 309: R160-168.” 
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This technique has proven invaluable in the testing of early hypotheses proposed 
by Wallin et al. (1994) and Macefield and colleagues (Macefield et al. 1994; Macefield 
& Wallin, 1999), among others (Tsukahara & Mano, 1997; Xie et al. 1999). With the 
use of this approach, an ordered pattern of recruitment was observed within the SNS 
during baseline rest, whereby larger axons with faster conduction velocities (i.e., shorter 
reflex latencies) are hierarchically recruited as integrated sympathetic bursts become 
stronger (i.e., larger) (Steinback et al. 2010b; Salmanpour et al. 2011a). This pattern 
was also observed during baroreflex- and chemoreflex-mediated sympathoexcitation 
(Steinback et al. 2010b; Salmanpour et al. 2011a). Furthermore, in response to 
prolonged voluntary apnea, Steinback et al. (2010b), and later, Breskovic et al. (2011), 
observed increased firing rates of sympathetic fibres already-active at baseline, and 
also, recruitment of previously silent (i.e., not present at baseline) sub-populations of 
higher-threshold, faster conducting (therefore, larger) sympathetic axons. Importantly, 
these larger, latent axons accounted for approximately 74% of the apnea-induced 
increase in sympathetic nerve activity (Steinback et al. 2010b). Therefore, it appears 
that increased sympathetic drive in response to physiological stress may be achieved 
predominantly through the recruitment of additional, larger sympathetic neurons, as 
previously hypothesized (Macefield & Wallin, 1999). However, in contrast to the 
discharge patterns observed during apnea (Steinback et al. 2010b; Breskovic et al. 
2011), recruitment of latent neural sub-populations was not observed during moderate 
levels of baroreceptor unloading (i.e., −60 mmHg LBNP) in approximately 70% of 
participants, whereby sympathetic activation was achieved primarily through increased 
firing rates of those axons already recruited as baseline (Salmanpour et al. 2011a). 
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Discrepancy in recruitment strategies between the two studies (or reflexes) may be due 
to stress severity (i.e., varying thresholds for recruitment) and/or differences between 
the reflexes themselves (i.e., ‘chemoreflex’ versus ‘baroreflex’). However, these two 
studies were conducted in different samples of individuals, thereby limiting conclusions 
as to the roles played by these factors. Therefore, reflex-specific neural recruitment 
strategies within the SNS, as well as the issue of stress severity and threshold for 
recruitment of these latent axons, require further investigation.  
Furthermore, a consistent finding to date has been an inverse relationship 
between AP size and AP latency; that is, larger APs express shorter reflex latencies 
(i.e., faster conduction velocities) (Steinback et al. 2010b; Salmanpour et al. 2011a,b). 
This finding forms the basis of the assumption that these larger APs reflect recruitment 
of larger axons. While this relationship has been observed at rest and during 
sympathoexcitatory stimuli (Steinback et al. 2010b; Salmanpour et al. 2011a), 
Salmanpour et al. (2011b) demonstrated that all APs active at baseline were recruited 
with a shorter reflex latency during a subsequent Valsalva maneuver, evidence perhaps 
for acute malleability of synaptic delays within the neural reflex arc. In contrast, in a 
preliminary manner, Salmanpour et al. (2011a) observed an acute upward-shift of the 
AP size-latency profile during −60 mmHg LBNP, such that lower-threshold axons were 
recruited with a slower latency during moderate levels of simulated orthostatic stress. 
Nonetheless, these observations appear to support the concept, initially proposed by 
Wallin et al. (1994), of acute synaptic delay variations, although additional data are 
required. Furthermore, the exact mechanism(s) for the reduction in neural activation 
latency during the Valsalva maneuver (Salmanpour et al. 2011b), but the increase 
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during LBNP-induced baroreceptor unloading (Salmanpour et al. 2011a), are unknown, 
but may reflect a central, perceptual component that is likely more pronounced during 
the Valsalva maneuver. As such, in addition to the study of reflex-specific discharge 
patterns, the exact roles played by central, perceptual components versus peripheral-
reflex mechanisms in mediating these sympathetic neural recruitment responses remain 
to be determined. 
Additionally, the majority of studies to date on sympathetic AP discharge 
properties have been conducted in young, healthy populations, and therefore, whether 
these neural coding strategies persist with increasing age and cardiovascular disease 
remains largely uncertain. Preliminary work in healthy aged-individuals and chronic 
heart failure patients suggests a comparable pattern, but perhaps slightly diminished in 
heart failure, of sympathetic neural recruitment in response to voluntary apnea (Maslov 
et al. 2014b) and premature ventricular contractions (Maslov et al. 2012). However, 
direct comparisons to a young, healthy group were not made. Furthermore, AP latency 
variations, reflecting synaptic delay modifications, were not studied in these 
investigations. Therefore, the malleability of these sympathetic neural recruitment 
strategies with increasing age and cardiovascular disease requires further study.  
Finally, voluntary apnea appears to provide the most powerful stimulus for 
sympathetic axonal recruitment (Steinback et al. 2010b). Yet, the exact mechanisms 
mediating the robust sympathetic response are uncertain and appear diverse. Indeed, 
one fundamental issue involves the roles played by ventilation (or the lack thereof) 
versus chemoreceptor activation in eliciting the recruitment response. For example, the 
chemoreflex stimulus to typical 20- to 30-second apneas in untrained breath-hold 
32 
 
performers is rather ordinary (Leuenberger et al. 2005; Heusser et al. 2009; Seitz et al. 
2013), raising the concern that additional factors are likely at play. Furthermore, 
voluntary apnea has shown to potentiate the sympathetic response to isocapnic hypoxia 
(Somers et al. 1989a,b), indicating the sympathoinhibitory nature of breathing. 
Therefore, the influence of chemoreflex stress per se, as opposed to the absence of 
ventilation itself, on sympathetic axonal discharge during apneic stress remains to be 
determined. 
Nonetheless, the existing multi-unit data, albeit limited, appear to support earlier 
hypotheses (Wallin et al. 1994; Macefield & Wallin, 1999) that, in response to acute 
homeostatic stress, the SNS has options to increase the firing rate of already-active, 
lower-threshold axons, recruit latent, higher-threshold neural sub-populations, as well 
as modify acutely synaptic delays and/or central processing times. In turn, it appears 
that these strategies may differ across reflexes and/or with stress severity, which may 
perhaps reflect a perceptual component. Therefore, as outlined above, many 
questions/issues remain regarding the mechanisms of control underlying the neural 
recruitment strategies used by the SNS, which include, among others: (1) the reflex-
specific recruitment strategies in efferent sympathetic nerves, (2) the threshold for 
recruitment of these neural sub-populations (i.e., stress severity), (3) the central, 
perceptual versus peripheral-reflex elements of sympathetic neural coding, (4) the 
effects of age and disease on neural discharge properties, and (5) the role of 
chemoreflex stress versus ventilation (or the lack thereof) in the apneic neural response. 
These important, but yet unanswered issues, form the basis of this dissertation.  
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Therefore, the overall objectives of this dissertation are to 1) Establish the 
neural recruitment strategies available to the SNS to respond to acute homeostatic 
challenge; and 2) To determine the various mechanisms of control underlying these 
neural coding patterns. The research contained herein tested the working hypothesis 
that efferent post-ganglionic MSNA exhibits neural coding strategies reflecting 
increased firing rates of lower-threshold axons, recruitment of latent, higher-threshold 
axons, and acute synaptic delays modifications, and further, that these are modified by 
factors such as reflex-specificity, stress severity, perception of effort or stress, age, and 
cardiovascular disease.  
 
 
 
 
 
 
 
 
 
 
 
 
34 
 
1.5 References 
Aicher SA, Milner TA, Pickel VM & Reis DJ (2000). Anatomical substrates for 
baroreflex sympathoinhibition in the rat. Brain Res Bull 51, 107-110. 
Alam M & Smirk FH (1937). Observations in man upon a blood pressure raising reflex 
arising from the voluntary muscles. J Physiol 89, 372-383. 
Ashley C, Burton D, Sverrisdottir YB, Sander M, McKenzie DK & Macefield VG 
(2010). Firing probability and mean firing rates of human muscle 
vasoconstrictor neurones are elevated during chronic asphyxia. J Physiol 588, 
701-712. 
Barman SM & Gebber GL (2000). “Rapid” rhythmic discharges of sympathetic nerves: 
sources, mechanisms of generation, and physiological relevance. J Biol Rhythms 
15, 365-379. 
Bernard C (1974). Lectures on the phenomena of life common to animals and plants 
(HE Hoff, R Guillemin, & L Guillemin, Trans.). Charles C Thomas, Springfield. 
Breskovic T, Steinback CD, Salmanpour A, Shoemaker JK & Dujic Z (2011). 
Recruitment pattern of sympathetic neurons during breath-holding at different 
lung volumes in apnea divers and controls. Auton Neurosci 164, 74-81. 
Brodde OE & Michel MC (1999). Adrenergic and muscarinic receptors in the human 
heart. Pharmacol Rev 51, 651-690. 
Burnstock G (1990). Noradrenaline and ATP as cotransmitters in sympathetic nerves. 
Neurochem Int 17, 357-368. 
35 
 
Cannon WB (1929). Organization of physiological homeostasis. Physiol Rev 9, 399-
431. 
Charkoudian N & Rabbitts JA (2009). Sympathetic neural mechanisms in human 
cardiovascular health and disease. Mayo Clin Proc 84, 822-830. 
Dampney R (1994). Functional organization of central pathways regulating the 
cardiovascular system. Physiol Rev 74, 323-364. 
Delius W, Hagbarth KE, Hongell A & Wallin BG (1972). General characteristics of 
sympathetic activity in human muscle nerves. Acta Physiol Scand 84, 65-81. 
DiBona GF, Jones SY & Sawin LL (1997). Reflex effects on renal nerve activity 
characteristics in spontaneously hypertensive rats. Hypertension 30, 1089-1096. 
Elam M & Macefield VG (2001). Multiple firing of single muscle vasoconstrictor 
neurons during cardiac dysrhythmias in human heart failure. J Appl Physiol 91, 
717-724. 
Elam M, McKenzie D & Macefield VG (2002). Mechanisms of sympathoexcitation: 
single-unit analysis of muscle vasoconstrictor neurons in awake OSAS subjects. 
J Appl Physiol 93, 297-303. 
Elam M, Sverrisdottir Y, Rundqvist B, McKenzie D, Wallin BG & Macefield VG 
(2003). Pathological sympathoexcitation: how is it achieved? Acta Physiol 
Scand 177, 405-411. 
36 
 
Esler M (2010). The 2009 Carl Ludwig Lecture: pathophysiology of the human 
sympathetic nervous system in cardiovascular diseases: the transition from 
mechanisms to medical management. J Appl Physiol 108, 227-237. 
Fagius J & Wallin BG (1980). Sympathetic reflex latencies and conduction velocities in 
normal man. J Neurol Sci 47, 433-448. 
Fagius J, Wallin BG, Sundlof G, Nerhed C & Englesson S (1985). Sympathetic outflow 
in man after anaesthesia of the glossopharyngeal and vagus nerves. Brain 108, 
423-438. 
Fairfax ST, Padilla J, Vianna LC, Davis MJ & Fadel PJ (2013). Spontaneous bursts of 
muscle sympathetic nerve activity decrease leg vascular conductance in resting 
humans. Am J Physiol Heart Circ Physiol 304, H759-H766. 
Floras JS (2009). Sympathetic nervous system activation in human heart failure. J Am 
Coll Cardiol 54, 375-385. 
Graham LN, Smith PA, Stoker JB, Mackintosh AF & Mary DA (2004). Sympathetic 
neural hyperactivity and its normalization following unstable angina and acute 
myocardial infarction. Clin Sci 106, 605-611. 
Graham LN, Smith PA, Stoker JB, Mackintosh AF & Mary DA (2002). Time course of 
sympathetic neural hyperactivity after uncomplicated acute myocardial 
infarction. Circulation 106, 793-797. 
Grassi G & Esler M (1999). How to assess sympathetic activity in humans. J Hypertens 
17, 719-734. 
37 
 
Grassi G, Seravalle G & Quarti-Trevano F (2010). The ‘neuroadrenergic hypothesis’ in 
hypertension: current evidence. Exp Physiol 95, 581-586. 
Hagbarth KE, Hallin RG, Hongell A, Torebjörk HE & Wallin BG (1972). General 
characteristics of sympathetic activity in human skin nerves. Acta Physiol Scand 
84, 164-176. 
Hagbarth KE & Vallbo AB (1968). Pulse and respiratory grouping of sympathetic 
impulses in human muscle nerves. Acta Physiol Scand 74, 96-108. 
Hashimoto I, Miyamura M & Saito M (1998). Initiation of increase in muscle 
sympathetic nerve activity delay during maximal voluntary contraction. Acta 
Physiol Scand 164, 293-297. 
Henneman E, Somjen G & Carpenter DO (1965). Functional significance of cell size in 
spinal motoneurons. J Neurophysiol 28, 560-580. 
Heusser K, Dzamonja G, Tank J, Palada I, Valic Z, Bakovic D, Obad A, Ivancev V, 
Breskovic T, Diedrich A, Joyner MJ, Luft FC, Jordan J & Dujic Z (2009). 
Cardiovascular regulation during apnea in elite divers. Hypertension 53, 719-
724. 
Huidobro-Toro JP & Donoso MV (2004). Sympathetic co-transmission: the coordinated 
action of ATP and noradrenaline and their modulation by neuropeptide Y in 
human vascular neuroeffector junctions. Eur J Pharmacol 500, 27-35. 
Hulme E, Birdsall N & Buckley N (1990). Muscarinic receptor subtypes. Annu Rev 
Pharmacol Toxicol 30, 633-673. 
38 
 
Ichinose M, Saito M, Fujii N, Kondo N & Nishiyasu T (2006). Modulation of the 
control of muscle sympathetic nerve activity during severe orthostatic stress. J 
Physiol 576, 947-958. 
Ichinose M, Saito M, Ogawa T, Hayashi K, Kondo N & Nishiyasu T (2004). 
Modulation of control of muscle sympathetic nerve activity during orthostatic 
stress in humans. Am J Physiol Heart Circ Physiol 287, H2147-H2153. 
Jänig W (2008). Integrative action of the autonomic nervous system: Neurobiology of 
homeostasis. Cambridge University Press, Cambridge. 
Jänig W & Häbler HJ (2003). Neurophysiological analysis of target‐related sympathetic 
pathways–from animal to human: Similarities and differences. Acta Physiol 
Scand 177, 255-274. 
Jänig W & McLachlan EM (1992). Characteristics of function-specific pathways in the 
sympathetic nervous system. Trends Neurosci 15, 475-481. 
Jouett NP, Watenpaugh DE, Dunlap ME & Smith ML (2015). Interactive effects of 
hypoxia, hypercapnia and lung volume on sympathetic nerve activity in humans. 
Exp Physiol 100, 1018-1029. 
Joyner MJ (2016). Preclinical and clinical evaluation of autonomic function in humans. 
J Physiol 594, 4009-4013. 
Joyner MJ, Barnes JN, Hart EC, Wallin BG & Charkoudian N (2015). Neural control of 
the circulation: how sex and age differences interact in humans. Compr Physiol 
5, 193-215. 
39 
 
Kaufman MP, Longhurst JC, Rybicki KJ, Wallach JH & Mitchell JH (1983). Effects of 
static muscular contraction on impulse activity of groups III and IV afferents in 
cats. J Appl Physiol 55, 105-112. 
Kienbaum P, Karlsson T, Sverrisdottir YB, Elam M & Wallin BG (2001). Two sites for 
modulation of human sympathetic activity by arterial baroreceptors? J Physiol 
531, 861-869. 
Kimmerly DS, O'Leary DD & Shoemaker JK (2004). Test–retest repeatability of 
muscle sympathetic nerve activity: influence of data analysis and head-up tilt. 
Auton Neurosci 114, 61-71. 
Kimmerly DS & Shoemaker JK (2003). Hypovolemia and MSNA discharge patterns: 
assessing and interpreting sympathetic responses. Am J Physiol Heart Circ 
Physiol 284, H1198-H1204. 
Koshiya N, Huangfu D & Guyenet PG (1993). Ventrolateral medulla and sympathetic 
chemoreflex in the rat. Brain Res 609, 174-184. 
Lambert E, Dawood T, Schlaich M, Straznicky N, Esler M & Lambert G (2008). 
Single-unit sympathetic discharge pattern in pathological conditions associated 
with elevated cardiovascular risk. Clin Exp Pharmacol Physiol 35, 503-507. 
Lambert E, Straznicky N, Schlaich M, Esler M, Dawood T, Hotchkin E & Lambert G 
(2007). Differing pattern of sympathoexcitation in normal-weight and obesity-
related hypertension. Hypertension 50, 862-868. 
40 
 
Lambert GW, Thompson JM, Turner AG, Cox HS, Wilkinson D, Vaz M, Kalff V, 
Kelly MJ, Jennings GL & Esler M (1997). Cerebral noradrenaline spillover and 
its relation to muscle sympathetic nervous activity in healthy human subjects. J 
Auton Nerv Syst 64, 57-64. 
Leuenberger UA, Brubaker D, Quraishi S, Hogeman CS, Imadojemu VA & Gray KS 
(2005). Effects of intermittent hypoxia on sympathetic activity and blood 
pressure in humans. Auton Neurosci 121, 87-93. 
Lundberg JM, Franco-Cereceda A, Lacroix JS & Pernow J (1990). Neuropeptide Y and 
sympathetic neurotransmissiona. Ann N Y Acad Sci 611, 166-174. 
Macefield VG, Rundqvist B, Sverrisdottir YB, Wallin BG & Elam M (1999). Firing 
properties of single muscle vasoconstrictor neurons in the sympathoexcitation 
associated with congestive heart failure. Circulation 100, 1708-1713. 
Macefield VG & Wallin BG (1999). Firing properties of single vasoconstrictor 
neurones in human subjects with high levels of muscle sympathetic activity. J 
Physiol 516, 293-301. 
Macefield VG, Wallin BG & Vallbo AB (1994). The discharge behaviour of single 
vasoconstrictor motoneurones in human muscle nerves. J Physiol 481, 799-809. 
Malpas SC (1995). A new model for the generation of sympathetic nerve activity. Clin 
Exp Pharmacol Physiol 22, 11-16. 
Malpas SC (1998). The rhythmicity of sympathetic nerve activity. Prog Neurobiol 56, 
65-96. 
41 
 
Malpas SC (2010). Sympathetic nervous system overactivity and its role in the 
development of cardiovascular disease. Physiol Rev 90, 513-557. 
Malpas SC, Bendle RD, Head GA & Ricketts JH (1996). Frequency and amplitude of 
sympathetic discharges by baroreflexes during hypoxia in conscious rabbits. Am 
J Physiol Heart Circ Physiol 271, H2563-H2574. 
Malpas SC & Ninomiya I (1992). Effect of asphyxia on the frequency and amplitude 
modulation of synchronized renal nerve activity in the cat. J Auton Nerv Syst 40, 
199-205. 
Mark AL, Victor RG, Nerhed C & Wallin BG (1985). Microneurographic studies of the 
mechanisms of sympathetic nerve responses to static exercise in humans. Circ 
Res 57, 461-469. 
Marshall JM (1994). Peripheral chemoreceptors and cardiovascular regulation. Physiol 
Rev 74, 543-594. 
Maslov PZ, Shoemaker JK & Dujic Z (2014a). Firing patterns of muscle sympathetic 
neurons during apnea in chronic heart failure patients and healthy controls. 
Auton Neurosci 180, 66-69. 
Maslov PZ, Breskovic T, Brewer DN, Shoemaker JK & Dujic Z (2012). Recruitment 
pattern of sympathetic muscle neurons during premature ventricular 
contractions in heart failure patients and controls. Am J Physiol Regul Integr 
Comp Physiol 303, R1157-R1164. 
42 
 
Maslov PZ, Shoemaker JK & Dujic Z (2014b). Firing patterns of muscle sympathetic 
neurons during apnea in chronic heart failure patients and healthy controls. 
Auton Neurosci 180, 66-69. 
McAllen RM & Malpas SC (1997). Sympathetic burst activity: characteristics and 
significance. Clin Exp Pharmacol Physiol 24, 791-799. 
McCloskey DI & Mitchell JH (1972). Reflex cardiovascular and respiratory responses 
originating in exercising muscle. J Physiol 224, 173-186. 
McLachlan E (2003). Transmission of signals through sympathetic ganglia–modulation, 
integration or simply distribution? Acta Physiol Scand 177, 227-235. 
Mitchell JH, Kaufman MP & Iwamoto GA (1983). The exercise pressor reflex: its 
cardiovascular effects, afferent mechanisms, and central pathways. Annu Rev 
Physiol 45, 229-242. 
Morgan BJ, Crabtree DC, Palta M & Skatrud JB (1995). Combined hypoxia and 
hypercapnia evokes long-lasting sympathetic activation in humans. J Appl 
Physiol 79, 205-213. 
Murai H, Takata S, Maruyama M, Nakano M, Kobayashi D, Otowa K, Takamura M, 
Yuasa T, Sakagami S & Kaneko S (2006). The activity of a single muscle 
sympathetic vasoconstrictor nerve unit is affected by physiological stress in 
humans. Am J Physiol Heart Circ Physiol 290, H853-H860. 
Narkiewicz K & Somers V (2003). Sympathetic nerve activity in obstructive sleep 
apnoea. Acta Physiol Scand 177, 385-390. 
43 
 
Nattie E & Li A (2012). Central chemoreceptors: locations and functions. Compr 
Physiol 2, 221-254. 
Ninomiya I, Malpas SC, Matsukawa K, Shindo T & Akiyama T (1993). The amplitude 
of synchronized cardiac sympathetic nerve activity reflects the number of 
activated pre- and postganglionic fibers in anesthetized cats. J Auton Nerv Syst 
45, 139-147. 
Parati G & Esler M (2012). The human sympathetic nervous system: its relevance in 
hypertension and heart failure. Eur Heart J 33, 1058-1066. 
Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J & Capon DJ 
(1987). Distinct primary structures, ligand-binding properties and tissue-specific 
expression of four human muscarinic acetylcholine receptors. EMBO J 6, 3923-
3929. 
Rea RF & Wallin BG (1989). Sympathetic nerve activity in arm and leg muscles during 
lower body negative pressure in humans. J Appl Physiol 66, 2778-2781. 
Ryan KL, Rickards CA, Hinojosa-Laborde C, Cooke WH & Convertino VA (2011). 
Arterial pressure oscillations are not associated with muscle sympathetic nerve 
activity in individuals exposed to central hypovolaemia. J Physiol 589, 5311-
5322. 
Saito M, Mano T, Iwase S, Koga K, Abe H & Yamazaki Y (1988). Responses in 
muscle sympathetic activity to acute hypoxia in humans. J Appl Physiol 65, 
1548-1552. 
44 
 
Salmanpour A, Brown LJ & Shoemaker JK (2010). Spike detection in human muscle 
sympathetic nerve activity using a matched wavelet approach. J Neurosci 
Methods 193, 343-355. 
Salmanpour A, Brown LJ, Steinback CD, Usselman CW, Goswami R & Shoemaker JK 
(2011a). Relationship between size and latency of action potentials in human 
muscle sympathetic nerve activity. J Neurophysiol 105, 2830-2842. 
Salmanpour A, Frances MF, Goswami R & Shoemaker JK (2011b). Sympathetic neural 
recruitment patterns during the Valsalva maneuver. Conf Proc IEEE Eng Med 
Biol Soc 2011, 6951-6954. 
Salmanpour A & Shoemaker JK (2012). Baroreflex mechanisms regulating the 
occurrence of neural spikes in human muscle sympathetic nerve activity. J 
Neurophysiol 107, 3409-3416. 
Seals DR, Chase PB & Taylor JA (1988). Autonomic mediation of the pressor 
responses to isometric exercise in humans. J Appl Physiol 64, 2190-2196. 
Seals DR & Esler MD (2000). Human ageing and the sympathoadrenal system. J 
Physiol 528, 407-417. 
Seitz MJ, Brown R & Macefield VG (2013). Inhibition of augmented muscle 
vasoconstrictor drive following asphyxic apnoea in awake human subjects is not 
affected by relief of chemical drive. Exp Physiol 98, 405-414. 
Shields RW (1993). Functional anatomy of the autonomic nervous system. J Clin 
Neurophysiol 10, 2-13. 
45 
 
Shoemaker JK, Badrov MB, Al-Khazraji BK & Jackson DN (2016). Neural control of 
vascular function in skeletal muscle. Compr Physiol 6, 303-329. 
Shoemaker JK, Mattar L, Kerbeci P, Trotter S, Arbeille P & Hughson RL (2007). WISE 
2005: stroke volume changes contribute to the pressor response during ischemic 
handgrip exercise in women. J Appl Physiol 103, 228-233. 
Somers VK, Dyken ME, Clary MP & Abboud FM (1995). Sympathetic neural 
mechanisms in obstructive sleep apnea. J Clin Invest 96, 1897-1904. 
Somers VK, Mark AL, Zavala DC & Abboud FM (1989a). Contrasting effects of 
hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J 
Appl Physiol 67, 2101-2106. 
Somers VK, Mark AL, Zavala DC & Abboud FM (1989b). Influence of ventilation and 
hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J 
Appl Physiol 67, 2095-2100. 
Steinback CD, Breskovic T, Frances M, Dujic Z & Shoemaker JK (2010a). Ventilatory 
restraint of sympathetic activity during chemoreflex stress. Am J Physiol Regul 
Integr Comp Physiol 299, R1407-R1414. 
Steinback CD, Salmanpour A, Breskovic T, Dujic Z & Shoemaker JK (2010b). 
Sympathetic neural activation: an ordered affair. J Physiol 588, 4825-4836. 
Sundlöf G & Wallin BG (1977). The variability of muscle nerve sympathetic activity in 
resting recumbent man. J Physiol 272, 383-397. 
46 
 
Sundlöf G & Wallin BG (1978a). Effect of lower body negative pressure on human 
muscle nerve sympathetic activity. J Physiol 278, 525-532. 
Sundlöf G & Wallin BG (1978b). Human muscle nerve sympathetic activity at rest. 
Relationship to blood pressure and age. J Physiol 274, 621-637. 
Sverrisdóttir YB, Rundqvist B & Elam M (1998). Relative burst amplitude in human 
muscle sympathetic nerve activity: a sensitive indicator of altered sympathetic 
traffic. Clin Auton Res 8, 95-100. 
Sverrisdóttir YB, Rundqvist B, Johannsson G & Elam M (2000). Sympathetic neural 
burst amplitude distribution: A more specific indicator of sympathoexcitation in 
human heart failure. Circulation 102, 2076-2081. 
Taylor JA, Hand GA, Johnson DG & Seals DR (1992). Sympathoadrenal-circulatory 
regulation of arterial pressure during orthostatic stress in young and older men. 
Am J Physiol Regul Integr Comp Physiol 263, R1147-R1155. 
Tompkins RP, Melling CW, Wilson TD, Bates BD & Shoemaker JK (2013). 
Arrangement of sympathetic fibers within the human common peroneal nerve: 
implications for microneurography. J Appl Physiol 115, 1553-1561. 
Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G & Butler J 
(2009). The sympathetic nervous system in heart failure: physiology, 
pathophysiology, and clinical implications. J Am Coll Cardiol 54, 1747-1762. 
Tsukahara R & Mano T (1997). The recruitment pattern of single vasoconstrictor 
neurons in human. J Auton Nerv Syst 66, 26-34. 
47 
 
Vallbo AB, Hagbarth KE & Wallin BG (2004). Microneurography: how the technique 
developed and its role in the investigation of the sympathetic nervous system. J 
Appl Physiol 96, 1262-1269. 
Victor RG, Bertocci LA, Pryor SL & Nunnally RL (1988). Sympathetic nerve discharge 
is coupled to muscle cell pH during exercise in humans. J Clin Invest 82, 1301-
1305. 
Victor RG & Leimbach W (1987). Effects of lower body negative pressure on 
sympathetic discharge to leg muscles in humans. J Appl Physiol 63, 2558-2562. 
Wallin BG, Burke D & Gandevia S (1994). Coupling between variations in strength and 
baroreflex latency of sympathetic discharges in human muscle nerves. J Physiol 
474, 331-338. 
Wallin BG & Charkoudian N (2007). Sympathetic neural control of integrated 
cardiovascular function: insights from measurement of human sympathetic 
nerve activity. Muscle Nerve 36, 595-614. 
Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R & Jennings G 
(1992). Simultaneous measurements of cardiac noradrenaline spillover and 
sympathetic outflow to skeletal muscle in humans. J Physiol 453, 45-58. 
Wallin BG, Thompson JM, Jennings GL & Esler MD (1996). Renal noradrenaline 
spillover correlates with muscle sympathetic activity in humans. J Physiol 491, 
881-887. 
48 
 
Wallin BG, Victor RG & Mark AL (1989). Sympathetic outflow to resting muscles 
during static handgrip and postcontraction muscle ischemia. Am J Physiol Heart 
Circ Physiol 256, H105-H110. 
Wehrwein EA, Orer HS & Barman SM (2016). Overview of the anatomy, physiology, 
and pharmacology of the autonomic nervous system. Compr Physiol 6, 1239-
1278. 
Westgaard R & De Luca C (2001). Motor control of low-threshold motor units in the 
human trapezius muscle. J Neurophysiol 85, 1777-1781. 
White DW, Shoemaker JK & Raven PB (2015). Methods and considerations for the 
analysis and standardization of assessing muscle sympathetic nerve activity in 
humans. Auton Neurosci 193, 12-21. 
Xie A, Skatrud JB, Puleo DS & Morgan BJ (1999). Arousal from sleep shortens 
sympathetic burst latency in humans. J Physiol 515, 621-628. 
 
 
49 
 
Chapter 2  
2 Sympathetic neural recruitment strategies: responses 
to severe chemoreflex and baroreflex stress 
(Published in Am J Physiol Regul Integr Comp Physiol 309: R160-R168, 2015) 
2.1 Introduction 
Patterns of neural coding form the basis of all neural processes requiring 
information exchange and processing. Neural coding patterns include variations in 
firing rate of single neurons (rate coding), the timing of activity amongst synchronized 
or pseudo-synchronized neurons (temporal coding), and varying thresholds for 
recruitment of sub-populations (population coding). Although established largely in 
intracerebral neural processing, these coding patterns exist in the control of peripheral 
organs as well, such as during the generation of ever-increasing muscular force 
(Henneman et al. 1965). Conversely, the neural strategies employed by the autonomic 
nervous system, which regulates homeostatic and life-sustaining outcomes, remain 
unclear, particularly in humans where access to direct neural recordings is limited. The 
multiple sites of control through which efferent sympathetic outflow can be modified 
include the brainstem autonomic nuclei (Barman & Gebber, 2000), spinal cord, and 
paraspinal ganglia (Jänig & McLachlan, 1992; McAllen & Trevaks, 2003). These 
junctures introduce opportunities for modifiable synaptic delays and latent neuronal 
sub-populations.  
Using microneurographic techniques (Hagbarth & Vallbo, 1968), direct 
recordings are made from the populations of post-ganglionic sympathetic neurons 
innervating the skeletal muscle vasculature (muscle sympathetic nerve activity; MSNA) 
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in humans. The measured bursts of activity reflect periods of efferent action potential 
synchronization (Delius et al. 1972b). The size of any given burst is determined by the 
proximity of the recording electrode to the individual neurons within the respective 
bundle of sympathetic axons (Tompkins et al. 2013), as well as the number (Ninomiya 
et al. 1993) and size (Salmanpour et al. 2011a) of action potentials. With the use of 
these features, the question of neural coding in efferent sympathetic nerve activity was 
advanced by the introduction of single fibre recordings (Macefield et al. 1994), which 
indicated that a given axon will fire approximately once per burst and perhaps two to 
three times during states of elevated sympathetic drive (Macefield & Wallin, 1999; 
Elam et al. 2002). To further study the existence of latent neuronal sub-populations 
and/or modifiable synaptic delays, our laboratory developed a technique that quantifies 
and classifies the populations of axons comprising each sympathetic burst (Salmanpour 
et al. 2010). With the use of this approach, a fundamental pattern was exposed within 
the sympathetic nervous system, whereby larger neurons with faster conduction 
velocities are hierarchically recruited as sympathetic bursts become stronger (i.e., 
larger), an observation made under baseline conditions (Salmanpour et al. 2011a) and 
during chemoreceptor activation (Steinback et al. 2010). Importantly, Steinback et al. 
(2010) documented recruitment of latent sub-populations of larger neurons during 
maximal end-inspiratory apnea, which were absent under baseline conditions. However, 
in a preliminary study, recruitment of latent axons was not observed during moderate 
baroreceptor unloading using −60 mmHg lower body negative pressure [LBNP; 
(Salmanpour et al. 2011a)]. Discrepancy in neuronal recruitment patterns between 
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studies may be due to reflex-specific strategies, varying thresholds for sub-population 
recruitment, and/or interindividual variations.  
To further understand rate and population coding within the efferent 
sympathetic nervous system, this study tested the hypothesis of reflex-specific 
sympathetic neural recruitment strategies during periods of high sympathetic stress in 
the same individuals, and whether these recruitment patterns demonstrated test-retest 
repeatability. 
2.2 Methods 
2.2.1 Participants 
Eleven normotensive individuals (6 males, 5 females) participated in the current 
investigation. Participants were aged 25 ± 3 years (mean ± SD) and were 173 ± 8 cm in 
height and 70 ± 9 kg in weight (body mass index = 24 ± 2 kg/m2). Participants were 
regular exercisers, non-smokers, and free of any overt cardiovascular or respiratory 
disease (as assessed by a standardized health questionnaire). All protocols in the current 
investigation were submitted to, and approved by, the Health Sciences Research Ethics 
Board at Western University in Canada. All participants provided written informed 
consent and were familiarized to all experimental procedures before study participation. 
2.2.2 Experimental Protocol 
All testing was conducted following at least a 3-hour fast and a 12-hour 
abstinence from alcohol, caffeine, and other stimulants. Female participants were tested 
during the early follicular menstrual cycle phase. Participants voided their bladder 
immediately prior to testing commencement to minimize the effect of bladder distention 
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on sympathetic nerve activity (Fagius & Karhuvaara, 1989). Experimentation entailed 
two protocols as follows. 
In the first protocol, the impact of progressive chemoreflex stress was studied in 
which data were obtained in the supine position during a 5-minute period of baseline 
(spontaneous breathing) and during a maximal end-inspiratory apnea, which was 
preceded by a rebreathing period designed to maximize the severity of chemoreflex 
stimulation through progressive hypoxia and hypercapnia [described previously in 
detail; (Usselman et al. 2015)]. Briefly, participants were fitted with a mouthpiece 
(series 9060, Hans Rudolph, Kansas City, MO) attached to a three-way valve allowing 
them to breathe either room air, or through a Y-connector (VacuMed, Ventura, CA) 
leading to two 3-liter breathing bags. Before the start of the protocol, participants 
expired into the breathing bags to fill them with air for the ensuing rebreathing period. 
After five minutes of baseline collection, the three-way valve was turned to initiate 
rebreathing. Once end-tidal partial pressure of oxygen (PETO2) reached 70 Torr, 
participants performed an end-inspiratory apnea of maximal voluntary duration. Upon 
cessation, participants breathed twice into and out of the bags to allow for the 
measurement of end-apnea PETO2 and end-tidal partial pressure of carbon dioxide 
(PETCO2). Blood gases were analyzed using an infrared carbon dioxide sensor and 
optical oxygen detector fed from a damped micro-vacuum sampling pump (ML206 Gas 
Analyzer, ADInstruments, Colorado Springs, CO). Values were calibrated using 
ambient air pressure values and converted to online measurements of PETO2 and 
PETCO2.  
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In the second protocol, the impact of severe baroreceptor unloading was studied. 
Data were collected in the supine position during a 5-minute period of baseline 
(spontaneous breathing) and during three minutes of −80 mmHg LBNP. One individual 
exhibited presyncopal symptoms (i.e., systolic blood pressure <90 mmHg) during the 
−80 mmHg LBNP protocol; however, data used for this participant included the first 
170 seconds of LBNP, prior to the onset of presyncopal symptoms. 
Heart rate was measured using a standard three-lead electrocardiogram. 
Continuous beat-to-beat mean arterial blood pressure was obtained through finger 
photoplethysmography (Finometer; Finapres Medical Systems, Amsterdam, The 
Netherlands). Finometer blood pressures were validated and calibrated to manual 
sphygmomanometer blood pressure measurements taken throughout the protocol. 
Stroke volume and cardiac output were obtained using the Finometer Modelflow 
algorithm. Participant sex, age, height, and weight were input manually into the 
Finometer to optimize estimation of stroke volume and cardiac output. Total peripheral 
resistance was calculated as mean arterial pressure divided by cardiac output. Data were 
collected using LabChart6 and PowerLab data acquisition system (ADInstruments).   
2.2.3 Sympathetic Neural Recordings 
Efferent post-ganglionic sympathetic outflow was measured in the fibular 
(peroneal) nerve of the right leg by microneurography (Hagbarth & Vallbo, 1968). 
Specifically, a tungsten microelectrode (35 mm long, 200 µm in diameter, and tapered 
to a 1-5 µm uninsulated tip) was inserted percutaneously into the nerve just posterior to 
the fibular head. A reference electrode was positioned subcutaneously 1-3 cm from the 
recording site. A suitable recording site was searched for by manually manipulating the 
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microelectrode until a characteristic pulse-synchronous burst pattern was observed. 
Confirmation of an MSNA site was determined by the absence of skin paresthesia and a 
signal that increased firing frequency in response to voluntary apnea, but not during 
arousal to loud noise (Delius et al. 1972a). The MSNA neurogram was measured with a 
nerve traffic analysis system (662C-3; Bioengineering of University of Iowa, Iowa City, 
IA). The neural signal was first preamplified with a gain of 1,000 (using preamplifier 
and isolation amplifier; gain of 100 and 10, respectively) and further amplified with a 
gain of 75 (using a variable gain amplifier; gain of 0.1-99). The neural activity was then 
band-pass filtered (bandwidth of 700-2,000 Hz) before being rectified and integrated 
(using a leaky integrator; 0.1 s time constant) to obtain a mean voltage neurogram. The 
raw, filtered, and integrated MSNA signals were sampled at a frequency of 10,000 Hz 
and stored for further offline analysis (PowerLab Software, ADInstruments). 
2.2.4 Integrated MSNA Analysis 
Integrated bursts of MSNA were included in the analysis if they exhibited pulse-
synchrony, had a signal-to-noise ratio of at least 2:1 with respect to the previous period 
of neuronal silence between bursts, and had characteristic rising and falling slopes. 
Occurrence of integrated sympathetic bursts was confirmed by visually inspecting the 
corresponding raw and filtered neurograms. 
Integrated sympathetic nerve activity was expressed both as burst frequency (the 
number of bursts per minute) and burst incidence (the number of bursts per 100 heart 
beats). Burst amplitudes during baseline and sympathoexcitatory maneuvers were 
normalized to the largest recorded burst during each relevant baseline and maneuver 
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period, which was given a value of 100. Total MSNA was quantified as the product of 
mean normalized burst amplitude and burst frequency. 
2.2.5 Action Potential Detection and Analysis 
Action potentials were detected and extracted from the filtered raw MSNA 
signal using the techniques developed in our laboratory and described previously in 
detail [See Figure 2.1; (Salmanpour et al. 2010)]. Briefly, this approach detects 
individual action potentials using a continuous wavelet transform (CWT). The CWT 
uses a ‘mother wavelet’ that was adapted to an actual average action potential 
waveform constructed from (and with the same morphology as) physiological 
recordings of efferent post-ganglionic sympathetic action potentials (Salmanpour et al. 
2010). The CWT was applied to the filtered raw MSNA signal to generate a 
resemblance index (i.e., wavelet coefficient) between the signal of interest (i.e., an 
action potential) and the mother wavelet, such that the wavelet coefficient was the 
greatest in the presence of action potentials and negligible when applied to noise. 
Wavelet coefficients related to action potentials and noise were separated based on 
thresholding analysis (Johnstone & Silverman, 1997). The exact location of the 
negative peak for each action potential was then detected by isolating the largest 
suprathreshold wavelet coefficient. With the use of this location information, the action 
potential waveforms were obtained from the original filtered raw MSNA signal by 
setting the estimated location of action potentials in the center of a predefined window 
(3.2 ms). As such, the amplitude and morphology of each extracted action potential 
remained unaltered. Extracted action potentials were then ordered based on their peak-
to-peak amplitude, and histogram analysis was performed to separate action potentials 
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into ‘clusters’ (i.e., bins or groups of action potentials with similar peak-to-peak 
amplitudes) defined by Scott’s rule (Scott, 1979). Scott’s rule proposes the optimal 
histogram bin width to minimize the integrated mean square error by defining bin width 
based on the sample size and an estimate of the SD of the data. As such, the number of 
total clusters varied by participant. To enable comparisons within maneuvers and 
individuals, bin characteristics across conditions (i.e., baseline vs. apnea; baseline vs. 
LBNP) were manipulated within each individual to ensure that minimum histogram bin 
width, maximum bin center, and total number of bins would be identical across 
conditions. This bin normalization ensured that corresponding clusters at baseline and 
subsequent sympathoexcitatory maneuvers contained action potentials with similar 
peak-to-peak amplitudes. As such, new clusters detected during sympathoexcitatory 
maneuvers represent recruitment of new, larger action potentials not present during 
baseline. 
Action potential indices assessed include action potential frequency (the number 
of action potentials per minute), action potential incidence (the number of action 
potentials per 100 heart beats), and the mean action potential content per integrated 
burst. Additionally, the number of total clusters detected and the number of active 
clusters per integrated burst were assessed. The conduction latency of each individual 
action potential was established as the time delay between the R-wave of the ECG of 
the preceding cardiac cycle and the negative peak of the action potential waveform. As 
such, action potential cluster latency was determined as the mean latency of all action 
potentials contained within each cluster. As the number of total clusters varied by 
individual, normalization procedures were completed when assessing action potential 
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content and latency as a function of cluster number between individuals (i.e., Figures 
2.4, 2.5, 2.8, and 2.9). Specifically, each participants’ number of total clusters was 
normalized to 10 total clusters (i.e., bins), each containing a 10% range of the largest 
detected cluster (i.e., 0-10%, 10-20%, etc.), which was given a value of 100%. For 
example, cluster 0-10% contained an average of all cluster numbers that were 0-10% of 
the largest cluster. This procedure was then repeated for the nine remaining clusters. 
2.2.6 Test-Retest Repeatability of Action Potential Detection 
To assess the test-retest repeatability of this technique to detect and extract 
action potentials from the filtered raw MSNA signal, male participants (n = 6) were 
studied a second time approximately one month following their initial testing day. All 
repeat testing was conducted at the same time of day as initial testing. Successful 
microneurographic recordings were obtained in both test dates in five participants, who 
are thus included in the test-retest repeatability analysis (chemoreflex protocol; n = 4). 
Test-retest repeatability of selected action potential variables (action potential 
frequency and active clusters per burst) was assessed using the Bland-Altman method 
of differences (Altman & Bland, 1983; Bland & Altman, 1986). To determine 
systematic differences or biases between the two test dates, we assessed measures of 
fixed bias and proportional bias. Fixed bias occurs when one test produces values that 
are consistently greater or lesser than those from a second test by a constant amount, 
whereas proportional bias occurs when one test produces values that are greater or 
lesser than those from a second test by an amount proportional to the level of the 
variable assessed (Ludbrook, 1997).  
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2.2.7 Statistical Analysis 
The effect of condition (baseline vs. apnea; baseline vs. LBNP) was assessed 
using two-tailed, paired t-tests. Cohen’s d values are provided as an estimate of effect 
size (Cohen, 1988). For test-retest repeatability analysis, fixed bias was tested using a 
one-sample t-test, where the mean difference between test dates was tested against a 
value of “0”. Proportional bias was determined to exist if the Pearson product-moment 
correlation coefficient was significantly different than r = 0. Statistical significance was 
set at P < 0.05 and all data are presented as means ± SD. All statistical analyses were 
performed using SigmaPlot 12.0 (Systat Software Inc., San Jose, CA).  
2.3 Results 
Baseline versus End-Inspiratory Apnea. Data were obtained and analyzed for 
297 ± 6 seconds at baseline and during 23 ± 10 seconds of a maximal end-inspiratory 
apnea. A representative sample of data collected for one subject at baseline and during 
chemoreflex conditions is shown in Figure 2.2. The rebreathe protocol and subsequent 
apnea elicited severe chemoreflex stress, as evident by the significant end-apnea 
decrease in PETO2 and increase in PETCO2 compared with baseline (all P < 0.0001; 
Table 2.1). Results from the integrated MSNA analyses at baseline and during apnea 
are presented in Table 2.2. Specifically, compared with baseline, burst frequency, burst 
incidence, mean normalized burst amplitude, and total MSNA were significantly 
increased during apnea (all P < 0.0001). The elevated sympathetic nerve activity during 
apnea was concomitant with significant increases in mean arterial blood pressure and 
total peripheral resistance (both P < 0.05; Table 2.1). 
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When compared with baseline, both action potential frequency and action 
potential incidence were elevated during apnea, yielding an increase in the mean action 
potential content per burst during apnea (all P < 0.01; Table 2.2). When detected action 
potentials were binned according to peak-to-peak amplitude, the number of total 
clusters of action potentials detected (13 ± 4 to 20 ± 8 total clusters; P = 0.0009; d = 
1.14; Figure 2.3a) increased during apnea. Moreover, the increased number of total 
clusters was associated with a significant increase in the number of active clusters per 
sympathetic burst (5 ± 2 to 8 ± 2 clusters/burst; P < 0.0001; d = 1.44; Figure 2.3b) 
during apnea. When histogram analysis was conducted to represent action potential 
content as a function of normalized cluster number (Figure 2.4), a shift in the median 
occurred during apnea compared with baseline (P < 0.0001), indicating preferential 
recruitment of larger-amplitude action potentials during apnea. 
At baseline and during apnea, a pattern emerged whereby action potential 
cluster latency decreased in each subject as cluster number increased (i.e., as peak-to-
peak cluster amplitude increased). The mean responses (Figure 2.5) were fitted using an 
exponential function model at baseline (R2 = 0.91; P < 0.001) and during apnea (R2 = 
0.98; P < 0.0001). Interestingly, the cluster latency profile was shifted downwards for 
every corresponding cluster number during apnea versus baseline (range −15 to −99 
ms; mean = −53 ± 27 ms), indicating that all action potentials with similar peak-to-peak 
amplitudes were detected approximately 53 ms earlier during apnea versus baseline.     
Baseline versus −80 mmHg LBNP. Data were obtained and analyzed for 274 ± 
39 seconds at baseline and for 188 ± 15 seconds at −80 mmHg LBNP. A representative 
sample of data collected for one subject at baseline and LBNP is shown in Figure 2.6. 
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Hemodynamic parameters at baseline and during LBNP are displayed in Table 2.3. 
Results from the integrated MSNA analyses during baseline and LBNP are presented in 
Table 2.4. Specifically, compared with baseline, burst frequency, burst incidence, mean 
normalized burst amplitude, and total MSNA were increased during LBNP (all P < 
0.001). The increase in MSNA during LBNP was associated with a pronounced 
tachycardia and reduction in stroke volume, as well as a significant increase in total 
peripheral resistance (all P < 0.05; Table 2.3).  
Action potential frequency, action potential incidence, and the mean action 
potential content per burst were increased during LBNP versus baseline (all P < 0.01; 
Table 2.4). When detected action potentials were binned according to their peak-to-
peak amplitude, the number of total action potential clusters increased from 15 ± 5 at 
baseline to 26 ± 8 during LBNP (P = 0.0012, d = 1.66; Figure 2.7a), indicating 
recruitment of approximately 11 additional, larger amplitude clusters of action 
potentials during LBNP. This was associated with an increase in the number of active 
clusters per sympathetic burst during LBNP (5 ± 1 to 8 ± 3 clusters/burst; P = 0.0076, d 
= 1.44; Figure 2.7b). Histogram analysis representing action potential content as a 
function of normalized cluster number (Figure 2.8) revealed a shift in the median value 
during LBNP compared with the baseline period (P = 0.0011), indicating preferential 
recruitment of larger amplitude action potentials during LBNP. 
As with the apnea outcomes, action potential cluster latency decreased in each 
participant as an inverse function of cluster number (i.e., as peak-to-peak amplitude 
increased) at both baseline and LBNP. Mean responses (Figure 2.9) were fitted using an 
exponential model at baseline (R2 = 0.97; P < 0.0001) and LBNP (R2 = 0.95; P < 
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0.0001). However, in contrast to apnea, the cluster latency-size profile during LBNP 
was shifted upwards relative to baseline for every corresponding cluster number (range 
+2 to +45 ms; mean = +31 ± 12 ms), indicating that action potentials with similar peak-
to-peak amplitudes were detected approximately 31 ms later during LBNP.     
Test-Retest Repeatability of Action Potential Detection. Results obtained from 
the Bland-Altman method of differences for action potential detection at baseline and 
during apnea and LBNP are summarized in Table 2.5. Specifically, action potential 
frequency and the number of active clusters per burst were without significant 
proportional or fixed bias during baseline, apnea, or LBNP in repeated test dates. 
Furthermore, all hemodynamic, integrated MSNA, and action potential indices assessed 
were without significant day-to-day variation (all P > 0.05). 
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Table 2.1: Hemodynamic parameters at baseline and during maximal end-
inspiratory apnea 
 Baseline Apnea 
MAP (mmHg) 
SBP (mmHg) 
DBP (mmHg) 
HR (beats min-1) 
SV (mL) 
CO (L min-1) 
TPR (mmHg L-1 min-1) 
PETO2 (Torr) 
PETCO2 (Torr) 
86 ± 8 
120 ± 13 
69 ± 8 
55 ± 4 
86 ± 12 
4.7 ± 0.6 
19 ± 2 
103 ± 3 
39 ± 3 
97 ± 16† 
134 ± 25* 
78 ± 15† 
62 ± 6† 
81 ± 11* 
5.0 ± 0.7 
21 ± 3* 
56 ± 3† 
56 ± 4† 
Values are mean ± SD. MAP, mean arterial pressure; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; HR, heart rate; SV, stroke volume; CO, cardiac output; 
TPR, total peripheral resistance; PETO2, end-tidal partial pressure of oxygen; PETCO2, 
end-tidal partial pressure of carbon dioxide. *Significantly different from baseline, P ≤ 
0.05; †Significantly different from baseline, P ≤ 0.01. 
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Table 2.2: Integrated MSNA and action potential indices at baseline and during 
maximal end-inspiratory apnea 
 Baseline Apnea 
Integrated MSNA 
Burst Frequency (bursts/min) 
Burst Incidence (bursts/100 heart beats) 
Normalized Burst Amplitude (AU) 
Total MSNA (AU) 
 
Action Potential Indices 
AP Frequency (spikes/min) 
AP Incidence (spikes/100 heart beats) 
APs/Burst (spikes/burst) 
 
15 ± 8 
28 ± 16 
24 ± 6 
366 ± 220 
 
 
174 ± 151 
325 ± 293  
11 ± 4 
 
48 ± 7† 
77 ± 9† 
58 ± 9† 
2745 ± 478† 
 
 
1083 ± 487† 
1766 ± 829† 
24 ± 12† 
Values are mean ± SD. MSNA, muscle sympathetic nerve activity; AU, arbitrary 
units; AP, action potential. †Significantly different from baseline, P ≤ 0.01. 
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Table 2.3: Hemodynamic parameters at baseline and during −80 mmHg lower 
body negative pressure 
 Baseline LBNP 
MAP (mmHg) 
SBP (mmHg) 
DBP (mmHg) 
HR (beats min-1) 
SV (mL) 
CO (L min-1) 
TPR (mmHg L-1 min-1) 
88 ± 8 
121 ± 14 
71 ± 9 
56 ± 6 
89 ± 19 
4.9 ± 1.0 
20 ± 4 
88 ± 9 
113 ± 14* 
75 ± 8* 
79 ± 14* 
59 ± 19† 
4.4 ± 1.0† 
21 ± 4* 
Values are mean ± SD. LBNP, lower body negative pressure; MAP, mean arterial 
pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart 
rate; SV, stroke volume; CO, cardiac output; TPR, total peripheral resistance. 
*Significantly different from baseline, P ≤ 0.05; †Significantly different from 
baseline, P ≤ 0.01. 
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Table 2.4: Integrated MSNA and action potential indices at baseline and during 
−80 mmHg lower body negative pressure 
 Baseline LBNP 
Integrated MSNA 
Burst Frequency (bursts/min) 
Burst Incidence (bursts/100 heart beats) 
Normalized Burst Amplitude (AU) 
Total MSNA (AU) 
 
Action Potential Indices 
AP Frequency (spikes/min) 
AP Incidence (spikes/100 heart beats) 
APs/Burst (spikes/burst) 
 
15 ± 7 
26 ± 13 
31 ± 12 
472 ± 302 
 
 
165 ± 83 
296 ± 140  
11 ± 2 
 
41 ± 15† 
52 ± 12† 
52 ± 4† 
2138 ± 769† 
 
 
839 ± 709† 
1027 ± 703† 
19 ± 9† 
Values are mean ± SD. MSNA, muscle sympathetic nerve activity; LBNP, lower 
body negative pressure; AU, arbitrary units; AP, action potential. †Significantly 
different from baseline, P ≤ 0.01. 
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Table 2.5: Proportional and fixed bias outcomes for action potential detection 
determined from the Bland-Altman method of differences during baseline, 
maximal end-inspiratory apnea, and −80 mmHg lower body negative pressure 
protocols 
 
N = 5 males; r, Pearson product-moment correlation coefficient for the Bland-Altman 
method of differences plots; PPB, P value for the Pearson product-moment correlation 
coefficient for the determination of proportional bias; SE, standard error; CI, 
confidence interval; PFB, P value for the one sample t-test on the mean differences 
versus 0 for the determination of fixed bias; AP, action potential. 
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Figure 2.1: Schematic representation of action potential (AP) detection and 
classification. 
MSNA, muscle sympathetic nerve activity. 
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Figure 2.2: Representative sample of data from one subject collected at baseline, 
during rebreathe, maximal end-inspiratory apnea, and recovery. 
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Figure 2.3: Total detected clusters (A) and active clusters/burst (B) at baseline and 
during maximal end-inspiratory apnea.  
*Significantly different from baseline, P < 0.001. 
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Figure 2.4: Histogram representing action potential (AP) content as a function of 
normalized cluster number at baseline and during maximal end-inspiratory 
apnea. 
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Figure 2.5: Mean action potential cluster latency across participants as a function 
of normalized cluster number at baseline and during maximal end-inspiratory 
apnea. 
Sample size for clusters in which not all 11 subjects are included are indicated in 
parentheses. Sample sizes <11 at baseline represent subjects in whom these clusters 
were not present at baseline but were recruited during apnea. 
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Figure 2.6: Representative sample of data from one subject collected at baseline 
and during −80 mmHg lower body negative pressure (LBNP) and recovery. 
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Figure 2.7: Total detected clusters (A) and active clusters/burst (B) at baseline and 
during −80 mmHg lower body negative pressure (LBNP). 
*Significantly different from baseline, P < 0.01. 
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Figure 2.8: Histogram representing action potential (AP) content as a function of 
normalized cluster number at baseline and −80 mmHg lower body negative 
pressure (LBNP). 
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Figure 2.9: Mean action potential cluster latency across participants as a function 
of normalized cluster number at baseline and −80 mmHg lower body negative 
pressure (LBNP). 
Sample size for clusters in which not all 11 subjects are included are indicated in 
parentheses. Sample sizes <11 at baseline represent subjects in whom these clusters 
were not present at baseline but were recruited during LBNP. 
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2.4 Discussion 
The results of the current investigation reveal two novel findings which advance 
our understanding of the neural coding patterns employed within the sympathetic 
nervous system. First, we demonstrate the ability to recruit sub-populations of 
previously silent (i.e., not present at baseline), larger amplitude, and faster conducting 
sympathetic axons during periods of severe chemoreflex- and baroreflex-mediated 
sympathoexcitation. We interpret this to be reflective of a reflex-independent 
sympathetic neural recruitment strategy involving a latent sub-population of recruitable 
neurons that are reserved for periods of severe stress. Second, our results demonstrate 
the potential for reflex-specific changes in neural activation latency during periods of 
severe sympathetic stress. Specifically, the action potential cluster latency profile was 
shifted downwards during severe chemoreflex stress and upwards during severe 
baroreceptor unloading. Of note, the deflections in the cluster latency response curve 
were observed equally across all clusters, suggesting that this recruitment strategy was 
applied to all action potentials and does not reflect slower axonal conduction. Rather, 
this finding suggests variable synaptic delays as a second strategy to modify post-
ganglionic sympathetic nerve activity. The combined data, observed in the same 
individuals, supports the idea that both synaptic delay variations and high-threshold 
sub-populations exist as recruitment strategies for post-ganglionic efferent sympathetic 
outflow.  
To date, available information on neural recruitment strategies within the 
sympathetic nervous system has been largely inferred from the integrated neurogram. 
For example, an early observation that larger integrated bursts exhibit shorter reflex 
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latency led Wallin and colleagues to hypothesize that reductions in central synaptic 
delays or variations in central pathways may occur and/or that there may exist 
populations of latent sympathetic neurons with faster conduction velocities (Wallin et 
al. 1994). More specific positioning of higher impedance electrodes enabled Macefield 
and colleagues to isolate action potential discharge patterns of single sympathetic axons 
within human peripheral nerves (Macefield et al. 1994). This approach revealed that, 
when active, individual neurons generally fire only once per integrated burst (Macefield 
et al. 1994), with the probability of multiple within-burst firing increasing during 
periods of high sympathetic drive (Macefield & Wallin, 1999; Elam et al. 2002). 
Results from these studies led to the idea that increased firing of already-active neurons 
was an important mechanism by which burst strength is elevated during periods of 
sympathetic stress (Macefield & Wallin, 1999).  
Results from the current investigation, which studied action potential 
recruitment from the multi-unit signal in both chemoreflex and baroreflex scenarios in 
the same individuals, validate and extend these previous observations and provide 
further insight into sympathetic neuronal recruitment strategies. First, evidence was 
provided that sub-populations of previously dormant, larger amplitude, and faster 
conducting sympathetic neurons are recruited during periods of high stress. 
Importantly, the present data suggest that this appears to be a reflex-independent 
strategy used within the sympathetic nervous system. These observations support the 
earlier report that, in addition to higher firing rates of axons already recruited during 
baseline, severe chemoreflex stress elicits activation of latent, higher-threshold, and 
faster conducting (therefore, larger diameter) axons (Steinback et al. 2010). This 
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discharge pattern was not observed during preliminary results using modest levels of 
simulated orthostatic stress (i.e., −60 mmHg LBNP), whereby higher frequency firing 
of action potential clusters already recruited at baseline was the primary determinant of 
elevated efferent activity, with about 30% of participants demonstrating recruitment of 
new, larger action potentials (Salmanpour et al. 2011a). Whereas orthostatic tolerance 
or reserve varies across individuals, it remains likely that the threshold for recruitment 
of this sub-population will also vary across individuals and with the level of stress. Our 
current data indicate that more severe baroreceptor unloading (−80 mmHg LBNP) can 
elicit recruitment of these latent axons. As such, it appears that during moderate levels 
of stress, sympathetic activity is elevated through the multiple firing of already-active 
neurons as previously hypothesized (Macefield & Wallin, 1999), whereas severe stress 
stimulates the recruitment of latent sub-populations of larger axons to achieve the high 
levels of sympathetic activity necessary. We therefore suggest that there may exist a 
type of sympathetic reserve, whereby latent sub-populations of larger diameter, faster 
conducting sympathetic neurons are reserved for severe sympathetic stress. 
As previously established (Steinback et al. 2010; Salmanpour et al. 2011a), and 
in support of observations from integrated MSNA analyses (Wallin et al. 1994), action 
potential cluster latency was inversely related to action potential cluster amplitude, 
whereby larger amplitude neurons exhibited shorter reflex latencies. This pattern was 
observed both at baseline and during subsequent chemoreflex- and baroreflex-induced 
sympathoexcitation. Interestingly, during severe chemoreflex stimulation, there was an 
acute downward shift in the latency-size profile of all corresponding action potential 
clusters (~ 53 ms; see Figure 2.5), such that the latency of all action potentials with 
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similar peak-to-peak amplitudes was reduced during severe chemoreflex activation. 
This systemic downward shift in the cluster latency profile was also demonstrated 
during the Valsalva maneuver (Salmanpour et al. 2011b), and is consistent with 
observed changes in mean reflex burst latency seen during several sympathoexcitatory 
maneuvers (Fagius et al. 1987). The common pattern of this downward shift in latency 
during both end-inspiratory apnea and Valsalva maneuver suggests a common 
mechanism may be operating. Specifically, each maneuver elevates intrathoracic 
pressure, thereby reducing venous return. Each also expresses a particular perceptual 
stress related to individual volitional tolerance for the maneuver. While these two 
observations are from different studies, they suggest a cardiac stimulus may have 
contributed to the apneic outcomes of the current study. Alternatively, variations in 
action potential latency during chemoreflex stress may be due to direct glutaminergic 
activation of the rostral ventrolateral medulla from the nucleus tractus solitarius 
(Koshiya et al. 1993), and/or faster conduction velocities within spinal descending 
pathways specific to chemoreflex stimulation (Jänig & Szulczyk, 1979). 
Conversely, we demonstrate that during −80 mmHg LBNP, the latency-size 
profile of all corresponding action potential clusters was shifted upward (~31 ms; see 
Figure 2.9), indicating that similarly sized post-ganglionic neurons were recruited with 
a slightly slower latency during severe baroreceptor unloading, a pattern consistent with 
that seen previously in a preliminary manner during −60 mmHg LBNP (Salmanpour et 
al. 2011a). These data indicate that the sympathetic nervous system displays a unique 
ability to modify acutely the reflex latency of all action potentials during severe 
orthostatic stress. In as much as the conduction velocity of given axon is relatively 
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fixed, these modifications in latency indicate malleability in the synaptic delays 
between the brainstem and the recording electrode. One limitation of the multi-unit 
recording approach is the inability to ensure that action potentials of the same size are 
the same neurons with varying latencies during severe sympathoexcitation. However, 
given the anatomical bundled distribution of axons in peripheral nerves (Tompkins et 
al. 2013), it is unlikely that the recordings reflect completely different populations of 
neurons. Regardless, all that can be concluded is that action potentials with similar 
peak-to-peak amplitudes exhibit altered reflex latencies during chemoreflex- and 
baroreflex-mediated sympathetic stress. 
A potential limitation of the present study is that larger amplitude action 
potentials observed during periods of severe sympathetic stress could theoretically be 
the result of summation of two smaller-sized neurons firing concurrently, thereby 
eliciting an artificially large action potential (Spickler & Kezdi, 1969; Andresen & 
Yang, 1989). However, the likelihood for action potential summation is very low [~ 
0.3%; (Salmanpour et al. 2010)]. Further, such occurrences can be detected if the 
resulting action potential is large and does not fit the latency-size pattern (Clamann & 
Henneman, 1976) so that it is automatically removed from the analysis. Furthermore, 
the mean signal-to-noise ratio of 4.15 ± 0.5 in the current data sets are expected to 
produce a correct detection rate of >90% and false detection rate of <3% (Salmanpour 
et al. 2010). Another consideration is that larger amplitude action potentials could be 
the result of firing of neurons in close proximity to the recording electrode tip. 
However, the consistent pattern that these larger action potentials reflect shorter 
latencies argues against that possibility. Finally, results from our test-retest repeatability 
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analysis, although completed in a small sample of men (n = 5), suggest that indices of 
action potential detection are reproducible across test dates. If larger amplitude action 
potentials were the result of summation or proximity to the recording electrode, one 
would expect action potential indices to differ in repeated test dates, when the physical 
relationship between the microelectrode placement and sympathetic axons is likely to 
differ.  
Perspectives and Significance 
The current data indicate the existence of neural coding patterns within the 
autonomic nervous system and enhances our understanding of how the sympathetic 
nervous system is activated during reflex-mediated stress. Specifically, there appears a 
fixed reflex-independent recruitment strategy, whereby the large increases in 
sympathetic outflow during severe chemoreflex and baroreflex stress are the result of 
recruitment of latent sub-populations of larger, faster conducting sympathetic neurons. 
In addition, it appears as though the sympathetic nervous system is able to acutely 
modify synaptic delays or central processing times and/or pathways, such that reflex 
latency of all action potentials are altered during severe sympathetic stress. Taken 
together, the data provide a new perspective on sympathetic stress responses. This new 
understanding opens opportunity to study how such axonal recruitment strategies may 
affect neurotransmitter discharge and overall vascular responses, as well as the effect of 
age and disease on the patterning of efferent sympathetic outflow. 
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Chapter 3  
3 Central vs. peripheral determinants of sympathetic 
neural recruitment: insights from static handgrip 
exercise and postexercise circulatory occlusion 
(Published in Am J Physiol Integr Comp Physiol 311: R1013-R1021, 2016) 
3.1 Introduction 
Neural coding patterns represent a fundamental feature in the exchange and 
processing of neural information. Recently, we have confirmed that neural coding 
principals operate within the sympathetic nervous system (Steinback et al. 2010; 
Breskovic et al. 2011; Salmanpour et al. 2011a,b; Badrov et al. 2015; Badrov et al. 
2016). Specifically, increases in muscle sympathetic nerve traffic in response to acute 
physiological stress are the result of increased firing of low-threshold axons (i.e., rate 
coding), as well as the recruitment of latent sub-populations of larger-sized axons that 
are otherwise silent at baseline (i.e., population coding) (Steinback et al. 2010; 
Breskovic et al. 2011; Salmanpour et al. 2011a; Badrov et al. 2015; Badrov et al. 
2016). Furthermore, it appears that synaptic delay variations exist as a third strategy to 
alter autonomic outflow (Salmanpour et al. 2011b; Badrov et al. 2015; Badrov et al. 
2016). These strategies have been confirmed in two fundamental reflexes; that is, the 
arterial baroreflex, studied during −80 mmHg lower body negative pressure (LBNP) 
(Salmanpour et al. 2011a; Badrov et al. 2015) and the Valsalva maneuver (Salmanpour 
et al. 2011b), as well as the arterial chemoreflex, as inferred during maximal voluntary 
apnea (Steinback et al. 2010; Breskovic et al. 2011; Badrov et al. 2015; Badrov et al. 
2016). However, a persistent question remains, particularly with the apnea response, as 
to whether or not these recruitment strategies are restricted to the perception of effort 
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during severe stress scenarios (i.e., a central command phenomenon), or to the severe 
reflex stress alone (i.e., a peripheral-reflex mechanism). Evidence from the Valsalva 
maneuver and voluntary apnea data do not exclude a role for a central perception of 
effort determinant, whereas the LBNP data suggest a dominant role for peripheral-
reflex mechanisms. Additionally, one feature that may especially relate to central versus 
peripheral features is the ability to acutely modify reflex latency. That is, compared to 
resting levels, neural activation latency was reduced during voluntary apnea (Badrov et 
al. 2015; Badrov et al. 2016) and the Valsalva maneuver (Salmanpour et al. 2011b), but 
increased during LBNP-induced baroreceptor unloading (Badrov et al. 2015). As such, 
the exact central versus peripheral mechanisms of these sympathetic neural recruitment 
strategies remain to be fully elucidated. 
The homeostatic response to fatiguing exercise represents a unique reflex in 
which the central and peripheral elements of the reflex can be studied separately as they 
develop over time. Specifically, alterations in efferent neural outflow during exercise 
are mediated through a highly coordinated and integrative system of reflexes involving 
feed-forward signals emanating from higher brain centres (i.e., central command) 
(Johansson, 1895; Krogh & Lindhard, 1913; Goodwin et al. 1972), as well as peripheral 
feedback from type III and IV muscle sensory afferents within active skeletal muscle 
(i.e., exercise pressor reflex) (Alam & Smirk, 1937; McCloskey & Mitchell, 1972; 
Kaufman et al. 1983; Mitchell et al. 1983). The exercise pressor reflex elicits large 
increases in muscle sympathetic nerve activity (MSNA) (Mark et al. 1985; Seals et al. 
1988; Victor et al. 1988; Wallin et al. 1989; Saito et al. 1990; Seals & Victor, 1991; 
Shoemaker et al. 2007), albeit after a workload-dependent delay of approximately 30 to 
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60 seconds (Mark et al. 1985). Sympathetic activity remains elevated during post-
exercise circulatory occlusion (PECO), which suggests that the mechanism of activation 
relates to muscle metabolism and a dominant metaboreflex component. Furthermore, a 
marked increase in integrated sympathetic burst size characterizes this reflex, most 
likely reflective of increases in the number (Ninomiya et al. 1993) and/or size 
(Salmanpour et al. 2011a) of action potentials (AP) firing more or less at the same time. 
Recently, Murai et al. (2006) examined the firing patterns of a single axon that was 
present at baseline and sustained during static handgrip (SHG) exercise and found 
elevations in total sympathetic activity, but no change in the probability of multiple 
within-burst firing of that axon. Combined, the observations of no change in the 
probability of a single axon firing, but the need for additional and/or larger axons to 
account for larger bursts, suggests that latent axons are recruited in the large 
sympathetic response to fatiguing exercise. Thus, fatiguing exercise and the muscle 
metaboreflex represents a unique model to study the central versus peripheral features 
of sympathetic neural recruitment, as it allows the opportunity to isolate the peripheral-
reflex component from the central component (Alam & Smirk, 1937). 
Therefore, to study the varying roles played by central versus peripheral 
elements in the neural coding strategies used by the sympathetic nervous system during 
acute physiological stress, we used a multi-unit AP approach to examine sympathetic 
outflow patterns during fatiguing SHG exercise and a period of PECO. The latter was 
designed to maintain and isolate the muscle metaboreflex (i.e., peripheral-reflex 
component) from the central command features of the reflex (Alam & Smirk, 1937). 
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3.2 Methods 
3.2.1 Participants 
Six young healthy, normotensive males (25 ± 3 yrs, 179 ± 7 cm, 82 ± 6 kg; body 
mass index = 26 ± 2 kg/m2) were studied after providing informed written consent. 
Participants were recreationally active, non-smokers, and otherwise healthy with no 
history of cardiovascular or respiratory disease. The study was approved by the Health 
Sciences Research Ethics Board at Western University in London, Canada.  
3.2.2 Experimental Protocol 
Participants were tested following a 3-hour fast, a 12-hour abstinence from 
caffeinated products and alcohol, and a 24-hour abstinence from strenuous exercise. 
Testing was completed in the supine position. Participants performed two maximal 
voluntary contractions (MVCs) with their non-dominant hand (left hand in all 
participants), and the largest of the two was used to calculate relative handgrip intensity 
for the ensuing SHG protocol. Following a 3-minute baseline rest period, participants 
performed SHG exercise for five minutes at 20% MVC, which was followed 
immediately by PECO for three minutes. PECO was initiated approximately five 
seconds prior to exercise completion by rapidly inflating a pneumatic cuff (Hokanson 
SC12D, D.E. Hokanson, Bellevue, WA) on the upper exercised arm to suprasystolic 
levels (~200 mmHg). Throughout SHG, visual feedback of exercise intensity was 
provided to aid participants in the maintenance of target force. Upon exercise 
completion, and before PECO onset, participants assessed their level of perceived 
exertion using the 20-point Borg Rating of Perceived Exertion Scale (Borg, 1970). 
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3.2.3 Experimental Measures 
Sympathetic neural recordings were obtained in the right peroneal nerve using 
microneurography (Hagbarth & Vallbo, 1968) (662C-3; Bioengineering of University 
of Iowa, Iowa City, IA). The methodology used in our laboratory have been described 
previously in detail (Steinback et al. 2010; Salmanpour et al. 2011a; Badrov et al. 
2015). Heart rate (HR) was determined throughout the study protocol from a standard 
three-lead electrocardiogram. Mean arterial pressure (MAP) was obtained on a beat-to-
beat basis using finger photoplethysmography (Finometer; Finapres Medical Systems, 
Amsterdam, The Netherlands) on the nonexercised hand, which was calibrated to 
manual sphygmomanometry values. The Finometer Modelflow algorithm was used to 
calculate stroke volume (SV) and cardiac output (CO), and total peripheral resistance 
(TPR) was calculated as MAP divided by CO. Data were collected using LabChart7 
and PowerLab (ADInstruments, Colorado Springs, CO). 
3.2.4 Data Analysis 
Data were analyzed for the 3-minute baseline period, each minute of the 5-
minute SHG exercise, and for the 3-minute PECO period. Sympathetic bursts were 
identified from the integrated MSNA neurogram if: 1) they exhibited pulse-synchrony; 
2) they had a signal-to-noise ratio of at least 2:1 with respect to the previous period of 
neural silence between bursts; 3) they presented with characteristic rising and falling 
slopes; and 4) APs were visible in the corresponding raw and filtered neurograms. The 
level of integrated sympathetic activity was assessed using burst frequency (bursts/min) 
and burst incidence (bursts/100 heart beats; hb). Furthermore, burst amplitude, which 
reflects both the size (Salmanpour et al. 2011a) and number (Ninomiya et al. 1993) of 
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APs recruited within each burst, was assessed. However, due to the potential influence 
of microelectrode placement on the amplitude of the integrated signal (Vallbo et al. 
1979; Tompkins et al. 2013), burst amplitude was normalized within each individual to 
the largest burst at baseline, which was assigned a value of 100 arbitrary units (AU). 
Finally, total MSNA (product of burst frequency and normalized burst amplitude) was 
determined. 
Sympathetic APs were extracted from the filtered raw MSNA signal using 
wavelet-based methodology, as first used by others (Diedrich et al. 2003; Brychta et al. 
2007), and modified in our laboratory (Salmanpour et al. 2010). Briefly, a continuous 
wavelet transform with a ‘mother wavelet’ (adapted from actual physiological 
recordings of post-ganglionic sympathetic APs) was applied to the filtered raw MSNA 
signal to extract sympathetic APs at their point of incidence. Extracted APs were 
ordered based on their peak-to-peak amplitude, and histogram analysis was conducted 
to separate APs into ‘clusters’ (i.e., bins of similarly-sized APs) (Scott, 1979). The AP 
detection, extraction, and classification process, as well as the reliability and 
repeatability of our AP detection technique has been described previously in detail, and 
readers are directed to this previous work (Salmanpour et al. 2010; Steinback et al. 
2010; Badrov et al. 2015). Next, within participants, cluster characteristics were 
normalized to ensure that bin width, maximum bin center, and the total number of bins 
would be identical across conditions (i.e., baseline to SHG to PECO). This 
normalization procedure ensured that corresponding clusters across conditions contain 
APs with similar peak-to-peak amplitudes. Therefore, an increase in total clusters 
during SHG or PECO represents recruitment of sub-populations of previously silent, 
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larger-sized AP families that were not present at baseline. Finally, the average signal-
to-noise ratio in the current study was 4.4 ± 0.6, and based on previous validation 
analysis of our analytical technique (Salmanpour et al. 2010), this is expected to 
produce a correct detection rate of >90% and a false positive rate of <3%. 
Patterns of AP activity were expressed using AP frequency (APs/min). 
Recruitment of sympathetic APs was quantified using the mean AP content per 
integrated sympathetic burst (APs/burst), the number of total AP clusters, and the 
number of active AP clusters per integrated sympathetic burst (clusters/burst). AP 
cluster latency was calculated as the mean AP latency of all APs present within that 
respective cluster, which was measured as the time delay between the R-wave of the 
preceding cardiac cycle and the negative peak of the AP waveform. As the number of 
total AP clusters varied between participants, the number of total clusters was 
normalized to 10 clusters, each containing 10% ranges of the largest detected cluster, 
which was given a value of 100% (i.e., 0-10%, 10-20%, etc.), when assessing the AP 
cluster size-latency relationship (Badrov et al. 2015; Badrov et al. 2016). 
3.2.5 Statistical Analysis 
One-way repeated measures ANOVAs assessed the effect of time (i.e., baseline 
to SHG to PECO) on each hemodynamic, integrated MSNA, and AP variable 
(SigmaPlot 12.0; Systat Software Inc., San Jose, CA). Data were tested for normal 
distribution using Shapiro-Wilk tests. Non-normally distributed data were assessed 
using Friedman repeated measures ANOVAs on ranks. Significant main effects were 
assessed using Tukey’s post-hoc analysis. Statistical significance was set at P < 0.05 
and all data are presented as mean ± SD. 
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3.3 Results 
Figure 3.1 displays original recordings of HR, MAP, integrated MSNA, filtered 
raw MSNA, and detected APs from one participant. On average, SHG exercise was 
completed at 20 ± 1% MVC and participants reported a Borg scale rating of 17 ± 2 at 
end exercise.  
Figure 3.2 displays the mean and individual hemodynamic responses to SHG 
and PECO and Table 2.1 provides the delta values on going from baseline to each 
period of the SHG and PECO protocol. At baseline, MAP was 94 ± 7 mmHg, HR was 
62 ± 5 beats/min, SV was 106 ± 17 mL, CO was 6.7 ± 1.4 L/min, and TPR was 15 ± 3 
mmHg/L/min. When compared with baseline, MAP was increased by minute two of 
SHG, and remained elevated throughout the duration of exercise and PECO (all P < 
0.01). HR was elevated during the entire SHG period and remained elevated during 
PECO (all P < 0.001), but at levels that were less than those observed during minutes 
three to five of SHG (all P < 0.05). When compared with baseline, SV was unchanged 
during SHG and PECO (all P > 0.05). CO was elevated throughout SHG and PECO (all 
P < 0.05). Finally, compared with baseline, TPR was reduced throughout SHG and 
PECO (all P < 0.05).  
Figure 3.3 illustrates the mean and individual integrated MSNA responses to 
SHG and PECO and Table 3.2 provides the delta values. At baseline, burst frequency 
was 18 ± 13 bursts/min, burst incidence was 28 ± 20 bursts/100 hb, burst amplitude was 
46 ± 13 AU, and total MSNA was 742 ± 519 AU/min. When compared with baseline, 
burst frequency and burst incidence were increased by minute three of SHG exercise 
and remained elevated for the duration of exercise and PECO (all P < 0.05). 
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Furthermore, burst amplitude increased above baseline by minute four of SHG and 
remained elevated at minute five and during PECO (all P < 0.01). Finally, total MSNA 
increased by minute three of SHG, remaining elevated above baseline levels for the 
duration of exercise and PECO (all P < 0.05).  
Figure 3.4 outlines the mean and individual AP responses to SHG and PECO 
and Table 3.2 provides the delta values. At baseline, AP frequency was 223 ± 271 
APs/min, the mean AP content per burst was 10 ± 5 APs/burst, the number of active 
clusters per burst was 5 ± 2, and the number of total clusters was 14 ± 6. When 
compared with baseline, AP frequency increased by minute three of SHG and remained 
elevated throughout SHG and PECO (all P < 0.05). The mean AP content per integrated 
sympathetic burst increased by minute four of SHG and remained elevated at minute 
five and PECO (all P < 0.05). Similarly, the number of active clusters per integrated 
burst was elevated by minute four and stayed elevated throughout the remainder of 
SHG and PECO (all P < 0.01). Finally, compared to baseline, the number of total AP 
clusters was increased at minutes four and five of SHG, and remained elevated during 
PECO (all P < 0.01). 
At baseline, AP cluster latency decreased as a function of normalized cluster 
number (i.e., as the peak-to-peak AP cluster amplitude increased), such that larger-sized 
APs exhibited shorter reflex latency. The mean response was fitted using an exponential 
function model (R2 = 0.73; P < 0.001). The same pattern was observed throughout SHG 
exercise (HG1: R2 = 0.92; HG2: R2 = 0.93; HG3: R2 = 0.83; HG4: R2 = 0.69; HG5: R2= 
0.91; all P < 0.01) and PECO (R2 = 0.65; P < 0.01). When compared with baseline, the 
AP cluster size-latency profile for corresponding clusters was not shifted significantly 
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upward or downward during the first three minutes of SHG exercise (HG1: mean = 8 ± 
16 ms, range −12 to 28 ms; HG2: mean = 4 ± 17 ms, range −17 to 27 ms; HG3: mean = 
−11 ± 18 ms, range −38 to 12 ms; all P > 0.05). However, compared with baseline, the 
AP cluster-size latency profile was shifted downward for every corresponding cluster 
during minutes four (mean = −32 ± 22 ms, range −5 to −61 ms; P < 0.05) and five 
(mean = −49 ± 17 ms, range −27 to −77 ms; P < 0.05; Figure 3.5) of SHG exercise, 
such that all similarly sized APs were recruited earlier during SHG. During PECO, the 
AP cluster size-latency profile was not different than baseline levels (mean = −9 ± 12 
ms, range −25 to 9 ms; P > 0.05). 
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Table 3.1: Hemodynamic responses to SHG and PECO 
 
Values are mean ± SD. SHG, static handgrip; PECO, post-exercise circulatory 
occlusion; HG, handgrip; MAP, mean arterial pressure; HR, heart rate; SV, stroke 
volume; CO, cardiac output; TPR, total peripheral resistance. *Significantly different 
from baseline, P < 0.05. 
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Table 3.2: Integrated MSNA and action potential responses to SHG and PECO 
 
Values are mean ± SD. MSNA, muscle sympathetic nerve activity; SHG, static 
handgrip; PECO, post-exercise circulatory occlusion; HG, handgrip; BF, burst 
frequency; BI, burst incidence; BA, burst amplitude; AU, arbitrary units; AP, action 
potential. *Significantly different from baseline, P < 0.05. 
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Figure 3.1: Representative sample of data collected from one subject at baseline 
(BSL) and during static handgrip and postexercise circulatory occlusion (PECO). 
HR, heart rate; BP, blood pressure; MSNA, muscle sympathetic nerve activity; AP, 
action potential. *Denotes noise spikes not included in analysis. 
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Figure 3.2: Hemodynamic responses to static handgrip (HG) and postexercise 
circulatory occlusion (PECO). 
Dashed lines represent individual data. Values are mean ± SD. MAP, mean arterial 
pressure; HR, heart rate; SV, stroke volume; CO, cardiac output; TPR, total peripheral 
resistance. *P < 0.05, significantly different from baseline (BSL). 
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Figure 3.3: Integrated muscle sympathetic nerve activity (MSNA) responses to 
static handgrip (HG) exercise and postexercise circulatory occlusion (PECO). 
Dashed lines represent individual data. Values are mean ± SD. AU, arbitrary units; hb, 
heartbeats. *P < 0.05, significantly different from baseline (BSL). 
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Figure 3.4: Sympathetic action potential (AP) responses to static handgrip (HG) 
exercise and postexercise circulatory occlusion (PECO). 
Dashed lines represent individual data. Values are means ± SD. *P < 0.05, significantly 
different from baseline (BSL). 
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Figure 3.5: Action potential (AP) cluster latency as a function of AP cluster size at 
baseline (BSL), minutes one to five of static handgrip (HG), and post-exercise 
circulatory occlusion (PECO). 
No significant upward or downward shift was seen in the AP cluster size-latency profile 
during HG1 (range −14 to 36 ms; range represents individual data), HG2 (range −18 to 
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35 ms), or HG3 (range −53 to 10 ms), whereas a significant downward shift in the 
profile was observed during HG4 (range 4 to −136 ms) and HG5 (range −9 to −198 
ms). Finally, no significant upward or downward shift was seen during PECO (range 
−28 to 22 ms). *Significantly different from BSL, P < 0.05. 
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3.4 Discussion 
This study examined AP recruitment patterns during the SHG and PECO phases 
of the exercise pressor response maneuver to gain insight into the role that central 
command elements versus peripheral-reflex mechanisms have in AP recruitment and 
sympathetic outflow patterns in humans. The major findings of the current study are as 
follows: 1) In response to exercise pressor reflex activation, the sympathetic nervous 
system increases efferent nerve discharge through increased firing of previously 
recruited axons, and also through the recruitment of latent sub-populations of larger-
sized, faster conducting axons. These larger and faster APs were present at the end of 
the SHG period and persisted throughout the PECO phase. 2) The latency of all APs 
was reduced towards the end of fatiguing SHG exercise, but not during the PECO 
phase. The results suggest that central command features may play a specific role in 
modifying the synaptic delay aspect of efferent sympathetic discharge timing, whereas 
peripheral muscle chemoreflex mechanisms affect the recruitment of latent high-
threshold APs. 
Fatiguing SHG exercise elicits robust increases in muscle sympathetic outflow 
through activation of mechanically- and metabolically-sensitive Type III and IV 
sensory afferents (Kaufman et al. 1983; Mitchell et al. 1983), and perhaps modulatory 
input from higher brain sites during more intense contraction (Victor et al. 1995). To 
date, quantification of the integrated MSNA neurogram has formed the basis of 
determining the sympathetic response to this reflex, with the finding that MSNA is 
increased after an initial delay (Mark et al. 1985), the timing of which is most likely 
influenced inversely by contraction intensity (Hashimoto et al. 1998). Indeed, in the 
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current study, MSNA burst frequency and incidence were elevated after approximately 
two minutes of SHG exercise completed at the relatively modest intensity of 20% 
MVC. 
Presently, using a multi-unit AP approach, we show for the first time that the 
sympathetic nervous system responds to fatiguing SHG exercise by increasing the firing 
of already recruited lower-threshold axons, and through the recruitment of sub-
populations of previously silent (i.e., not present at baseline), higher-threshold and 
faster conducting (and therefore, larger) axons. This is similar to patterns observed 
previously during both baroreflex (Salmanpour et al. 2011a; Badrov et al. 2015) and 
arterial chemoreflex (Steinback et al. 2010; Breskovic et al. 2011; Badrov et al. 2015; 
Badrov et al. 2016) stimuli, and is supported by the concept that C-fiber diameter 
variations (~0.5 to 2.0 µm) exist within the human peroneal nerve (Tompkins et al. 
2013). Since these larger and faster APs became evident after three minutes of exercise, 
and persisted throughout the PECO period, their recruitment appears to be related to 
peripheral events within the muscle and, therefore, related to the metaboreflex. These 
observations discount a role for central factors in eliciting the recruitment of these latent 
fibres, at least in this reflex model. Interestingly, the different time-course of change 
between integrated MSNA indices (i.e., increased after two minutes) and AP 
recruitment (i.e., increased after three minutes) may lend important information as to 
the order of discharge options used by the sympathetic nervous system. Specifically, 
MSNA burst frequency increased before the number of APs per burst or total AP 
clusters increased, which suggests that the first option for the sympathetic nervous 
system is to increase firing frequency and the second option is recruitment of additional 
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fibres, as previously hypothesized (Macefield & Wallin, 1999), and similar to the 
ordered recruitment observed in the motor system (i.e., Henneman’s Size Principle) 
(Henneman et al. 1965). This also supports the conjecture that these axons are reserved 
for periods of high or severe physiological stress (Salmanpour et al. 2011a; Badrov et 
al. 2015). In line with this, recruitment of new, larger axons was observed in all 
individuals during −80 mmHg LBNP, but in only approximately 30% of these same 
individuals during −60 mmHg LBNP (Salmanpour et al. 2011a). Taken together, it 
appears as though a fixed, reflex-independent recruitment strategy exists within the 
sympathetic nervous system, whereby sub-populations of larger neurons are recruited 
during severe stress scenarios requiring high sympathetic outflow, albeit with some 
interindividual variations. Furthermore, the current results suggest that peripheral-reflex 
mechanisms play a dominant role in mediating this recruitment response. Whether this 
conclusion applies across all reflexes will require additional study. However, central 
command likely has a small role in LBNP, lending further support to the reflexive role 
played by peripheral sensory mechanisms in AP recruitment. 
In addition to the above described recruitment options, the sympathetic nervous 
system also modifies efferent firing of lower-threshold axons through acute variations 
of reflex activation latency (Salmanpour et al. 2011b; Badrov et al. 2015; Badrov et al. 
2016). In further support of this, we show here that the AP cluster size-latency profile 
was shifted downwards towards the end of fatiguing SHG exercise, such that during 
minutes four and five of SHG, all APs expressed a shorter latency. Similar observations 
have been made during the Valsalva maneuver (Salmanpour et al. 2011b) and during 
maximal voluntary apnea (Badrov et al. 2015; Badrov et al. 2016). That this downward 
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shift occurred during both peripheral chemoreflex activation (i.e., during volitional 
apnea) (Badrov et al. 2015; Badrov et al. 2016) and muscle chemoreflex activation (i.e., 
during SHG) suggests perhaps that chemoreflex stress may be involved. However, 
during isolation of the metaboreflex with PECO in the current study, the AP cluster 
size-latency profile was shifted back toward baseline resting levels, indicating that the 
muscle chemosensitive sensory afferents are unlikely to play a role in our observed 
findings. Rather, the common pattern of a downward shift in the AP cluster size-latency 
profile during the Valsalva maneuver (Salmanpour et al. 2011b), during maximal 
voluntary apnea (Badrov et al. 2015; Badrov et al. 2016), and toward the end of 
fatiguing SHG exercise here, suggests that a perceptual component (i.e., central 
command) may be involved in this outcome. Specifically, each maneuver exhibits a 
certain level of volitional stress that is related to individual tolerance and perception of 
the maneuver. The exact mechanism(s)/source(s) for this change in AP latency cannot 
be discerned from the current analysis and requires additional study. However, in as 
much as conduction velocity of a given axon is relatively stable, our observations 
suggest the possibility of variations in synaptic delays somewhere within the neural 
pathway. Indeed, Macefield et al. (1994) noted that the AP latency of a single axon can 
vary rather significantly (i.e., 358 ± 33 ms), demonstrating the potential for 
considerable modification of synaptic delays and/or central processing times. The 
functional significance of this systemic and coordinated shift to shorter reflex latency 
remains unknown. However, the consistent observation of this downward shift in 
latency during several sympathoexcitatory maneuvers suggests it may be a response 
reserved for severe stress scenarios requiring high, and perhaps faster occurring, 
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sympathetic outflow. Nonetheless, it appears that acute malleability of synaptic delays 
and/or central processing times may represent a unique option available to alter efferent 
sympathetic outflow during fatiguing SHG exercise, and this is perhaps mediated 
through a central command phenomenon.  
While the use of fatiguing SHG exercise and PECO offers a unique model to 
study the central versus peripheral features of sympathetic neural recruitment, we 
cannot conclude with certainty that the PECO phase represents solely peripheral (i.e., 
metaboreflex) feedback to the central nervous system, without any lingering central, or 
perceptual, component. Indeed, the discomfort experienced during this period, and 
retained pressor response, may sustain and/or modify residual centrally-determined 
sympathetic patterns. In this sense, the lack of a control exercise recovery (i.e., no 
PECO phase following SHG exercise) period, as performed by other groups (Crisafulli 
et al. 2003; Mulliri et al. 2016), may represent a limitation of the current study. 
However, data from these groups using a handgrip model without PECO supports the 
concept that the occlusion phase represents selectively peripheral, metaboreflex-
mediated input, as the exercise pressor response is maintained during PECO, but absent 
during the control recovery phase (Crisafulli et al. 2003). Furthermore, a ‘resting’ 
circulatory occlusion period (i.e., not preceded by exercise) had no effect on baseline 
resting cardiovascular parameters, further discounting a role for central, or perceptual, 
elements during our PECO phase in the current study.    
In summary, alterations in efferent sympathetic neural outflow during fatiguing 
exercise occur as a result of increased firing frequency and probability of lower-
threshold axons, as a result of recruitment of previously silent sub-populations of 
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larger-sized, faster conducting axons, and perhaps through acute changes of synaptic 
delays and/or central processing times. Taken together, it appears as though this 
represents a generalized central neural coding response to severe stress within the 
sympathetic nervous system. Our findings here, although in one reflex model, suggest a 
role for central command features in mediating the synaptic delay aspect of sympathetic 
discharge patterning, whereas peripheral-reflex mechanisms appear largely responsible 
for recruitment of latent sympathetic fibres.  
Perspectives and Significance 
The current work and analytical technique complements traditional integrated 
methodology, but provides a novel perspective on sympathetic discharge patterns 
during exercise pressor reflex activation and, therefore, may offer new insights into 
important unanswered concepts, such as 1) the influence of these neural coding patterns 
on neurotransmitter release and end-organ vascular responses; 2) the apparent 
decoupling between elevated sympathetic outflow and vascular resistance in the 
inactive limb during metaboreflex activation (i.e., neurovascular transduction) 
(Shoemaker et al. 2016); 3) the complex interplay between and neurocircuitry involved 
in central command and perception of effort during exercise and the potential for 
feedback-related central control (Williamson, 2010; Basnayake et al. 2012); and 4) the 
exaggerated sympathetic responses to exercise (and in turn, limited exercise capacity) 
observed in certain clinical pathologies (i.e., congestive heart failure) (Notarius et al. 
2001; Murai et al. 2009). 
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Chapter 4  
4 Effects of aging and coronary artery disease on 
sympathetic neural recruitment strategies during end-
inspiratory and end-expiratory apnea 
(Published in Am J Physiol Heart Circ Physiol 311: H1040-H1050, 2016) 
4.1 Introduction 
 Sympathetic nervous system dysregulation represents a hallmark of increasing 
age and cardiovascular disease. This dysregulation has been well-studied at rest, where 
aging and cardiovascular disease are characterized by a net elevation in baseline 
sympathetic outflow (Seals & Esler, 2000; Grassi et al. 2015), which contributes to 
numerous deleterious consequences, including cardiac and vascular damage and 
remodeling, cardiac dysrhythmias, and an elevated risk of mortality (Pauletto et al. 
1991; Barretto et al. 2009; Grassi et al. 2011). However, the mechanisms involved in 
aberrant sympathetic control with aging and cardiovascular disease, such as the distinct 
features of central recruitment strategies, are not known.  
 Normally, sympathetic neural control involves central integration of sensory and 
cortical/sub-cortical signals within the brain stem and spinal cord (Barman & Gebber, 
2000), synapses at the sympathetic ganglia (Jänig & McLachlan, 1992), efferent post-
ganglionic nerve traffic, neurotransmitter release, and the subsequent vascular effect at 
the end-organ (Shoemaker et al. 2016). These elements introduce multiple sites of 
control in which sympathetic outflow can be coded and modified in response to acute 
physiological perturbation. Data from direct single- and multi-fibre recordings of 
central sympathetic outflow in young healthy individuals indicate that the sympathetic 
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nervous system has options to increase the firing frequency and probability of low-
threshold axons (Macefield & Wallin, 1999; Salmanpour et al. 2011a), recruit latent 
sub-populations of higher-threshold and faster conducting axons (Steinback et al. 
2010b; Badrov et al. 2015), as well as acutely modify synaptic delays and/or central 
processing times (Salmanpour et al. 2011b; Badrov et al. 2015). These patterns 
illustrate unique properties of the central nervous system to fine-tune autonomic 
homeostatic control.  
 Whether these neural coding strategies are affected by increasing age and 
cardiovascular pathology normally associated with advancing age remains uncertain. 
While recordings from single muscle vasoconstrictor axons reveal an increased firing 
probability and frequency of single-units in cardiovascular disease (Greenwood et al. 
1999; Macefield et al. 1999), the typical observation that a given neuron will fire 
usually only once per sympathetic burst at rest appears unchanged in congestive heart 
failure with reduced left ventricular ejection fraction (LVEF) (Macefield et al. 1994; 
Macefield et al. 1999). Conversely, within-burst firing frequency of single axons at 
baseline is increased in other states of chronic sympathetic arousal, such as obstructive 
sleep apnea (Elam et al. 2002) and chronic obstructive pulmonary disease (Ashley et al. 
2010), as well as in response to an acute physiological challenge (Macefield & Wallin, 
1999; Elam & Macefield, 2001; Murai et al. 2006). However, information regarding the 
several recruitment strategies available (i.e., recruitment of new axons) to the 
sympathetic nervous system cannot be extracted from single-unit recordings, but 
requires a multi-unit analysis model. Using multi-fibre recordings, we have documented 
recruitment of new sub-populations of larger axons (Steinback et al. 2010b; Breskovic 
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et al. 2011; Badrov et al. 2015), as well as modifiable synaptic delays (Badrov et al. 
2015), in response to voluntary apnea-induced sympathoexcitation in young healthy 
individuals. However, the ability to recruit latent neuronal sub-populations may be 
diminished with healthy aging and cardiovascular disease (Maslov et al. 2012; Maslov 
et al. 2014). 
 Therefore, the current study examined the hypothesis that cardiovascular disease 
impairs sympathetic neural recruitment. Coronary artery disease (CAD) patients with 
preserved LVEF completed maximal voluntary apneas, which served as a stimulus for 
sympathoexcitation, and the response was compared to that of young healthy and older 
healthy individuals to account for the concurrent effect of age. 
4.2 Methods 
4.2.1 Participants 
Forty-two individuals participated in the current investigation after providing 
informed written consent. Participants comprised three groups: 1) young healthy 
individuals (YH; n = 14, 5 females), 2) older healthy individuals (OH; n = 14; 6 
females), and 3) CAD patients (CAD; n = 14, 3 females). Participant characteristics are 
summarized in Table 4.1. YH and OH participants were non-smokers, free of overt 
disease, and non-medicated. CAD patients included those who were discharged from 
hospital following an acute ST elevation (n = 7) or non-ST elevation (n = 7) myocardial 
infarction (MI) as documented by their attending physician. In all instances, patients 
presented with their first MI. Eleven patients underwent percutaneous coronary 
intervention and four underwent coronary artery bypass grafting surgery. No CAD 
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patients had a history of congestive heart failure, renal insufficiency, or diabetes 
mellitus, and all had preserved LVEF at the time of study. Although all patients were on 
anti-hypertensive medications, all presented with resting blood pressures within the 
normal range (i.e., <140/90 mmHg). Six patients were former or current smokers at the 
time of study. On average, testing took place 67 ± 37 days following hospital discharge. 
Medication use in the CAD patients included beta-blockers (n = 13; 93%), angiotensin 
converting enzyme inhibitors (n = 13; 93%), calcium channel blockers (n = 3; 21%), 
diuretics (n = 1; 8%), statins (n = 13; 93%), and anti-platelets, including aspirin (n = 14; 
100%). All experimental protocols were approved by the Health Sciences Research 
Ethics Board at Western University. 
4.2.2 Experimental Protocols 
 Participants arrived for testing having fasted and abstained from caffeine and 
alcohol for 12 hours, and vigorous exercise for 24 hours. Data were collected in the 
supine position during 1) a 1-minute baseline period and a subsequent end-inspiratory 
(EI) apnea of maximal voluntary duration, and 2) a 1-minute baseline period and a 
subsequent end-expiratory (EE) apnea of maximal voluntary duration. Both EI- and EE-
apnea were repeated twice, with each trial separated by three minutes of rest. EI- and 
EE-apnea were used as stimuli to increase muscle sympathetic nerve activity (MSNA) 
in order to study the neural recruitment strategies employed by the sympathetic nervous 
system during reflex-mediated sympathoexcitation. Both EI- and EE-apnea elicit 
marked increases in sympathetic outflow, albeit through different mechanisms. 
Voluntary EI-apnea increases MSNA through a variety of factors including unloading 
of the baroreceptors, chemoreflex activation, and an increased central drive-to-breathe 
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(Ferrigno et al. 1986; Somers et al. 1989; Hardy et al. 1994; Steinback et al. 2010a). 
On the other hand, EE-apnea increases MSNA predominantly through chemoreflex 
stimulation, as well as a lack of ventilatory restraint on sympathetic outflow, and 
increased central drive-to-breathe (Somers et al. 1989; Hardy et al. 1994; Steinback et 
al. 2010a). 
4.2.3 Experimental Measures 
Sympathetic neural recordings were obtained in the right peroneal nerve by 
microneurography, using standard procedures originally defined by Hagbarth and 
Vallbo (1968) and used frequently in our hands (Steinback et al. 2010b; Salmanpour et 
al. 2011a; Badrov et al. 2015) (662C-3; Bioengineering of University of Iowa, Iowa 
City, IA). Blood pressure was obtained throughout the experimental protocol using 
finger photoplethysmography (Finometer; Finapres Medical Systems, Amsterdam, The 
Netherlands), which was calibrated to manual sphygmomanometry. Heart rate (HR) 
was calculated from a standard three-lead electrocardiogram. Stroke volume (SV) and 
cardiac output (CO) were acquired using the Finometer Modelflow algorithm and total 
peripheral resistance (TPR) was calculated as the quotient of mean arterial pressure 
(MAP) and CO. All data were collected and analyzed offline using LabChart6 and 
PowerLab (ADInstruments, Colorado Springs, CO).  
4.2.4 Data Analysis 
 For both the EI- and EE-apnea protocols, data were analyzed for the 1-minute 
baseline period and during the second half of maximal voluntary apnea. MSNA was 
analyzed from the integrated neurogram and from our technique to detect and extract 
action potentials (APs) from the filtered raw MSNA signal (Salmanpour et al. 2010). 
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Integrated MSNA was quantified using burst frequency and burst incidence [bursts per 
minute and bursts per 100 heart beats (hb), respectively]. Furthermore, burst amplitude 
(normalized to the largest burst at baseline, which was given a value of 100) and total 
MSNA (product of normalized burst amplitude and burst frequency) were determined.  
 Individual APs were extracted from the filtered raw MSNA signal using 
wavelet-based methodology, as first reported by others (Diedrich et al. 2003; Brychta et 
al. 2007), and modified in our hands (Salmanpour et al. 2010). Our approach, described 
in detail elsewhere (Salmanpour et al. 2010; Badrov et al. 2015), uses a continuous 
wavelet transform constructed from real post-ganglionic sympathetic APs (Salmanpour 
et al. 2010), that extracts APs at their point of occurrence, and classifies them according 
to their peak-to-peak amplitude into clusters (i.e., bins) of similarly-sized APs using 
Scott’s rule (Scott, 1979). To enable investigation into whether recruitment of new, 
larger AP clusters occurred during apnea, a secondary analysis stage was introduced 
whereby cluster characteristics were manipulated within each participant so that 
minimum bin width, maximum bin center, and the total number of bins would be 
identical across conditions. Therefore, corresponding clusters at baseline and apnea 
contain APs with similar peak-to-peak amplitudes, while additional clusters during 
apnea represent recruitment of latent sub-populations of larger-sized axons (i.e., not 
present at baseline). 
 AP variables were quantified using AP frequency and AP incidence (APs per 
minute and APs per 100 hb, respectively), as well as the mean AP content per 
integrated sympathetic burst. Furthermore, the number of total AP clusters and the 
number of active clusters per burst are presented. AP cluster latency was calculated as 
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the average latency of all APs present within that cluster (as measured by the time delay 
between the R-wave of the electrocardiogram of the preceding cardiac cycle and the 
negative peak of the AP waveform). To adjust for the impact of interindividual 
variations in total cluster number on calculations of changes in AP cluster latency, the 
number of total clusters was normalized to 10 bins (i.e., 10% ranges of the largest 
detected cluster, which was given a value of 100%) for this analysis step, as described 
previously (Badrov et al. 2015). 
4.2.5 Statistical Analysis 
Mixed model ANOVAs (SigmaPlot 12.0; Systat Software Inc., San Jose, CA) 
assessed the effect of group versus time (baseline vs. EI-apnea; baseline vs. EE-apnea) 
on MSNA and hemodynamic variables. Bonferroni-corrected post hoc procedures were 
used to evaluate specific differences between means. Regression analyses were used to 
determine specific relationships between variables when applicable. For the EE-apnea 
protocol, six participants (YH, n = 2; OH, n = 2; CAD, n = 2) were excluded as their 
MSNA signal was obscured by motor-unit activation and/or a signal-to-noise ratio 
(SNR) that was too poor to allow for adequate AP analysis. Statistical significance was 
set at P < 0.05 and all data are means ± SD, unless otherwise stated.   
4.3 Results 
 As noted above, some MSNA recordings lacked appropriate SNR or were 
contaminated by motor-unit activation. Also, variations exist between individuals in the 
duration of apnea, as well as within individuals in terms of the response and duration to 
repeated apneas. To address these issues, Bland-Altman analyses assessed the 
123 
 
agreement between the first and second EI- and EE-apneas for all MSNA and AP 
variables. Participants with SNR >3.7 (i.e., to allow for adequate AP detection) for both 
apneas were included in the analysis (EI-apnea, n = 33; EE-apnea, n = 21). Briefly, 
while the second EI- and EE-apnea were of longer duration (EI-apnea: 41 ± 17 vs. 36 ± 
17 s; EE-apnea: 21 ± 10 vs. 19 ± 10 s; both P < 0.05), no differences existed between 
the first and second sympathetic response to either EI- or EE-apnea (all P = NS), and all 
MSNA and AP variables were without significant fixed or proportional bias (EI-apnea: 
Total MSNA: 127 ± 139, mean difference ± SE; APs/burst: 0.6 ± 0.5; Clusters/burst: 
0.1 ± 0.1; Total Clusters: 0.2 ± 0.5; EE-apnea: Total MSNA: −474 ± 315; APs/burst: 
0.6 ± 0.7; Clusters/burst: 0.3 ± 0.2; Total Clusters: −0.5 ± 0.6). With no within-
individual differences between the first and second apnea, the average of the two EI- 
and two EE-apneas were used in the final analysis. Re-examination of results with 
removal of statistical outliers (i.e., those individuals with data points that were more 
than 1.5 interquartile ranges below the first quartile or above the third quartile) did not 
significantly alter the results; therefore, data from these individuals were retained in the 
final analysis (Tukey, 1977). Finally, the mean SNR in the current study was 4.1 ± 0.5, 
which is expected to produce a correct detection rate of >90% and a false positive rate 
of <3% (Salmanpour et al. 2010). 
 Figure 4.1 displays representative recordings of the integrated MSNA 
neurogram and detected APs from one YH individual, one OH individual, and one 
CAD patient at baseline and during EI-apnea and EE-apnea. 
Baseline versus End-Inspiratory Apnea. The duration of the second half of EI-
apnea was 46 ± 17 s (range 27 to 78 s) in YH, 35 ± 15 s (range 15 to 70 s) in OH, and 
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28 ± 6 s (range 19 to 44 s) in CAD patients. In a pointwise contrast, CAD patients had a 
lower EI-apnea duration compared to YH (P < 0.01). MAP, HR, and TPR exhibited 
effects of time, whereby each increased during EI-apnea, while reductions in SV and 
CO occurred (all P < 0.05; Table 4.2); however, no group differences existed in the 
hemodynamic response to EI-apnea (all P = NS). 
Table 4.3 outlines the integrated MSNA and AP indexes during EI-apnea and 
their relative baseline values. Compared to YH, baseline burst frequency and burst 
incidence were higher in OH and CAD (all P < 0.01), but no differences were observed 
between OH and CAD (P = NS). Compared with baseline, all integrated MSNA 
variables increased during EI-apnea in all groups (all P < 0.01). However, compared to 
YH, the change in integrated MSNA was blunted in OH and CAD (all P < 0.01), with 
no differences between OH and CAD (P = NS). Whereas EI-apnea resulted in increased 
AP frequency and AP incidence in all groups (all P < 0.01), CAD patients had a 
reduced ability to increase AP frequency and AP incidence compared to YH (both P < 
0.01). No differences in the AP frequency and AP incidence response existed between 
YH and OH (P = NS) or OH and CAD (P = NS). 
Compared with baseline, the mean AP content per burst increased during EI-
apnea in YH (11 ± 8 to 17 ± 11 APs/burst; P < 0.01) and OH (10 ± 5 to 13 ± 7 
APs/burst; P < 0.01), while no change occurred in CAD patients (10 ± 4 to 11 ± 5 
APs/burst; P = NS; Figure 4.2a). The magnitude of response was reduced in both OH 
and CAD compared to YH (P < 0.01), and further reduced in CAD versus OH (P < 
0.01). When APs were binned according to their peak-to-peak amplitude, the number of 
total clusters of APs increased in YH (9 ± 3 to 14 ± 4 total clusters; P < 0.01) and OH 
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(13 ± 3 to 14 ± 3 total clusters; P < 0.01) during EI-apnea, but not in CAD patients (14 
± 3 to 12 ± 3 total clusters; P = NS; Figure 4.2b). The ability to recruit new clusters of 
APs was diminished in OH and CAD patients compared to YH (P < 0.01), and further 
decreased in CAD versus OH (P < 0.01). Finally, the number of active clusters per 
burst increased during EI-apnea in YH (4 ± 2 to 6 ± 2 clusters/burst; P < 0.01) and OH 
(5 ± 1 to 6 ± 2 clusters/burst; P < 0.01), but not in CAD patients (5 ± 1 to 5 ± 1 
clusters/burst; P = NS; Figure 4.2c). The magnitude of change was lower in OH and 
CAD compared with YH (both P < 0.01), and further lowered in CAD compared with 
OH (P < 0.01). When all subjects were pooled, EI-apnea duration correlated poorly 
with the mean AP content per burst response (r = 0.207; P = NS) and the active clusters 
per burst response (r = 0.277; P = NS) to apnea. EI-apnea duration correlated 
moderately well with the total clusters response (r = 0.553; P < 0.01) to apnea; 
however, when accounting for age and incidence of CAD, EI-apnea duration no longer 
predicted the total cluster response to apnea (P = NS). 
In all groups, at baseline (YH: R2 = 0.93; OH: R2 = 0.90; CAD: R2 = 0.77; all P < 
0.01) and during EI-apnea (YH: R2 = 0.97; OH: R2 = 0.94; CAD: R2 = 0.91; all P < 
0.01), a pattern emerged whereby AP cluster latency decreased as a function of 
normalized cluster number (i.e., as peak-to-peak AP cluster amplitude increased). The 
mean responses (Figure 4.3) were fitted using an exponential function model at baseline 
and during EI-apnea. Interestingly, the cluster size-latency profile shifted downward for 
every corresponding cluster during apnea in YH (range −8 to −48 ms; mean: −28 ± 15 
ms; P < 0.01), OH (range −15 to −38 ms; mean: −32 ± 7 ms; P < 0.01), and CAD 
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patients (range −5 to −58 ms; mean: −21 ± 17 ms; P < 0.01). No differences were found 
in the magnitude of change between groups (all P = NS). 
Baseline versus End-Expiratory Apnea. The duration of the second half of EE-
apnea was 20 ± 10 s (range 12 to 47 s) in YH, 22 ± 11 s (range 8 to 45 s) in OH, and 16 
± 5 s (range 10 to 27 s) in CAD patients. No differences in duration were observed for 
EE-apnea between groups (P = NS). Both MAP and TPR exhibited effects of time, 
whereby values increased during EE-apnea; in contrast, reductions occurred in SV and 
CO (all P < 0.05; Table 4.2). However, no group differences existed in the 
hemodynamic response to EE-apnea (all P = NS). 
Table 4.4 outlines the integrated MSNA and AP indexes during EE-apnea and 
their relative baseline values. Once again, compared with YH, baseline burst frequency 
and burst incidence were higher in OH and CAD (all P < 0.01), but no differences were 
observed between OH and CAD (P = NS). Compared with baseline, all integrated 
MSNA variables increased during EE-apnea in all groups (all P < 0.01). However, 
compared with YH, the changes in burst frequency, burst amplitude, and total MSNA 
were blunted in OH and CAD (all P < 0.01), while the change in burst incidence was 
lower in CAD versus YH (P < 0.01). No differences were found between OH and CAD 
for any integrated MSNA variable (all P = NS). Additionally, compared to baseline, 
EE-apnea resulted in increased AP frequency and AP incidence in all groups (P < 
0.05); however, CAD patients had a decreased ability to increase AP frequency and AP 
incidence compared with YH (P < 0.01), while no differences existed between OH and 
CAD (P = NS).  
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Compared to baseline, the mean AP content per burst increased in YH (11 ± 6 to 
20 ± 9 APs/burst; P < 0.01) and OH (11 ± 4 to 15 ± 8 APs/burst; P < 0.01) in response 
to EE-apnea, but was unchanged in CAD patients (11 ± 6 to 13 ± 6 APs/burst; P = NS; 
Figure 4.4a). The change in the mean AP content per burst was lower in OH and CAD 
than in YH (both P < 0.01); however, no difference existed between OH and CAD (P = 
NS). When APs were binned according to their peak-to-peak amplitude, the number of 
total clusters of APs increased in YH (8 ± 4 to 14 ± 5 total clusters; P < 0.01), but was 
unchanged in both OH (12 ± 3 to 13 ± 4 total clusters; P = NS) and CAD patients (13 ± 
4 to 12 ± 2 total clusters; P = NS; Figure 4.4b). As such, the ability to recruit new 
clusters of APs was diminished in OH and CAD compared with YH (both P < 0.01). 
Finally, compared with baseline, the number of active clusters per burst increased 
during EE-apnea in YH (4 ± 2 to 6 ± 2 clusters/burst; P < 0.01) and OH (5 ± 1 to 6 ± 2 
clusters/burst; P < 0.01), but not in CAD patients (5 ± 1 to 6 ± 1 clusters/burst; P = NS; 
Figure 4.4c). The magnitude of change was lower in OH and CAD compared with YH 
(P < 0.01). When all subjects were pooled, EE-apnea duration correlated poorly with 
the mean AP content per burst response (r = 0.029; P = NS), the active clusters per 
burst response (r = 0.117; P = NS), as well as the total clusters response (r = 0.297; P = 
NS) to apnea. 
Similar to EI-apnea, a pattern emerged during baseline (YH: R2 = 0.76; OH: R2 = 
0.85; CAD: R2 = 0.88; all P < 0.01) and EE-apnea (YH: R2 = 0.95; OH: R2 = 0.97; CAD: 
R2 = 0.87; all P < 0.05), whereby AP cluster latency decreased as a function of 
normalized cluster number (i.e., as peak-to-peak AP cluster amplitude increased). The 
mean responses (Figure 4.5) were fitted using an exponential function model at baseline 
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and during EE-apnea. Once again, the cluster size-latency profile shifted downward for 
every corresponding cluster during apnea in YH (range −12 to −74 ms; mean: −35 ± 23 
ms; P < 0.01), OH (range 0 to −47 ms; mean: −30 ± 14 ms; P < 0.01), and CAD 
patients (range −31 to −87 ms; mean: −59 ± 17 ms; P < 0.01). No differences were 
found in the magnitude of change between groups (all P = NS). 
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Table 4.1: Participant characteristics 
 YH OH CAD 
      
Age (y) 25±3 59±9* 61±10* 
Height (cm) 173±8 168±7 169±9 
Weight (kg) 74±13 68±11 86±15*† 
Body Mass Index (kg/m2) 25±4 25±2 30±5*† 
Systolic BP (mmHg) 113±13 121±16 120±21 
Diastolic BP (mmHg) 69±10 74±10 66±9 
HR (beats/min) 63±6 58±8 60±8 
CO (L/min) 6.2±1.3 5.4±1.4 6.2±1.2 
TPR (mmHg/L/min) 14±4 18±7 14±4 
LVEF (%) 68±4 68±4 61±9 
Burst Frequency (bursts/min) 18±8 34±9* 41±7* 
Burst Incidence (bursts/100 hb) 29±13 58±14* 69±11* 
Total MSNA (AU) 989±380 1916±540* 2331±372* 
Glucose (mmol/L) 5.1±0.6 5.2±0.4 5.6±0.7 
Total Cholesterol (mmol/L) 3.6±1.0 4.3±0.6 3.2±0.6† 
HDL Cholesterol (mmol/L) 1.2±0.2 1.5±0.3 1.0±0.1† 
LDL Cholesterol (mmol/L) 2.0±1.0 2.4±0.6 1.7±0.5 
Triglycerides (mmol/L) 0.9±0.3 0.9±0.4 1.0±0.3 
HbA1C (%) 5.4±0.2 5.7±0.2* 5.8±0.3* 
      
Values are the mean of the two baseline periods (mean ± SD). YH, young healthy; 
OH, older healthy; CAD, coronary artery disease; BP, blood pressure; HR, heart rate; 
CO, cardiac output; TPR, total peripheral resistance; LVEF, left ventricular ejection 
fraction; hb, heart beats; MSNA, muscle sympathetic nerve activity; AU, arbitrary 
units. HDL, high density lipoprotein; LDL, low density lipoprotein; HbA1C, 
hemoglobin A1C. *Significantly different from YH, P < 0.01; †Significantly different 
from OH, P < 0.01. 
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Table 4.2: Hemodynamic responses to end-inspiratory and end-expiratory apnea 
 YH OH CAD 
      
End-Inspiratory Apnea    
∆ MAP (mmHg) 9±5 6±8 8±8 
∆ HR (beats/min) 2±9 3±10 2±4 
∆ SV (mL) −20±13 −22±12 −17±17 
∆ CO (L/min) −1.1±1.0 −1.2±0.9 −1.0±0.9 
∆ TPR (mmHg/L/min) 5±3 7±5 5±3 
    
End-Expiratory Apnea    
∆ MAP (mmHg) 11±4 8±6 7±5 
∆ HR (beats/min) 4±11 0±9 0±3 
∆ SV (mL) −4±10 −12±8 −7±10 
∆ CO (L/min) 0.1±0.5 −0.6±0.6 −0.5±0.5 
∆ TPR (mmHg/L/min) 2±2 5±4 3±2 
      
Values are mean ± SD. YH, young healthy; OH, older healthy; CAD, coronary artery 
disease; MAP, mean arterial pressure; HR, heart rate; SV, stroke volume; CO, 
cardiac output; TPR, total peripheral resistance. 
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Table 4.3: Integrated MSNA and action potential indexes at baseline and during 
maximal end-inspiratory apnea 
 Baseline EI-Apnea ∆ 
Integrated MSNA Indices    
Burst Frequency (bursts/min)    
YH 17±8 41±8† 25±10 
OH 35±9* 51±11† 16±7‡ 
CAD 41±7* 53±8† 11±8‡ 
Burst Incidence (bursts/100 hb)    
YH 27±14 65±15† 38±18 
OH 60±14* 82±13† 22±14‡ 
CAD 70±10* 88±6† 18±10‡ 
Burst Amplitude (AU)    
YH 57±8 100±25† 43±20 
OH 57±6 80±16† 24±15‡ 
CAD 57±5 69±13† 12±12‡ 
Total MSNA (AU)    
YH 908±389 4144±1379† 3236±1476 
OH 2002±614* 4077±1211† 2075±1113‡ 
CAD 2357±415* 3624±811† 1267±700‡ 
    
Action Potential Indices    
AP Frequency (spikes/min)    
YH 189±222  691±480† 502±356 
OH 372±226 698±402† 326±223 
CAD 410±180 584±279† 174±196‡ 
AP Incidence (spikes/100 hb)    
YH 307±353  1081±757† 774±581 
OH 614±343 1136±681† 522±461 
CAD 694±302 968±465† 274±305‡ 
    
Values are mean ± SD. EI, end-inspiratory; MSNA, muscle sympathetic nerve 
activity; YH, young healthy; OH, older healthy; CAD, coronary artery disease; hb, 
heart beats; AU, arbitrary units; AP, action potential. *Significantly different from 
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YH baseline value, P < 0.01; †Significantly different from baseline, P < 0.01; 
‡Significantly different from YH delta value, P < 0.01. 
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Table 4.4: Integrated MSNA and action potential indexes at baseline and during 
maximal end-expiratory apnea 
 Baseline EE-Apnea ∆ 
Integrated MSNA Indices    
Burst Frequency (bursts/min)    
YH 19±7 42±12† 24±13 
OH 33±9* 49±11† 16±6‡ 
CAD 41±8* 51±5† 10±7‡ 
Burst Incidence (bursts/100 hb)    
YH 29±11 64±17† 34±20 
OH 56±16* 83±13† 27±14 
CAD 70±11* 89±5† 18±13‡ 
Burst Amplitude (AU)    
YH 57±7 124±55† 67±51 
OH 56±9 79±25† 22±22‡ 
CAD 58±5 81±19† 23±16‡ 
Total MSNA (AU)    
YH 1006±381 5147±2379† 4141±2523 
OH 1839±557 3793±1170† 1953±1165‡ 
CAD 2372±425* 4103±996† 1731±762‡ 
    
Action Potential Indices    
AP Frequency (spikes/min)    
YH 216±207  852±491† 636±351 
OH 370±191 731±430† 361±303 
CAD 447±262 662±301† 215±155‡ 
AP Incidence (spikes/100 hb)    
YH 347±340  1278±669† 931±499 
OH 609±298 1219±738† 610±589 
CAD 760±418 1162±531† 402±312‡ 
    
Values are mean ± SD. EE, end-expiratory; MSNA, muscle sympathetic nerve 
activity; YH, young healthy; OH, older healthy; CAD, coronary artery disease; hb, 
heart beats; AU, arbitrary units; AP, action potential. *Significantly different from 
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YH baseline value, P < 0.01; †Significantly different from baseline, P < 0.01; 
‡Significantly different from YH delta value, P < 0.01.  
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Figure 4.1: Representative recordings of the integrated muscle sympathetic nerve 
activity (MSNA) neurogram and detected action potentials (APs) from one young 
healthy (YH) individual (A), one older healthy (OH) individual (B), and one 
coronary artery disease (CAD) patient (C) at baseline and during end-inspiratory 
(EI) and end-expiratory (EE) apnea. 
HR, heart rate; MAP, mean arterial pressure; bpm, beats per minute. 
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Figure 4.2: Action potential (AP) content per burst (A), total clusters (B), and 
active clusters per burst (C) in young healthy (YH), older healthy (OH), and 
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coronary artery disease (CAD) patients at baseline and during end-inspiratory 
(EI) apnea. 
Left panel; individual lines represent individual data. Right panel represents the 
absolute delta change from baseline to EI-apnea. *Significantly different from baseline, 
P < 0.01. †Significantly different from YH, P < 0.01. ‡Significantly different from OH, 
P < 0.01. 
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Figure 4.3: Action potential (AP) cluster latency as a function of normalized 
cluster number (i.e., size) at baseline and during end-inspiratory (EI) apnea in 
young healthy (YH; left panel), older healthy (OH; middle panel), and coronary 
artery disease patients (CAD; right panel). 
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Figure 4.4: Action potential (AP) content per burst (A), total clusters (B), and 
active clusters per burst (C) in young healthy (YH), older healthy (OH), and 
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coronary artery disease (CAD) patients at baseline and during end-expiratory 
(EE) apnea. 
Left panel; individual lines represent individual data. Right panel represents the 
absolute delta change from baseline to EE-apnea. *Significantly different from baseline, 
P < 0.01. †Significantly different from YH, P < 0.01. 
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Figure 4.5: Action potential (AP) cluster latency as a function of normalized 
cluster number (i.e., size) at baseline and during end-expiratory (EE) apnea in 
young healthy (YH; left panel), older healthy (OH; middle panel), and coronary 
artery disease patients (CAD; right panel). 
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4.4 Discussion 
The novel findings of the current work are: 1) compared with young individuals, 
the ability to increase within-burst firing frequency of already recruited sympathetic 
fibres was reduced with aging and CAD; 2) the capacity of the sympathetic nervous 
system to recruit sub-populations of previously silent and faster conducting fibres was 
reduced with aging and lost in CAD; and 3) the ability to acutely modify synaptic 
delays and/or central processing times appears preserved with aging and CAD. Taken 
together, this work supports the hypothesis that cardiovascular disease impairs 
sympathetic recruitment during apneic stress. 
Voluntary apnea represents a robust stimulus for efferent sympathetic outflow 
through various mechanisms including hypoxia and hypercapnia-induced 
chemoreceptor activation, removal of the inhibitory influence of lung-stretch receptors, 
and an increased central drive-to-breathe (Somers et al. 1989; Hardy et al. 1994; 
Steinback et al. 2010a). Early work from single-unit recordings demonstrated that the 
homeostatic adjustment to apnea involves an increased neural firing frequency and 
probability, as well as an increase in the incidence of multiple within-burst firing of 
single axons (Macefield & Wallin, 1999). Our previous work (Steinback et al. 2010b; 
Breskovic et al. 2011; Badrov et al. 2015), and the results from the current study using 
a multi-unit approach, are in agreement with this finding, at least in YH individuals. 
Although both OH individuals and CAD patients achieved an elevation in total 
sympathetic outflow through increased frequency and incidence of AP firing during 
apnea, the ability to increase the number of APs per sympathetic burst was reduced with 
143 
 
healthy aging and lost in CAD patients. Therefore, the impact of CAD appears to be 
additive to normal age-related changes in central autonomic integration. 
Previously, we observed recruitment of latent sub-populations of larger and 
faster conducting sympathetic axons during periods of severe autonomic stress, elicited 
via voluntary apnea (Steinback et al., 2010b; Breskovic et al. 2011; Badrov et al. 2015) 
and by −80 mmHg lower body negative pressure (Salmanpour et al. 2011a; Badrov et 
al. 2015). However, the current work extends this knowledge to pathological states with 
known sympathetic dysregulation. In accordance with previous work (Maslov et al. 
2012; Maslov et al. 2014), we show here that older individuals have a reduced capacity 
to recruit these latent neural sub-populations compared with their young counterparts, 
while the ability to do so is further reduced and perhaps lost all together in CAD. The 
mechanism of this dysregulation is unknown. One possibility is that the elevation in 
efferent sympathetic outflow at rest observed with healthy aging and cardiovascular 
disease is, in part, mediated by the additional recruitment of these latent sub-
populations, thereby reducing the residual capacity for further recruitment during acute 
physiological stress. However, the capacity for neural recruitment was not hindered in 
otherwise healthy, younger subjects with high baseline MSNA (~75 bursts/100 hb) 
(Macefield & Wallin, 1999), discounting the possibility that a ceiling effect impairs the 
ability to observe normal recruitment patterns. Furthermore, if these larger axons were 
already recruited at rest, one may presume that older individuals and CAD patients 
would have greater AP content per sympathetic burst during baseline resting conditions; 
however, this was not the case in our study. These observations point to abnormal 
central features of neural recruitment with healthy aging and perhaps more so with 
144 
 
cardiovascular disease, rather than a loss of sympathetic reserve due to elevated resting 
sympathetic outflow. 
Synaptic delay variations and/or altered central processing times appear to exist 
as a third recruitment strategy used by the sympathetic nervous system to modify 
efferent sympathetic outflow in the face of physiological challenge (Salmanpour et al. 
2011b; Badrov et al. 2015). The current observations replicate earlier observations 
(Badrov et al. 2015), in that voluntary apnea caused an acute downward shift in the AP 
cluster size-latency relationship in YH individuals, such that all APs with similar peak-
to-peak amplitudes were recruited with a shorter latency during the reflex-mediated 
stress. Previous reports indicate that single axons display large latency variations at rest 
(Macefield et al. 1994), and that reflex latency can change acutely with stress (Coote & 
Macleod, 1974; Fagius et al. 1987). The multi-unit approach used here suggests that a 
systemic and coordinated change in synaptic delay can occur as well. Interestingly, this 
systemic downward shift in the AP cluster size-latency profile with apnea was 
preserved with aging, as well as CAD, suggesting that, in contrast to actual recruitment, 
the option for synaptic delay variations is preserved in these individuals. The location(s) 
or source of the change in synaptic delay during apnea-induced stress remains 
unknown, but may be due to the direct activation of the rostral ventrolateral medulla 
from the nucleus tractus solitarius (Koshiya et al. 1993) specific to chemoreceptor 
activation, and/or the presence of faster conduction velocities within spinal descending 
pathways specific to chemoreceptor stimulation (~5.5 m/s) versus baroreceptor 
activation (~3.3 m/s) (Jänig & Szulczyk, 1979). 
Methodological Considerations  
145 
 
Whether the recruitment impairment in OH individuals and CAD patients was 
due to a smaller reflex stimulus, or to the pathology, cannot be determined specifically 
from the current analysis. In the context of stimulus strength, variations in the apnea 
stimulus may have influenced the between-group variations reported in the current 
study. As mentioned above, the determinants of the apnea autonomic response are not 
certain and may include the magnitude of chemoreflex stress, loss of lung-stretch 
afferent activity, or an emotional drive to breathe (Somers et al. 1989; Hardy et al. 
1994; Steinback et al. 2010a), and various factors influence the breakpoint for 
voluntary apnea (Parkes, 2006). In this context, lack of arterial blood gas measures 
represents a potential limitation of the current study. Although the apnea duration 
varied within and amongst groups, they were each of maximal voluntary duration and 
elicited near-maximal levels of burst probability; therefore, these represent maximal 
sympathetic efforts. Furthermore, in the current study, EI- and EE-apnea duration 
correlated poorly with indexes of AP recruitment. While apnea duration related 
significantly to the total clusters response (r = 0.554) to EI-apnea (but not EE-apnea; r = 
0.297), this was no longer the case when the effects of age and CAD were accounted 
for. Therefore, at least in our data set, variations in apnea duration are an unlikely 
determinant of the current observations. 
Second, as is commonly practiced (Macefield et al. 1999; Murai et al. 2009; 
Maslov et al. 2014), CAD patients were studied during their standard pharmacological 
treatment, and no data exist regarding the effect of medications on sympathetic neural 
recruitment strategies. However, medication use is a ‘life-long’ therapy for CAD 
patients, increasing the relevance of studying these participants in the 
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pharmacologically treated state. In addition, all OH individuals studied currently were 
unmedicated and still displayed impaired central recruitment. If the pharmacological 
treatment in CAD was causing the further detriment in recruitment observed in CAD 
versus OH during EI-apnea, one would expect the same further detriment in recruitment 
during EE-apnea; however, this was not the case. Taken together, these observations 
provide evidence to the fact that anti-hypertensive medications are unlikely to be 
playing a role in our observed findings.  
Furthermore, CAD patients had greater body mass index (BMI) than their YH 
and OH counterparts, and increased BMI has been known to alter baseline integrated 
MSNA (Scherrer et al. 1994). Whether elevated BMI affects AP recruitment patterns 
remains unknown; however, in the current study, BMI correlated poorly to all but one 
indice of sympathetic recruitment, suggesting it did not play a role in our observed 
findings. Nonetheless, when all subjects were pooled, BMI was correlated moderately 
to the total cluster response to EI- (r = 0.441, P = 0.003) and EE- (r = 0.371, P = 0.026) 
apnea. However, when accounting for age and incidence of CAD, BMI no longer 
predicted the total cluster response to either apnea. In addition, these aberrant AP 
recruitment patterns were observed within two to four months of the coronary event, 
and their persistence will require additional study.  
Finally, we acknowledge that the use of only one sympathoexcitatory reflex 
limits the applicability of the apnea outcomes to other important reflexes, and therefore, 
future study should assess responses to additional reflex stimuli (i.e., baroreflex, 
metaboreflex, cold pressor test, etc.) to determine if the observed impairment in central 
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recruitment with aging and cardiovascular disease is specific to apneic stress or a 
generalized pattern across reflexes. 
Summary 
Autonomic nervous system dysregulation represents a hallmark of increasing 
age and cardiovascular disease. Studied primarily under resting conditions, healthy 
aging and cardiovascular disease are characterized by chronic sympathetic activation, 
and this state has deleterious consequences for overall health and prognosis. For the 
first time, the current data indicate that this sympathetic dysfunction extends to the 
neural coding strategies used by the sympathetic nervous system to respond to acute 
homeostatic challenge. Specifically, the sympathetic nervous system normally has 
options to increase the firing of already-recruited axons, recruit latent sub-populations 
of higher-threshold and faster conducting axons, and modify acutely synaptic delays in 
response to autonomic arousal. The ability to acutely modify synaptic delays and/or 
central processing times appears preserved with aging and CAD. However, the ability 
to increase firing frequency and probability of low-threshold axons is reduced with 
healthy aging and more so with CAD. Furthermore, the ability to recruit previously 
silent sub-populations is reduced with increasing age and perhaps lost altogether with 
CAD. As such, CAD augments the impact of age on recruitment strategies employed by 
the sympathetic nervous system.  
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Chapter 5  
5 Ventilation inhibits sympathetic action potential 
recruitment even during severe chemoreflex stress 
5.1 Introduction 
 The chemoreflex represents a highly coordinated and integrative pattern of 
response to systemic hypoxia and/or hypercapnia that ultimately regulates and defends 
perfusion to critical organs and tissues within the body. As such, the homeostatic 
challenges presented by central and/or peripheral chemoreceptor stimulation are 
corrected through reflexive increases in ventilation, as well as autonomic circulatory 
arousal (Guyenet, 2014). Indeed, the compensatory response to chemoreflex activation 
involves large elevations in efferent sympathetic nerve outflow directed to skeletal 
muscle (i.e., muscle sympathetic nerve activity; MSNA) and other vascular beds (Saito 
et al. 1988; Malpas & Ninomiya, 1992a,b; Morgan et al. 1995; Leuenberger et al. 
2005). Furthermore, the sympathetic response to voluntary apnea and/or pathological 
apnea (i.e., obstructive sleep apnea) is large (Morgan et al. 1993; Hardy et al. 1994; 
Leuenberger et al. 1995; Steinback et al. 2010b) and, in turn, has been linked to poor 
clinical outcomes (Kara et al. 2003). 
 The mechanisms mediating the robust sympathetic response to apnea remain 
uncertain and appear to be diverse. Indeed, one fundamental issue is the identification 
of the specific roles played by the ventilatory response (or the lack thereof in the case of 
volitional apnea) versus the chemoreflex activation itself. For example, voluntary apnea 
potentiated the sympathetic response to isocapnic hypoxia, indicating the 
sympathoinhibitory nature of ventilation (Somers et al. 1989a,b). Furthermore, the 
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chemoreflex stimulus to typical 20- to 30-second apneas in untrained breath-hold 
performers is rather unremarkable (Leuenberger et al. 2005; Heusser et al. 2009; Seitz 
et al. 2013), yet the MSNA response is large; therefore, factors other than chemoreflex 
stress must be involved in eliciting sympathetic activation. The possible factors 
affecting the sympathoinhibitory effect of ventilation during chemoreflex stimulation 
may include central pathways that coordinate respiratory drive with sympathetic 
inhibition. Evidence for such pathways has been difficult to find in humans (St. Croix et 
al. 1999), whereby MSNA is inhibited during inspiration (or at high lung volumes) and 
increases during expiration (or at low lung volumes) (Eckberg et al. 1985; Seals et al. 
1993); however, current evidence in the intact human argues against a significant role 
played by central respiratory drive on the ventilatory modulation of MSNA (Seals et al. 
1993; St. Croix et al. 1999). In contrast, such pathways can be induced in anesthetized 
rodents (Numao et al. 1987; Haselton & Guyenet, 1989; Darnall & Guyenet, 1990), 
leading Guyenet (Guyenet et al. 2010; Guyenet 2014) to speculate that species 
differences exist. Nonetheless, current evidence suggests that the sympathetic response 
to apnea has more to do with the lack of breathing rather than the chemoreflex stimulus 
per se.  
 Yet, much remains uncertain regarding the interactions between chemoreflex 
stress and ventilation on sympathetic neuro-circulatory control. For example, the degree 
of chemoreflex stress may be an important caveat in understanding the role of 
respiratory movements in sympathetic control. The central motor hypothesis has been 
studied in humans mainly under normoxic and normocapnic conditions (St. Croix et al. 
1999) or low levels of hypercapnia (Seals et al. 1993), raising the possibility that 
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potentiation of central pathways associated with the drive-to-breathe and sympathetic 
inhibition with breathing may be augmented with concurrent chemoreflex activation. 
Observations arguing against this possibility are provided from our earlier study 
(Steinback et al. 2010a), in which the very large sympathetic responses occurring 
during prolonged apnea at functional residual capacity (FRC), performed by elite 
breath-hold divers, were acutely inhibited by a two-breath rebreathe protocol performed 
immediately following the apnea, despite a sustained chemoreflex stimulus. However, 
the acute versus chronic effects were not studied, nor was it determined whether this 
has to do with reduction of the emotional component of resisting the breathing 
movements, the absence of lung-stretch during apnea, or the actual degree of 
chemoreflex stimulus (Steinback et al. 2010a).  
 In addition, the mode of studying sympathetic nerve activity likely has an 
impact on determinations of chemoreflex versus ventilatory control over sympathetic 
nerve recruitment. Indeed, early work from single-unit action potential (AP) recordings 
demonstrated that the sympathetic adjustment to apnea involves not only an increase in 
neural firing probability, but also, a shift towards greater within-burst firing of single 
axons (Macefield & Wallin, 1999). Therefore, the content and variability of 
sympathetic APs within and between integrated bursts more accurately represents the 
neural signal, and ultimately, reflects the neural discharge and recruitment patterns used 
by the central nervous system to fine-tune sympathetic outflow. The need to study AP 
behaviour becomes especially relevant when one considers that burst frequency, 
reflecting the rate of discharge, and burst size, reflecting the number and/or size of 
recruited APs (Ninomiya et al. 1993; Salmanpour et al. 2011), may be differentially 
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regulated during chemoreflex stress, emphasizing increases in burst size (i.e., AP 
recruitment) (Malpas et al. 1996; Lim et al. 2015). Using a multi-unit AP approach, we 
have found that the central recruitment strategies used to alter sympathetic drive in 
response to apneic stress involve both an increased firing of previously-recruited axons 
and recruitment of sub-populations of larger, latent axons (Steinback et al. 2010b; 
Breskovic et al. 2011; Badrov et al. 2015; Badrov et al. 2016a). However, whether 
neural recruitment is restrained and/or inhibited in the presence of ventilation remains 
unknown.  
 Therefore, the objective of the current investigation was to determine the 
influence of ventilation on sympathetic AP recruitment during varying levels of high 
chemoreflex stress. To do so, we studied sympathetic AP discharge during apnea at 
FRC (i.e., absence of ventilation) and during asphyxic rebreathing (i.e., presence of 
ventilation) in trained breath-hold divers. Trained breath-hold divers were studied 
because of their unique ability to perform apneas for prolonged periods of time and 
their capacity to endure high levels of chemoreflex stress (Heusser et al. 2009). We 
tested the hypothesis that the sympathoinhibitory effect of ventilation on chemoreflex-
induced sympathetic activation is limited to mild chemoreflex stress. If so, then it can 
be expected that for similar levels of chemoreflex stimuli, the presence of ventilation 
during rebreathing would restrain sympathetic AP recruitment as compared to apnea. 
However, during more severe rebreathe-induced chemoreflex levels, the inhibitory 
influence of ventilation would be overridden, such that AP recruitment would be similar 
to that observed during apnea. 
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5.2 Methods 
5.2.1 Participants 
 Seven healthy individuals (1 female; 33±12 yr, 181±10 cm, 74±12 kg, body 
mass index = 22±2 kg/m2) participated in the current investigation after providing 
informed written consent. Participants were non-smokers without any history of 
cardiovascular or respiratory disease. All studies were conducted at the University of 
Split, adhering to the standards set by the latest revision of the Declaration of Helsinki, 
and all experimental procedures were approved by the Research Ethics Board at the 
University of Split School of Medicine in Croatia. 
5.2.2 Experimental Protocol 
 All experiments were conducted following a 3-hour fast and a 12-hour 
abstinence from caffeine, alcohol, and vigorous exercise. Participants voided their 
bladder immediately prior-to study. All testing was completed in the supine position. 
Participants were fitted with a mouthpiece (series 9060, Hans Rudolph, Kansas City, 
MO) connected to a three-way valve, allowing them to breathe either room air, or 
through a Y-connector (VacuMed, Ventura, CA) leading to two 3-litre breathing bags. 
An infrared probe connected to a pulse oximeter (Poet II, Criticare Systems, Waukesha, 
WI) was applied to the index finger to monitor arterial oxygen saturation (i.e., 
hemoglobin saturation; HbSat). Respiratory gases were analyzed using an infrared 
carbon dioxide sensor and optical oxygen detector fed from a damped micro-vacuum 
sampling pump (ML206 Gas Analyzer, ADInstruments, Colorado Springs, CO) and 
calibrated using ambient air pressure values, which were converted to online 
measurements of oxygen (PO2) and carbon dioxide (PCO2) partial pressures. End-tidal 
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values for PO2 (PETO2) and PCO2 (PETCO2) were acquired using peak parameters 
software (LabChart7; ADInstruments, Colorado Springs, CO).    
 Participants completed three protocols in random order, each separated by five 
minutes of recovery. Prior-to the onset of each protocol, participants expired into the 
breathing bags to fill them with air for an ensuing rebreathing period. The first protocol 
(i.e., apnea protocol) assessed the impact of high levels of chemoreflex stress on 
sympathetic axonal recruitment in the absence of ventilation. Specifically, following 
three minutes of baseline data collection, the three-way valve was turned at end-
expiration to begin an initial period of rebreathing, in an attempt to maximize the 
severity of chemoreflex stimulation incurred during the ensuing apnea period 
(Usselman et al. 2013; Badrov et al. 2015). This initial rebreathe period continued until 
PETO2 reached 70 Torr, at which point participants performed an end-expiratory apnea 
at FRC until they achieved ~85% of their self-perceived ‘maximal’ tolerance for the 
maneuver. Upon cessation, participants breathed twice into and out of the breathing 
bags for the measurement of end-apnea PETO2 and PETCO2. Average apnea duration in 
the current study was 89±18 seconds. The second protocol (i.e., rebreathing protocol) 
assessed the impact of chemoreflex stress on sympathetic axonal recruitment in the 
presence of ventilation. Specifically, following three minutes of baseline data 
collection, the three-way valve was turned to initiate rebreathing and participants were 
instructed to rebreathe until, once again, they achieved ~85% of their self-perceived 
‘maximal’ tolerance for the maneuver. Finally, a third protocol (FRC-RBRALT protocol; 
n=6) was completed in which baseline data were collected for two minutes, followed by 
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alternating 30-second periods of FRC apnea and rebreathing until ~85% maximal 
tolerance. 
5.2.3 Experimental Measures 
 Multi-unit recordings of MSNA were obtained from the right peroneal nerve by 
microneurography (Hagbarth & Vallbo, 1968) (662C-3; Bioengineering of University 
of Iowa, Iowa City, IA), using standard methodology described in detail elsewhere 
(Badrov et al. 2015). Heart rate (HR) was determined from a standard three-lead 
electrocardiogram. Continuous beat-to-beat blood pressure was obtained throughout all 
protocols using finger photoplethysmography (Finometer; Finapres Medical Systems, 
Amsterdam, The Netherlands), the values of which were calibrated to manual 
sphygmomanometry values taken at baseline. Stroke volume (SV) and cardiac output 
(CO) were determined using the Finometer Modelflow algorithm (Wesseling et al., 
1993) and total peripheral resistance (TPR) was calculated as the quotient of mean 
arterial pressure (MAP) and CO. All data were collected using LabChart7 and 
PowerLab data acquisition system (ADInstruments, Colorado Springs, CO). 
5.2.4 Data Analysis 
 As a first aim, the study addressed the effect of the ‘absence or presence’ of 
ventilation on sympathetic neural recruitment during similar (i.e., matched) levels of 
chemoreflex stress. To address this aim, data were analyzed from the apnea protocol for 
the 3-minute baseline period, the rebreathe period (i.e., until 70 Torr PETO2), and the 
second half of the FRC apnea maneuver (i.e., FRCApnea). For the rebreathe protocol, 
data were analyzed for the 3-minute baseline period, the initial rebreathe period (i.e., 
until 70 Torr PETO2), and during the period of continued rebreathe that corresponded to 
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the same HbSat levels incurred during the second half of FRCApnea (i.e., RBRMatched). 
Therefore, this represents the FRCApnea versus RBRMatched comparison at the same level 
of chemoreflex stress, as inferred from the HbSat values (i.e., because PETCO2 could 
not be measured in the FRCApnea component).  
 The second aim determined the influence of ventilation on sympathetic neural 
recruitment at more severe levels of chemoreflex stress than that induced by FRCApnea. 
Therefore, we compared data from the second half of the FRCApnea protocol, as above, 
to data observed at the end of the continued rebreathe protocol (i.e., RBREnd). The 
duration of data studied in the RBREnd period was matched to that of the last half of the 
FRCApnea, used in the first aim. Therefore, this represents the FRCApnea versus RBREnd 
comparison.  
 A third aim addressed the issue that the apnea or continued rebreathe protocols 
always occurred at the end of each protocol, and therefore, this aim compared 
alternating periods of FRC apnea with rebreathe during progressively increasing 
chemoreflex stress. For the FRC-RBRALT protocol, as the number of alternating FRC 
apnea and rebreathe periods differed between participants, the 2-minute baseline and 
the final three FRC apnea and rebreathe periods for each participant were used for 
analysis. 
 MSNA data were analyzed in two manners. First, the integrated neurogram was 
quantified as per traditional methodology. Second, we studied the patterns of change in 
APs from the filtered raw MSNA signal as per our approach detailed previously 
(Salmanpour et al. 2010). Integrated sympathetic bursts were identified as exhibiting a 
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pulse-synchronous burst pattern, having a signal-to-noise ratio of at least 2:1 with 
respect to the previous period of neural silence, presenting with characteristic rising and 
falling slopes, and having APs visible in the corresponding raw and filtered 
neurograms. Integrated sympathetic activity was quantified using burst frequency (the 
number of bursts per minute), burst incidence (the number of bursts per 100 heartbeats; 
hb), burst amplitude (normalized to the largest burst recorded at baseline, which was 
given a value of 100), and total MSNA (the product of normalized burst amplitude and 
burst frequency). 
 For the analysis of sympathetic AP patterns, wavelet-based methodology was 
used to detect and extract APs from the filtered raw MSNA signal (Salmanpour et al. 
2010). Specifically, as described in detail previously (Steinback et al. 2010b; 
Salmanpour et al. 2011; Badrov et al. 2015), a continuous wavelet transform was used, 
in which a “mother wavelet” (adapted from actual physiological recordings of 
postganglionic sympathetic APs) was applied to the filtered raw MSNA neurogram to 
identify and extract APs at their point of occurrence. Next, extracted APs were ordered 
based on their peak-to-peak amplitude into ‘clusters’ (i.e., bins of similarly-sized APs) 
(Scott, 1979). Within participants, cluster characteristics were normalized within (i.e., 
baseline to rebreathe to maneuver) and between (i.e., FRCApnea vs. RBRMatched vs. 
RBREnd) protocols to ensure that bin width, maximum bin center, and the total number 
bins would be identical across conditions. This procedure ensured that corresponding 
clusters within and between protocols contain APs with the same peak-to-peak 
amplitude. Therefore, within protocols (i.e., baseline to rebreathe to maneuver), an 
increase in the number of total clusters represents recruitment of latent sub-populations 
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of larger-sized axons not present at baseline, whereas between protocols (i.e., FRCApnea 
vs. RBRMatched vs. RBREnd), a greater number of total clusters represents further 
recruitment of these latent sub-populations as compared to other protocols. Sympathetic 
AP patterns were quantified using AP frequency (the number of APs per minute), while 
sympathetic AP recruitment was expressed using the mean AP content per integrated 
sympathetic burst (APs/burst), the number of active AP clusters per integrated 
sympathetic burst (clusters/burst), and the number of total AP clusters (total clusters). 
Based on previous validation analysis of our technique (Salmanpour et al. 2010), the 
average signal-to-noise ratio in the current study (i.e., 4.8±0.6) is expected to produce a 
correct AP detection rate of >90% and a false positive rate of <3%. 
5.2.5 Statistical Analysis 
All statistical analyses were performed using SigmaPlot 12.0 (Systat Software, 
San Jose, CA). All data were normally distributed as confirmed by Shapiro-Wilk tests. 
Two-way repeated measures ANOVAs assessed the effect of protocol (i.e., FRCApnea 
vs. RBRMatched; FRCApnea vs. RBREnd) vs. time (i.e., baseline vs. rebreathe vs. 
maneuver). For the FRC-RBRALT protocol, one-way repeated measures ANOVAs 
assessed the effect of time (i.e., baseline vs. FRC vs. RBR). Bonferroni corrected post-
hoc procedures were used to assess specific differences between means, when 
appropriate. Statistical significance was set at P<0.05 and all data are presented as 
means ± SD. 
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5.3 Results 
 Figure 5.1 displays representative recordings of the integrated MSNA 
neurogram and detected APs (and associated chemoreflex stimuli) from one individual 
during the FRC apnea and rebreathing protocols.  
 FRCApnea vs. RBRMatched. Both FRCApnea and RBRMatched elicited large 
reductions in HbSat (Table 5.1; P < 0.001) at end-maneuver. By design, HbSat levels 
were similar (i.e., matched) between maneuvers (71 ± 6 vs. 71 ± 6%; P = NS). 
Compared to baseline, PETCO2 (FRCApnea: +17 ± 2 Torr; RBRMatched: +19 ± 2 Torr; both 
P < 0.001) increased, while PETO2 (FRCApnea: −68 ± 7 Torr; RBRMatched: −84 ± 7 Torr; 
both P < 0.001) decreased, during FRCApnea and RBRMatched. 
 Integrated MSNA indexes during the baseline, rebreathe, and maneuver 
periods of the FRCApnea and RBRMatched protocols are outlined in Table 5.2. Specifically, 
compared to baseline, burst frequency (FRCApnea: +29 ± 7 bursts/min; RBRMatched: +12 
± 9 bursts/min; both P < 0.01) and burst incidence (FRCApnea: +52 ± 16 bursts/100 hb; 
RBRMatched: +14 ± 12 bursts/100 hb; both P < 0.05) increased during both maneuvers; 
however, values of burst frequency and burst incidence were greater during FRCApnea 
than RBRMatched (both P < 0.001). Similarly, burst amplitude (FRCApnea: +165 ± 85%; 
RBRMatched: +69 ± 55%; both P < 0.01) increased above baseline levels during both 
maneuvers, though levels were greater during FRCApnea (P < 0.001). As such, compared 
to baseline, total MSNA was elevated during both maneuver periods (FRCApnea: +695 ± 
397%; RBRMatched: +336 ± 481%; both P < 0.05); yet, once again, levels of total MSNA 
were greater during FRCApnea (P < 0.001). 
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 Figure 5.2 presents the sympathetic AP discharge indexes during the baseline, 
rebreathe, and maneuver periods of the FRCApnea and RBRMatched protocols. Specifically, 
compared to baseline, AP frequency (FRCApnea: +1122 ± 534 APs/min; RBRMatched: 
+328 ± 172 APs/min; both P < 0.05) increased during both maneuvers; however, AP 
frequency was greater during FRCApnea compared to RBRMatched (1304 ± 534 vs. 511 ± 
167 APs/min; P < 0.001). This increase in AP frequency was due to the elevated levels 
of burst frequency, but also, an increase in the AP content per integrated sympathetic 
burst (FRCApnea: +18 ± 7 APs/burst; RBRMatched: +7 ± 3 APs/burst; both P < 0.01) 
during both maneuvers, as compared to baseline. The AP content per integrated 
sympathetic burst, however, was greater during FRCApnea than RBRMatched (28 ± 9 vs. 18 
± 4 APs/burst; P < 0.001). Furthermore, when APs were binned according to peak-to-
peak amplitude (i.e., into clusters), the number of total AP clusters increased during 
FRCApnea (+10 ± 2 total clusters; P < 0.001), but not during RBRMatched (+1 ± 2 total 
clusters; P = NS). As such, the number of total AP clusters was greater during FRCApnea 
(P < 0.001). Finally, the number of active clusters per burst (FRCApnea: +4 ± 2 
clusters/burst; RBRMatched: +2 ± 1 clusters/burst; both P < 0.01) was elevated above 
baseline levels during both maneuvers, though levels were greater during FRCApnea than 
RBRMatched (P < 0.01). 
 The hemodynamic responses to both maneuvers were consistent with the 
sympathetic response patterns as shown in Table 5.1. Specifically, compared to 
baseline, MAP (FRCApnea: +18 ± 9 mmHg; RBRMatched: +10 ± 7 mmHg; both P < 0.01) 
increased during both maneuvers; yet, the pressor response was greater during FRCApnea 
(P < 0.001). The greater pressor response was associated with a greater TPR during 
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FRCApnea (P < 0.001). HR decreased during FRCApnea and increased during RBRMatched 
(both P < 0.05), whereas reductions in SV were similar between maneuvers (P = NS). 
Subsequently, compared to baseline, CO decreased during FRCApnea (P < 0.001), but 
remained unchanged during RBRMatched (P = NS). 
 FRCApnea vs. RBREnd. By design, when rebreathing was allowed to continue 
and analyzed at the end (i.e., RBREnd), the RBREnd maneuver elicited a larger reduction 
in HbSat versus FRCApnea (56 ± 13 vs. 71 ± 6%; P < 0.001; Table 5.3). Similarly, larger 
increases in PETCO2 (FRCApnea: +17 ± 2 Torr; RBREnd: +21 ± 3 Torr; both P < 0.001), 
and larger decreases in PETO2 (FRCApnea: −68 ± 7 Torr; RBREnd: −94 ± 4 Torr; both P < 
0.001), were observed during RBREnd compared to FRCApnea (Table 5.3; both P < 
0.001). 
 Table 5.4 outlines the integrated MSNA indexes during the baseline, rebreathe, 
and maneuver periods of the FRCApnea and RBREnd protocols. Compared to baseline, 
burst frequency (FRCApnea: +29 ± 7 bursts/min; RBREnd: +32 ± 17 bursts/min; both P < 
0.001) increased to similar levels during both maneuvers (P = NS), whereas burst 
incidence (FRCApnea: +52 ± 16 bursts/100 hb; RBRMatched: +33 ± 17 bursts/100 hb; both 
P < 0.001) increased to a greater extent during FRCApnea than RBREnd (P = 0.001). Burst 
amplitude (FRCApnea: +165 ± 85%; RBREnd: +103 ± 46%; both P < 0.01) increased 
above baseline levels during both maneuvers, though levels were greater during 
FRCApnea than RBREnd (P < 0.05). Finally, compared to baseline, total MSNA was 
elevated during both maneuver periods (FRCApnea: +695 ± 397%; RBREnd: +785 ± 
903%; both P < 0.01); however, levels of total MSNA were not different during 
FRCApnea and RBREnd (P = NS). 
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 Sympathetic AP discharge indexes during the baseline, rebreathe, and 
maneuver periods of the FRCApnea and RBREnd protocols are displayed in Figure 5.3. 
Compared to baseline, AP frequency (FRCApnea: +1122 ± 534 APs/min; RBREnd: +912 
± 429 APs/min; P < 0.001) increased during both maneuvers; however, AP frequency 
was not different during FRCApnea and RBREnd (1304 ± 534 vs. 1095 ± 423 APs/min; P 
= NS). Once again, the increased AP frequency was due to the elevated burst 
frequency, but also, an increase in the AP content per integrated sympathetic burst 
(FRCApnea: +18 ± 7 APs/burst; RBREnd: +11 ± 5 APs/burst; both P < 0.001) during both 
maneuvers, as compared to baseline. However, the AP content per integrated 
sympathetic burst was greater during FRCApnea than RBREnd (28 ± 9 vs. 23 ± 5 
APs/burst; P < 0.05). Furthermore, when APs were binned according to peak-to-peak 
amplitude (i.e., into clusters), the number of total AP clusters increased during FRCApnea 
(+10 ± 2 total clusters; P < 0.001) and RBREnd (+6 ± 4 total clusters; P < 0.001); yet, 
total AP clusters was greater during FRCApnea (P < 0.01). Finally, the number of active 
clusters per burst (FRCApnea: +4 ± 2 clusters/burst; RBREnd: +2 ± 1 clusters/burst; both P 
< 0.001) was elevated above baseline levels during both maneuvers, whereby no 
differences were observed during FRCApnea versus RBREnd (P = NS). 
 The hemodynamic responses to FRCApnea and RBREnd are shown in Table 5.3. 
Compared to baseline, MAP (FRCApnea: +18 ± 9 mmHg; RBRMatched: +20 ± 12 mmHg; 
both P < 0.001) increased similarly during both maneuvers (P = NS). However, this 
pressor response was achieved differently for FRCApnea and RBREnd. Specifically, 
compared to baseline, TPR increased during FRCApnea (P < 0.001), but not during 
RBREnd (P=NS), whereas CO was increased during RBREnd (P < 0.01), but decreased 
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during FRCApnea (P < 0.001). The latter was due to an increase in HR (P < 0.001) 
during RBREnd versus no change during FRCApnea (P = NS), and a similar decrease in 
SV during both maneuvers (both P < 0.001). 
 FRC-RBRALT. Figure 5.4 displays representative recordings of the integrated 
MSNA neurogram and detected APs (and associated chemoreflex stimuli) from one 
individual during the FRC-RBRALT protocol. HbSat levels were decreased versus 
baseline during each of the final two FRC and RBR periods of the FRC-RBRALT 
protocol (Table 5.5; all P < 0.001). Compared to baseline, PETCO2 was increased and 
PETO2 decreased during each FRC and RBR period (Table 5.5; all P < 0.001). No 
differences existed between corresponding periods of FRC and RBR for HbSat or 
PETCO2 and PETO2 levels (all P = NS). 
 Table 5.6 displays the integrated MSNA indexes during baseline and FRC and 
RBR periods of the FRC-RBRALT protocol. Specifically, compared to baseline, all 
integrated MSNA variables were elevated during each FRC (all P < 0.001), but not 
during any of the three RBR periods (all P = NS). As such, every corresponding FRC-
RBR period was associated with greater levels of integrated MSNA during FRC versus 
RBR (all P < 0.001). 
 Sympathetic AP discharge indexes at baseline and during the FRC and RBR 
periods of the FRC-RBR ALT protocol are shown in Figure 5.5. Compared to baseline, all 
AP indices were increased during each FRC (all P < 0.001), but not during any RBR 
period (all P = NS). Therefore, every corresponding FRC-RBR period was associated 
with greater AP recruitment during FRC than RBR (all P < 0.001). 
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 Finally, the hemodynamic responses to the FRC-RBRALT protocol are provided 
in Table 5.5. Compared to baseline, MAP increased during the final FRC and RBR 
periods (both P < 0.001), whereas TPR increased during each FRC (all P < 0.001), but 
not during RBR (all P = NS). HR was reduced during the final FRC versus the final 
RBR (P < 0.001), whereas SV remained unchanged throughout the FRC-RBRALT 
protocol (all P = NS). CO decreased during each FRC (P < 0.001), was above baseline 
levels during the first RBR period (P < 0.001), but not in each of the final two RBR 
periods (both P = NS). 
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Table 5.1: Hemodynamic responses to FRCApnea and RBRMatched protocols 
      Baseline Rebreathe Maneuver 
MAP (mmHg)       
 FRCApnea 87±3 89±3 105±9*† 
 RBRMatched 87±3 88±2 97±6* 
HR (beats/min)       
 FRCApnea 70±14 68±13 60±9*† 
 RBRMatched 68±12 66±13 75±19* 
SV (mL)       
 FRCApnea 97±20 90±18 84±18 
 RBRMatched 96±19 91±19 86±24 
CO (L/min)       
 FRCApnea 6.6±1.3 6.0±1.0 5.0±0.7*† 
 RBRMatched 6.4±0.9 5.9±0.8 6.1±0.9 
TPR (mmHg/L/min)       
 FRCApnea 13.5±2.3 15.1±2.1 21.6±3.3*† 
 RBRMatched 13.7±1.7 15.2±1.9 16.1±2.8* 
HbSat (%)       
 FRCApnea 99.5±0.3 97.2±1.5 71.3±6.3 
 RBRMatched 99.5±0.4 97.5±1.8 71.3±6.3 
PETCO2 (Torr)       
 FRCApnea 27±6 41±5* 44±4*† 
 RBRMatched 28±6 40±6* 47±5* 
PETO2 (Torr)       
 FRCApnea 118±5 66±5* 50±5*† 
  RBRMatched 117±7 68±6* 33±3* 
Values are mean ± SD. MAP, mean arterial pressure; HR, heart rate; SV, stroke 
volume; CO, cardiac output; TPR, total peripheral resistance; HbSat, hemoglobin 
saturation; PETCO2, end-tidal partial pressure of carbon dioxide; PETO2, end-tidal 
partial pressure of oxygen. *Significantly different from baseline, P < 0.05; 
†Significantly different from RBRMatched, P < 0.05. Effects of time were found for SV 
and HbSat, whereby the maneuver periods were reduced versus baseline, both P ≤ 
0.001. 
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Table 5.2: Integrated MSNA responses to FRCApnea and RBRMatched protocols 
      Baseline Rebreathe Maneuver 
Burst Frequency (bursts/min)       
 FRCApnea  17±5 17±6 46±8*† 
 RBRMatched  16±7 17±6 28±7* 
Burst Incidence (bursts/100 hb)       
 FRCApnea  25±10 26±11 77±15*† 
 RBRMatched  24±13 26±11 38±11* 
Burst Amplitude (AU)       
 FRCApnea  50±10 53±9 127±32*† 
 RBRMatched  51±4 63±15 87±33* 
Total MSNA (AU/min)       
 FRCApnea  832±298 877±251 5774±1572*† 
  RBRMatched   780±386 1019±307 2496±1434* 
Values are mean ± SD. MSNA, muscle sympathetic nerve activity; hb, heart beats; 
AU, arbitrary units. *Significantly different from baseline, P < 0.05; †Significantly 
different from RBRMatched, P < 0.001. 
 
 
 
 
 
 
 
 
171 
 
Table 5.3: Hemodynamic responses to FRCApnea and RBREnd protocols 
      Baseline Rebreathe Maneuver 
MAP (mmHg)       
 FRCApnea 87±3 89±3 105±9 
 RBREnd  87±3 88±2 106±11 
HR (beats/min)       
 FRCApnea 70±14 68±13 60±9† 
 RBREnd  68±12 66±13 84±23* 
SV (mL)       
 FRCApnea 97±20 90±18 84±18 
 RBREnd  96±19 91±19 87±23 
CO (L/min)       
 FRCApnea 6.6±1.3 6.0±1.0 5.0±0.7*† 
 RBREnd  6.4±0.9 5.9±0.8 7.0±1.1 
TPR (mmHg/L/min)       
 FRCApnea 13.5±2.3 15.1±2.1 21.6±3.3*† 
 RBREnd  13.7±1.7 15.2±1.9 15.5±2.1 
HbSat (%)       
 FRCApnea 99.5±0.3 97.2±1.5 71.3±6.3*† 
 RBREnd  99.5±0.4 97.5±1.8 51.9±13.1* 
PETCO2 (Torr)       
 FRCApnea 27±6 41±5* 44±4*† 
 RBREnd  28±6 40±6* 49±6* 
PETO2 (Torr)       
 FRCApnea 118±5 66±5* 50±5*† 
  RBREnd   117±7 68±6* 23±5* 
Values are mean ± SD. MAP, mean arterial pressure; HR, heart rate; SV, stroke 
volume; CO, cardiac output; TPR, total peripheral resistance; HbSat, hemoglobin 
saturation; PETCO2, end-tidal partial pressure of carbon dioxide; PETO2, end-tidal 
partial pressure of oxygen. *Significantly different from baseline, P < 0.01; 
†Significantly different from RBREnd, P < 0.01. An effect of time was found for 
MAP, whereby the rebreathe and maneuver period were greater than baseline, both P 
< 0.001. An effect of time was found for SV, whereby the maneuver period was 
reduced versus baseline, P < 0.001. 
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Table 5.4: Integrated MSNA responses to FRCApnea and RBREnd protocols 
      Baseline Rebreathe Maneuver 
Burst Frequency (bursts/min)       
 FRCApnea  17±5 17±6 46±8 
 RBREnd  16±7 17±6 47±15 
Burst Incidence (bursts/100 hb)       
 FRCApnea  25±10 26±11 77±15*† 
 RBREnd  24±13 26±11 57±15* 
Burst Amplitude (AU)       
 FRCApnea  50±10 53±9 127±32*† 
 RBREnd  51±4 63±15 104±29* 
Total MSNA (AU/min)       
 FRCApnea  832±298 877±251 5774±1572 
  RBREnd   780±386 1019±307 5170±2745 
Values are mean ± SD. MSNA, muscle sympathetic nerve activity; hb, heart beats; 
AU, arbitrary units. *Significantly different from baseline, P < 0.05; †Significantly 
different from RBREnd, P < 0.001. Effects of time were found for burst frequency 
and total MSNA, whereby the rebreathe and maneuver periods were greater than 
baseline, all P < 0.001. 
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Table 5.5: Hemodynamic responses to the FRC-RBRALT protocol 
 
Values are mean ± SD. FRC, functional residual capacity apnea; RBR, rebreathe; 
MAP, mean arterial pressure; HR, heart rate; SV, stroke volume; CO, cardiac output; 
TPR, total peripheral resistance; HbSat, hemoglobin saturation; PETCO2, end-tidal 
partial pressure of carbon dioxide; PETO2, end-tidal partial pressure of oxygen. 
*Significantly different from baseline, P<0.001; †Significantly different from 
corresponding RBR period, P<0.001.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Baseline FRC1 RBR1 FRC2 RBR2 FRC3 RBR3 
MAP (mmHg) 88±3 92±3 88±3 96±7 96±6 105±11* 101±10* 
HR (beats/min) 63±6 57±7 63±7 60±9 66±11 58±10† 69±12 
SV (mL) 97±23 88±21 88±21 87±24 87±24 90±28 91±26 
CO (L/min) 6.0±1.1 5.0±0.9* 5.4±0.9* 5.1±1.1* 5.6±0.8 5.1±1.0*† 6.1±0.8 
TPR (mmHg/L/min) 15.1±2.6 19.2±3.9* 16.4±2.2 20.0±4.0* 17.6±3.0 21.5±5.6*† 17.0±3.2 
HbSat (%) 99.5±0.5 95.3±2.3 95.3±3.5 88.6±5.5* 88.7±6.9* 75.9±2.9* 72.1±11.9* 
PETCO2 (Torr) 28±7 40±3* 41±4* 44±4* 44±5* 47±5* 48±7* 
PETO2 (Torr) 114±12 67±11* 69±11* 50±4* 50±10* 40±4* 36±8* 
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Table 5.6: Integrated MSNA responses to the FRC-RBRALT protocol 
 
Values are mean ± SD. MSNA, muscle sympathetic nerve activity; FRC, functional 
residual capacity apnea; RBR, rebreathe; BF, burst frequency; BI, burst incidence; 
hb, heart beats; BA, burst amplitude; AU, arbitrary units. *Significantly different 
from baseline, P < 0.001; †Significantly different from corresponding RBR period, P 
< 0.001.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
175 
 
 
Figure 5.1: Representative recordings of the integrated muscle sympathetic nerve 
activity (MSNA) neurogram and detected action potentials (APs) (and associated 
chemoreflex stimuli) from one individual during the functional residual capacity 
(FRC) apnea and rebreathing protocols. 
PO2, partial pressure of oxygen; PCO2, partial pressure of carbon dioxide; HbSat, 
hemoglobin saturation. Highlighted (i.e., boxed) areas represent portions of the 
maneuver used for analysis. 
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Figure 5.2: Sympathetic action potential (AP) recruitment during baseline (BSL), 
initial rebreathe (RBR), and maneuver (MAN) periods of the FRCApnea and 
RBRMatched protocols. 
*Significantly different from BSL, P < 0.05; †Significantly different from RBRMatched, P 
< 0.01. 
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Figure 5.3: Sympathetic action potential (AP) recruitment during baseline (BSL), 
initial rebreathe (RBR), and maneuver (MAN) periods of the FRCApnea and 
RBREnd protocols. 
*Significantly different from BSL, P < 0.05; †Significantly different from RBREnd, P < 
0.01. 
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Figure 5.4: Representative recordings of the integrated muscle sympathetic nerve 
activity (MSNA) neurogram and detected action potentials (APs) (and associated 
chemoreflex stimuli) from one individual during the alternating functional 
residual capacity (FRC) apnea and rebreathe (RBR) protocol (i.e., FRC-RBRALT). 
PO2, partial pressure of oxygen; PCO2, partial pressure of carbon dioxide; HbSat, 
hemoglobin saturation. Highlighted (i.e., boxed) area represents the portion of the 
maneuver used for analysis. 
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Figure 5.5: Sympathetic action potential (AP) recruitment during baseline (BSL) 
and alternating periods of apnea at functional residual capacity (FRC) and 
rebreathe (RBR). 
HbSat, hemoglobin saturation. *Significantly different from BSL, P < 0.001; 
†Significantly different from corresponding RBR, P < 0.001. 
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5.4 Discussion 
 The current study was designed to study the dissociated influences of 
chemoreceptor stimuli (i.e., hypoxia and hypercapnia) and ventilation on sympathetic 
AP recruitment patterns during chemoreflex stress. First, we demonstrate that during 
similar levels of (high) chemoreflex stress, the act of ventilation per se restrained the 
increased firing of already-active, lower-threshold axons, and furthermore, inhibited the 
recruitment of latent, higher-threshold axons that appeared during apnea. Second, 
recruitment of previously-silent axons was observed during severe chemoreflex 
stimulation induced by the continued rebreathe protocol; however, sympathetic AP 
recruitment was still restrained as compared to apnea. Finally, during alternating 
periods of apnea and rebreathe, the act of rebreathing between apneas was associated 
with a rapid and complete withdrawal of sympathetic AP recruitment, despite the ever-
increasing chemoreflex stimulus. As such, it appears that the sympathoinhibitory effect 
of ventilation during chemoreceptor activation extends to the central recruitment 
strategies used by the sympathetic nervous system to respond to homeostatic stress, 
whereby both the frequency of neural discharge and recruitment of latent axons are 
restrained/inhibited in the presence of ventilation, even at excessive levels of 
chemoreflex stress. 
 The sympathoexcitatory response to voluntary apnea is robust, and indeed, 
includes a powerful stimulus for efferent sympathetic axonal recruitment (Steinback et 
al. 2010b; Breskovic et al. 2011; Badrov et al. 2015; Badrov et al. 2016a). 
Chemoreceptor activation is believed to form a primary mechanism driving this 
response. Nevertheless, previous work demonstrates that the absence of ventilation 
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during apnea acts to augment this sympathetic drive (Somers et al. 1989a,b; Steinback 
et al. 2010a). Certainly, albeit indirectly, ventilation has been shown to be a powerful 
within-breath modulator of sympathetic neural recruitment (Seals et al. 1990). 
Specifically, during deep breathing, the typical observation of increased and decreased 
MSNA during expiration and inspiration, respectively (Eckberg et al. 1985), was 
extended to show that, over multiple breaths, MSNA inhibition during inspiration was 
compensated for by augmented burst amplitude during expiration (Seals et al. 1990). 
Therefore, the total MSNA response was not affected. Furthermore, since burst size 
reflects AP content (Ninomiya et al. 1993; Salmanpour et al. 2011), ventilation affects 
sympathetic AP synchronization and recruitment of additional and/or larger 
sympathetic axons (Ninomiya et al. 1993; Salmanpour et al. 2011). Our current results 
support the conjecture that ventilation modulates sympathetic postganglionic axonal 
recruitment and extend this conclusion to include high/severe levels of chemoreflex 
stress.  
 The current data illustrate, like never before, the unfailing ability of inhalation 
to inhibit sympathetic activity across a wide range of chemoreflex stress, at least 
acutely, and to inhibit AP recruitment even during what likely are the most severe cases 
of chemoreflex stress that can be imposed voluntarily. Specifically, replicating earlier 
studies (Steinback et al. 2010b; Badrov et al. 2015; Badrov et al. 2016a), the large 
increases in neural outflow during apnea were associated with increases in the within-
burst firing frequency of already-recruited sympathetic fibers, as well as the recruitment 
of latent (i.e., not present at baseline) sub-populations of larger-sized axons. However, 
for similar levels of hypoxia and hypercapnia, but in the presence of ventilation (i.e., 
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during RBRMatched), these neural recruitment patterns were not achieved. Indeed, 
RBRMatched was associated with a lower firing frequency and a restrained increase in the 
number of APs per integrated burst, such that, overall, sympathetic AP frequency 
increased approximately 700% during FRCApnea, but only about 300% during 
RBRMatched. Furthermore, the capacity of the sympathetic nervous system to recruit 
latent neural sub-populations was inhibited during RBRMatched, despite the same 
chemoreflex load, indicating the profound effect of ventilation on AP recruitment 
patterns. 
 Nonetheless, the current data do support the idea that the sympathoinhibitory 
effect of ventilation is less effective at more severe levels of chemoreflex stress. 
Specifically, latent axons were recruited during the more severe chemoreflex stress 
induced by the continued rebreathe protocol, despite the presence of ventilation (i.e., 
RBREnd). Interestingly, in this scenario (i.e., FRCApnea vs. RBREnd) the total integrated 
MSNA response was similar between protocols but the underlying patterns of AP 
recruitment differed by maneuver. These data highlight the importance of studying AP 
behaviour and support the notion that these latent, higher-threshold axons, are reserved 
for severe stress scenarios (Badrov et al. 2015).  
 The protocol alternating between FRC and rebreathing further enforces the 
role of ventilation in AP recruitment, across many levels of progressive chemoreflex 
stress. In this case, all occurrences of rebreathe, despite no relief of chemical drive, 
were associated with an inhibition of sympathetic AP discharge to baseline levels. 
Specifically, while each apnea was associated with increased within-burst firing of 
lower-threshold axons and recruitment of latent, larger-sized axons, each subsequent 
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period of rebreathe was accompanied by a total withdrawal of this sympathetic AP 
recruitment. This withdrawal of sympathetic drive following the resumption of 
breathing in the face of similar and/or elevated chemical drive is consistent with 
findings from the integrated MSNA neurogram (Watenpaugh et al. 1999; Steinback et 
al. 2010a; Seitz et al. 2013). For example, Steinback et al. (2010a) found that 
sympathetic burst activity was silenced during brief periods of rebreathe following 
apnea. Furthermore, Seitz et al. (2013) demonstrated an immediate inhibition of MSNA 
following the break point of end-expiratory apnea, which was not influenced by 
whether subjects inhaled room air or asphyxic gas upon the resumption of breathing.  
 Therefore, the present data support previous findings that indicate ventilation 
per se is responsible for the sympathoinhibition across a wide range of chemoreflex 
stress. However, acute periods of rebreathe following apnea were associated with 
complete withdrawal of AP discharge, whereas when rebreathe was allowed to continue 
(i.e., RBREnd protocol), sympathetic axonal recruitment did occur over time, albeit still 
at lesser levels than apnea. These observations suggest that the sympathoinhibitory 
influence of breathing may be robust acutely, but perhaps, less effective over time as 
the chemoreflex load continues to extreme levels. 
 The mechanisms underlying the ventilatory restraint of sympathetic axonal 
recruitment during high levels of chemoreflex stress remain unknown and cannot be 
elucidated from the current results. Possible contributors include lung-stretch receptor 
feedback (Somers et al. 1989b) and perceptual factors associated with the stress 
experienced during prolonged breath-holding (Fowler, 1954; Heusser et al. 2009). 
Stated differently, the volitional effort not to breathe coupled with the growing desire-
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to-breathe during voluntary apnea may result in a greater perception of stress than that 
of rebreathing, thereby influencing sympathetic drive. Callister et al. (1992) have 
shown that levels of perceived stress influence directly the sympathetic response during 
cognitive challenge. However, stress-induced sympathetic responses related to such 
prolonged breath-holds and chemoreflex duress produced by these elite breath-hold 
competitors has not been quantified. However, components of the current observations 
argue against a “stress” determinant of sympathetic drive during apnea. First, all 
participants were instructed to engage in and continue each protocol until they achieved 
~85% of their self-perceived ‘maximal’ tolerance for the maneuver. As such, the 
FRCApnea and RBREnd protocols were ‘matched’ for levels of perceived stress, whereby 
greater AP recruitment was still observed during apnea. Second, we deliberately studied 
breath-hold divers who are uniquely trained to endure this level of stress and perform 
these maneuvers often. Thus, the fact that these were not ‘maximal’ efforts, combined 
with the participants’ familiarity with the maneuvers, likely suggests that levels of 
perceived stress during voluntary apnea were not maximal. However, we acknowledge 
that the perceptual levels of stress magnitude in sympathetic activation in the context of 
apneas are not known. Finally, albeit in a volitional handgrip contraction and 
metaboreflex activation model, we have found that a central perceptual component has 
little to do with actual axonal recruitment, as opposed to the effects of peripheral-reflex 
mechanisms (Badrov et al. 2016b). Therefore, we do not regard a specific role of 
perceptual factors in the current results as important in the observations. Furthermore, 
whether a baroreflex mechanism contributed to the divergent sympathetic recruitment 
responses between conditions is unknown, but unlikely. Specifically, the differing AP 
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recruitment responses persisted despite large and similar (or slightly greater during 
apnea) increases in MAP during both maneuvers. Therefore, it is likely that resetting of 
the arterial baroreflex occurred during both maneuvers (Muenter Swift et al. 2003), the 
magnitude of which might be greater during apnea. Nonetheless, ventilation appears to 
modulate sympathetic axonal recruitment during high and even severe chemoreflex 
stress. The mechanisms mediating this restraint on sympathetic neural recruitment will 
require additional study. 
 In summary, the present study demonstrated that the sympathetic axonal 
recruitment strategies that are normally observed during apnea are largely restrained by 
the act of ventilation per se, despite similar and/or greater levels of high, and even, 
extreme, chemoreflex stress. Specifically, during severe levels of hypoxia and 
hypercapnia, both the frequency of within-burst firing of already-active sympathetic 
fibres and the recruitment of sub-populations of previously-silent, higher-threshold 
axons are restrained in the presence of ventilation. Therefore, the robust increases in 
sympathetic nerve activity seen during apnea are largely influenced by the lack of 
breathing itself, rather than the increasing chemical drive, although the latter 
undoubtedly plays a role (Hardy et al. 1994). Nonetheless, the pronounced sympathetic 
neural recruitment in response to apnea, and in turn, the large systemic vascular 
resistance and blood pressure response may lend important mechanistic insight into 
observed relationship between obstructive sleep apnea and cardiovascular disease 
(Kasai et al. 2012). 
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Chapter 6 
6 General Discussion 
6.1 Overview 
The SNS represents a fundamental system of control through which homeostatic 
adjustments to physiological stress are achieved, occurring largely through the reflexive 
regulation of blood pressure and blood flow. In turn, this process (i.e., neural control of 
the circulation) is characterized by a highly integrative and finely-tuned system that is 
layered with multiple levels of unique, albeit complex, control. Briefly, these include 
post-ganglionic sympathetic nerve outflow, neurotransmitter release, and the end-organ 
vascular response. Indeed, since the first human recordings of efferent sympathetic 
nerve activity in the late 1960’s (Hagbarth & Vallbo, 1968), integrative physiologists 
have been interested in the patterned nature of sympathetic neural discharge and, in 
turn, its implication for, and role in, the neurovascular control complex. Stated 
differently, the patterning of neural discharge reflects the strategies used by the CNS to 
fine-tune sympathetic outflow, and ultimately, control systemic vascular resistance and 
blood pressure, thereby maintaining homeostasis in the face of physiological 
perturbation. As such, in the current dissertation, we investigated recruitment strategies 
in efferent post-ganglionic sympathetic nerve activity with the hopes of gaining greater 
insight into one of the complex mechanisms by which sympathetic neuro-circulatory 
control is governed.  
6.2 Major Findings 
The series of studies contained herein investigated the neural coding patterns 
employed by the SNS to alter efferent sympathetic outflow in response to homeostatic 
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challenge, and further, the modifiers of, and mechanisms of control underlying these 
recruitment strategies. Overall, these studies support the working hypothesis and 
confirm that neural coding principles operate within the SNS. Specifically, these reflect 
the ability to increase discharge frequency or rate of already-active, lower-threshold 
axons (i.e., rate coding), recruit latent, higher-threshold neural sub-populations (i.e., 
population coding), as well as modify acutely synaptic delays and/or central processing 
times (i.e., temporal coding) in response to reflex-mediated sympathoexcitatory stress.  
A major finding of this series of studies was the ability of the SNS to recruit 
sub-populations of previously silent (i.e., not active at baseline), larger amplitude, and 
faster conducting sympathetic axons in response to severe physiological stress. In turn, 
this recruitment option appears to be a fixed, reflex-independent recruitment strategy 
available to the SNS, as this pattern was observed during severe chemoreflex- (i.e., 
Studies 1, 3, and 4), baroreflex- (i.e., Study 1), and metaboreflex- (i.e., Study 2) 
mediated sympathoexcitation. These data of latent, but recruitable, higher-threshold 
axons are consistent with rat work in which approximately 20% of post-ganglionic C-
fibres are quiet at rest (Habler et al. 1994), and are further supported by the concept that 
C-fibre diameter variations (~0.5 to 2.0 um) exist within the human peroneal nerve 
(Tompkins et al. 2013). However, recruitment of latent axons was not observed during 
preliminary studies using more modest levels of baroreceptor unloading (i.e., −60 
mmHg LBNP) (Salmanpour et al. 2011a), or in the current dissertation, during low 
levels of metaboreflex activation (i.e., the first three minutes of SHG exercise; Study 3). 
In these low- to moderate- stress situations, sympathetic outflow was elevated primarily 
through the increased firing of axons already-active at baseline. Therefore, it appears 
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that the option to recruit latent neural sub-populations is reserved for severe stress 
scenarios requiring high sympathetic drive. In this sense, original hypotheses from 
Macefield and colleagues (Macefield & Wallin, 1999), in which they suggested that 
recruitment of new axons may be a primary mechanism by which sympathetic 
activation is achieved, are confirmed presently. However, it appears that a threshold for 
recruitment of these latent sub-populations exists that varies with stress severity (i.e., 
reserved for severe stress). Therefore, during low- to moderate- levels of stress, the 
SNS elevates sympathetic neural drive through increased firing of lower-threshold 
axons (i.e., those already-active at baseline), whereas during severe stress scenarios, 
latent sub-populations of higher-threshold sympathetic axons are also recruited to help 
achieve the high levels of sympathetic outflow necessary to maintain cardiovascular 
homeostasis. As such, the SNS operates on a principle of ordered recruitment, similar to 
that of the skeletal motor system during the generation of ever-increasing muscular 
contraction force (i.e., Henneman’s size principle) (Henneman et al. 1965). 
Furthermore, results from Study 2 suggest that peripheral-reflex mechanisms play a 
dominant role in mediating this recruitment option. Specifically, latent, higher-
threshold axons were present (i.e., recruited) towards the end of fatiguing SHG 
exercise, and importantly, persisted throughout the PECO phase (i.e., in the absence of 
central, volitional factors). However, this important finding pertains to a metaboreflex-
model, and, therefore, whether this conclusion applies across all reflexes will require 
future study. Yet, central factors likely play a small and insignificant role during LBNP 
(i.e., Study 1), lending further support to the concept that peripheral sensory 
mechanisms are responsible for mediating this recruitment strategy. Nonetheless, the 
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present studies confirm the presence of neural coding patterns in the SNS, reflecting 
both rate- and population coding strategies in response to acute reflex-mediated 
sympathoexcitatory stress.  
Another major and novel finding of this series of studies is that, in addition to 
actual recruitment, the SNS exhibits a third strategy to alter efferent sympathetic 
outflow in response to physiologic stress; that is, the ability to modify acutely synaptic 
delays and/or central processing times. Specifically, the AP cluster size-latency profile 
was shifted acutely downward during maximal voluntary apnea (i.e., Studies 1 and 3) 
and towards the end of fatiguing SHG exercise (i.e., minutes four and five; Study 2), 
such that the latency of all corresponding APs with similar peak-to-peak amplitudes 
(i.e., AP clusters) was reduced during severe stress. Stated differently, lower-threshold 
axons were recruited with a shorter latency during reflex-mediated stress. In line with 
these observations, a similar systemic downward shift in the AP cluster size-latency 
profile was found during the Valsalva maneuver (Salmanpour et al. 2011b). These 
findings suggest the possibility of a neural short-cut somewhere within the neural 
reflex-arc; however, the exact mechanism(s) and/or source(s) of these synaptic delay 
changes cannot be discerned from the current analyses and will require future study. 
Interestingly, in contrast to voluntary apnea (i.e., Studies 1 and 3) and SHG exercise 
(i.e., Study 2), during −80 mmHg LBNP-induced baroreceptor unloading (i.e., Study 1), 
the AP cluster size-latency profile was shifted acutely upward, such that all APs were 
recruited with a slower latency during lower body suction. The physiological relevance 
of this observation is unknown. Nevertheless, the common pattern of a systemic shift to 
shorter reflex latency during maximal voluntary apnea (i.e., Studies 1 and 3), the 
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Valsalva maneuver (Salmanpour et al. 2011b), and towards the end of fatiguing SHG 
exercise, but not during PECO (i.e., Study 2), suggests that central, perceptual factors 
may play a role in mediating the synaptic delay component of sympathetic neural 
discharge. Furthermore, just like for that observed in the recruitment of latent neural 
sub-populations, it seems that a threshold level of stress (or perception of stress) exists 
for this recruitment option; that is, despite central, volitional factors being active 
throughout all five minutes of SHG (i.e., Study 2), a downward shift in the AP cluster 
size-latency profile was not observed until minutes four and five of exercise, when 
levels of perceived stress were likely quite high. Nonetheless, in line with early theories 
from Wallin et al. (1994), it appears that acute malleability of synaptic delays and/or 
central processing times exists as an option available to the SNS to alter sympathetic 
drive.  
Furthermore, findings from Study 3 provide the first insight into the malleability 
of these sympathetic neural recruitment strategies with increasing age and 
cardiovascular disease. Importantly, it was demonstrated that the sympathetic 
dysregulation commonly observed at rest with age and cardiovascular disease extends 
to the neural coding patterns used by the SNS to respond to acute physiologic stress. 
Specifically, while the ability to acutely modify synaptic delays and/or central 
processing times appears preserved, both the ability to increase within-burst firing 
frequency of already-recruited axons, and importantly, the capacity of the SNS to 
recruit latent sub-populations of higher-threshold axons are reduced with healthy aging 
and perhaps lost altogether with CAD. Therefore, aging, and even more so, 
cardiovascular disease, impairs sympathetic axonal recruitment during apneic stress. 
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However, future study is needed to assess recruitment responses to additional reflex 
stimuli (i.e., baroreflex, metaboreflex, cold pressor test, etc.) to determine if the 
presently observed impairment in neural discharge patterns with aging and 
cardiovascular disease is specific to the apnea maneuver itself, or whether it represents 
a generalized impairment across reflexes. 
 Finally, results from Study 4 suggest that, while voluntary apnea appears to 
provide the most robust stimulus for sympathetic neural recruitment (Steinback et al. 
2010), the response is largely due to the lack of ventilation itself. That is, increased 
firing of already-active axons, and also, the recruitment of latent, higher-threshold 
axons, is largely restrained/inhibited by the act of breathing, despite similar and/or 
greater levels of severe chemoreflex stress. Therefore, the lack of ventilation per se, 
rather than the increasing chemical drive, appears largely responsible for the robust 
increases in sympathetic nerve activity observed during apnea. 
6.3 Perspectives and Significance 
The findings of the studies contained herein enhance our understanding of how 
the SNS is activated during reflex-mediated physiological stress, and, importantly, 
provide a novel perspective on sympathetic neural recruitment that may offer additional 
insight into the complex nature of sympathetic neurovascular control in health and 
disease. For example, the patterning of sympathetic neural discharge likely exerts 
important influences on neurotransmitter release which, in turn, likely affects the end-
organ homeostatic response. Indeed, the pattern of nerve discharge frequency appears to 
affect neurotransmitter release, whereby ATP is dominantly released during low 
frequency nerve activation (Todorov et al. 1994), followed by NE release at higher 
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frequencies (Stjärne & Brundin, 1977), and finally, NPY release at even higher 
frequencies (Pernow et al. 1989). However, the effect of increased firing probabilities 
and recruitment of latent axons on neurotransmitter release patterns and the end-organ 
vascular response (i.e., ‘neurovascular transduction’) remains to be determined. Yet, it 
appears reasonable that these recruitment strategies may code for and/or combine to 
elicit different functional responses within the end-organ, that, in turn, optimize the 
ability of the SNS to buffer acute homeostatic perturbation. Indeed, efforts from the 
integrated MSNA neurogram have demonstrated that total burst activity, likely 
reflective of the integration and details of these sympathetic axonal recruitment patterns 
(i.e., increased firing probability, latent neural sub-populations, synaptic delays, etc.), 
influence directly the magnitude of decrease in leg vascular conductance (Fairfax et al. 
2013). Nonetheless, the exact role(s) of these recruitment strategies available to the 
SNS in the overall sympathetic neuro-circulatory control complex remains to be 
discovered.  
 Furthermore, the data from this dissertation suggest that there are implications 
of these recruitment strategies for cardiovascular disease, which, by extension, may 
provide novel mechanistic insight into the aberrant sympathetic control seen in certain 
cardiovascular-related pathologies. For example, findings of exaggerated sympathetic 
and pressor responses to exercise in certain pathologies like hypertension (Delaney et 
al. 2010) and chronic heart failure (Notarius et al. 2001; Murai et al. 2009) point to 
abnormal central features of sympathetic neural recruitment. Yet, how these 
observations integrate with the current observations of diminished recruitment in CAD 
patients remains to be investigated. Nonetheless, the current analytical technique may 
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offer a novel and innovative approach in the understanding of the mechanisms 
contributing to abnormal sympathetic discharge patterns in humans. Certainly, these 
important issues warrant further study.  
6.4 Conclusion 
In conclusion, the series of studies contained within this dissertation confirm the 
presence of neural coding patterns in efferent post-ganglionic sympathetic nerve 
activity, and further, offer novel insight into the recruitment strategies used by the SNS 
to respond to homeostatic challenge. Specifically, in response to acute physiological 
stress, the SNS has options to increase the firing frequency of already-active, lower-
threshold axons, recruit latent sub-populations of larger-sized, higher-threshold axons, 
as well as modify acutely synaptic delays and/or central processing times. The 
recruitment of latent neuronal sub-populations represents a reflex-independent strategy 
within the SNS that is reserved for severe stress scenarios requiring high sympathetic 
outflow, and further, is likely mediated via peripheral-reflex sensory mechanisms. 
However, it appears that the capacity of the SNS to recruit these latent axons is reduced 
with aging and perhaps lost altogether in cardiovascular disease. In contrast, the 
synaptic delay component of efferent nerve discharge is reflex-specific, is influenced by 
central, perceptual factors, and appears preserved with increasing age and 
cardiovascular disease. 
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